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A B S T R A C T
Background
Improving upper limb function is a core element of stroke rehabilitation needed to maximise patient outcomes and reduce disability.
Evidence about effects of individual treatment techniques and modalities is synthesised within many reviews. For selection of effective
rehabilitation treatment, the relative effectiveness of interventions must be known. However, a comprehensive overview of systematic
reviews in this area is currently lacking.
Objectives
To carry out a Cochrane overview by synthesising systematic reviews of interventions provided to improve upper limb function after
stroke.
Methods
Search methods: We comprehensively searched the Cochrane Database of Systematic Reviews; the Database of Reviews of Effects; and
PROSPERO (an international prospective register of systematic reviews) (June 2013). We also contacted review authors in an effort to
identify further relevant reviews.
Selection criteria: We included Cochrane and non-Cochrane reviews of randomised controlled trials (RCTs) of patients with stroke
comparing upper limb interventions with no treatment, usual care or alternative treatments. Our primary outcome of interest was
upper limb function; secondary outcomes included motor impairment and performance of activities of daily living. When we identified
overlapping reviews, we systematically identified the most up-to-date and comprehensive review and excluded reviews that overlapped
with this.
Data collection and analysis: Two overview authors independently applied the selection criteria, excluding reviews that were superseded
by more up-to-date reviews including the same (or similar) studies. Two overview authors independently assessed the methodological
quality of reviews (using a modified version of the AMSTAR tool) and extracted data. Quality of evidence within each comparison in
each review was determined using objective criteria (based on numbers of participants, risk of bias, heterogeneity and review quality) to
apply GRADE (Grades of Recommendation, Assessment, Development and Evaluation) levels of evidence. We resolved disagreements
through discussion. We systematically tabulated the effects of interventions and used quality of evidence to determine implications for
clinical practice and to make recommendations for future research.
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Main results
Our searches identified 1840 records, from which we included 40 completed reviews (19 Cochrane; 21 non-Cochrane), covering
18 individual interventions and dose and setting of interventions. The 40 reviews contain 503 studies (18,078 participants). We
extracted pooled data from 31 reviews related to 127 comparisons. We judged the quality of evidence to be high for 1/127 comparisons
(transcranial direct current stimulation (tDCS) demonstrating no benefit for outcomes of activities of daily living (ADLs)); moderate
for 49/127 comparisons (covering seven individual interventions) and low or very low for 77/127 comparisons.
Moderate-quality evidence showed a beneficial effect of constraint-inducedmovement therapy (CIMT),mental practice,mirror therapy,
interventions for sensory impairment, virtual reality and a relatively high dose of repetitive task practice, suggesting that these may be
effective interventions; moderate-quality evidence also indicated that unilateral arm training may be more effective than bilateral arm
training. Information was insufficient to reveal the relative effectiveness of different interventions.
Moderate-quality evidence from subgroup analyses comparing greater and lesser doses of mental practice, repetitive task training and
virtual reality demonstrates a beneficial effect for the group given the greater dose, although not for the group given the smaller dose;
however tests for subgroup differences do not suggest a statistically significant difference between these groups. Future research related
to dose is essential.
Specific recommendations for future research are derived from current evidence. These recommendations include but are not limited to
adequately powered, high-quality RCTs to confirm the benefit of CIMT, mental practice, mirror therapy, virtual reality and a relatively
high dose of repetitive task practice; high-quality RCTs to explore the effects of repetitive transcranial magnetic stimulation (rTMS),
tDCS, hands-on therapy, music therapy, pharmacological interventions and interventions for sensory impairment; and up-to-date
reviews related to biofeedback, Bobath therapy, electrical stimulation, reach-to-grasp exercise, repetitive task training, strength training
and stretching and positioning.
Authors’ conclusions
Large numbers of overlapping reviews related to interventions to improve upper limb function following stroke have been identified,
and this overview serves to signpost clinicians and policy makers toward relevant systematic reviews to support clinical decisions,
providing one accessible, comprehensive document, which should support clinicians and policy makers in clinical decision making for
stroke rehabilitation.
Currently, no high-quality evidence can be found for any interventions that are currently used as part of routine practice, and evidence is
insufficient to enable comparison of the relative effectiveness of interventions. Effective collaboration is urgently needed to support large,
robust RCTs of interventions currently used routinely within clinical practice. Evidence related to dose of interventions is particularly
needed, as this information has widespread clinical and research implications.
P L A I N L A N G U A G E S U M M A R Y
Interventions to improve arm and hand function in people after stroke
Research question
Which interventions help to promote arm and hand recovery after a person has had a stroke?
Background
Problems with arm function (upper limb impairments) are very common after a stroke. These upper limb impairments commonly
include difficulty moving and co-ordinating the arms, hands and fingers, often resulting in difficulty carrying out daily activities such
as eating, dressing and washing. More than half of people with upper limb impairment after stroke will still have problems many
months to years after their stroke. Improving arm function is a core element of rehabilitation. Many possible interventions have been
developed; these may involve different exercises or training, specialist equipment or techniques, or they could take the form of a drug
(pill or injection) given to help arm movement.
Upper limb rehabilitation after stroke often involves several different interventions and generally requires the co-operation of the patient,
carers and rehabilitation team.
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To help people easily access information about effective interventions, and to help them compare the effects of different interventions,
we have carried out a Cochrane overview. We aimed to bring together all systematic reviews of interventions provided to improve upper
limb (arm) function after stroke.
Review characteristics
We searched for Cochrane and non-Cochrane reviews of the effectiveness of interventions to improve arm function after stroke. We
included 40 systematic reviews (19 Cochrane reviews and 21 non-Cochrane reviews). The evidence is current to June 2013.
The reviews covered 18 different types of interventions, as well as the dose of the intervention and the setting in which the intervention
was delivered. These reviews varied in relation to the populations included (initial upper limb impairment and stroke severity) and in
relation to the comparison groups included (which were given control interventions, no treatment and conventional therapy).
We extracted details of 127 comparisons that had been explored within the reviews. These showed the extent to which different
interventions had had an effect on upper limb function, upper limb impairment and ability to perform activities of daily living.
Key results
Currently no high-quality evidence is available for any interventions currently used as part of routine practice. Evidence is insufficient
to show which are the most effective interventions for improving upper limb function.
Moderate-quality evidence suggests that the following interventions may be effective: constraint-induced movement therapy (CIMT),
mental practice, mirror therapy, interventions for sensory impairment, virtual reality and a relatively high dose of repetitive task practice.
Moderate-quality evidence also indicates that unilateral arm training (exercise for the affected arm) may be more effective than bilateral
arm training (doing the same exercise with both arms at the same time).
Some evidence shows that a greater dose of an intervention is better than a lesser dose. Additional research to identify the optimal dose
of arm rehabilitation is essential.
Bringing together all available systematic review evidence has helped us make specific recommendations for future research. These
recommendations include (but are not limited to) large randomised controlled trials of CIMT, mental practice, mirror therapy and
virtual reality. We recommend high-quality up-to-date reviews and further primary research for several specific interventions.
Quality of the evidence
We judged the quality of evidence to be high in relation to one intervention: a type of brain stimulation called transcranial direct
current stimulation (tDCS), which is not currently used within routine practice. This high-quality evidence shows that tDCS does not
improve people’s ability to perform activities of daily living.
We judged the quality of evidence to be moderate for 48 comparisons (covering seven individual interventions) and low or very low for
76 comparisons. Reasons for downgrading the quality of evidence to moderate, low or very low include small numbers of studies and
participants, poor methodological quality or reporting of studies included within reviews, substantial heterogeneity (variation) between
study results and poor review quality or reporting of methods.
We conclude that high-quality evidence related to the effectiveness of interventions to improve upper limb function is urgently needed,
in particular for those interventions for which moderate-quality evidence currently suggests a beneficial effect.
B A C K G R O U N D
Stroke is the thirdmost common cause of death and themain cause
of acquired adult disability in high-income countries (Warlow
2008). This affects from 112 to 223 per 100,000 people in high-
income countries, and from 73 to 165 per 100,000 in low-in-
come countries (Feigin 2009). The annual incidence of stroke is
795,000 people in the USA (Go 2013), more than 110,000 in
England (NHS Choices) and around 15,000 in Scotland (Stroke
in Scotland 2010). Motor impairment, typically affecting move-
ment of the face, arm and leg of one side of the body, affects about
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80% of stroke survivors (Langhorne 2009). Upper limb (i.e. arm,
hand and/or finger) motor impairments are often persistent and
disabling (Lai 2002); only half of all stroke survivors with an ini-
tial plegic (paralysed) upper limb regain some useful upper limb
function after six months (Kwakkel 2003), and, of those with ini-
tial arm impairment, 50% have problems with arm function four
years post stroke (Broeks 1999). Activities of daily living (ADLs)
largely depend on arm function (Sveen 1999), particularly for
personal activities such as feeding, dressing and grooming. One
year after stroke, armmotor impairment is associated with anxiety
(Morris 2013) and poorer perception of health-related quality of
life (Franceschini 2010) and subjective well-being (Wyller 1997).
Therefore, improving upper limb function is a core element of re-
habilitation after stroke to maximise recovery (Langhorne 2003).
Therapists have developed many diverse techniques that aim to
rehabilitate arm function after stroke. Evidence on the effects of
individual treatment techniques/modalities has been synthesised
in a large number of reviews, including at least 11 Cochrane re-
views. Most Cochrane reviews compare an intervention versus a
placebo intervention, no intervention or usual care, whereas, in
practice, clinicians need information to judge the relative effec-
tiveness of different interventions when selecting the most effec-
tive treatment. Therefore, this Cochrane overview will draw to-
gether information from systematic reviews of all interventions to
improve arm function after stroke to help inform clinicians and
policy makers.
Description of the condition
A stroke causes damage within the brain that can directly affect
movement and sensation of the arm. Damage to the sensory mo-
tor cortex, subcortical areas and/or cerebellum can result in the
following.
• Loss of motor control, which causes difficulties with, or
prevents, the voluntary production of movement, and
compromises dexterity and co-ordination of the fingers, hands
and arms.
• Sensory and proprioceptive deficits, which reduce
awareness of limb position and movement.
The reduced level of movement predisposes to changes in muscle,
connective and neural tissues, resulting in several secondary prob-
lems, which may include the following.
• Shortening of muscles (’contracture’) and weakening of
muscles (’paresis’).
• Disordered muscle contraction (’spasticity’).
• Compromised motor and sensory nerve function, as unused
neural pathways lose connectivity.
• Shoulder subluxation (partial, temporary dislocation of the
shoulder joint), caused by lack of motor control and muscle
weakness in the rotator cuff muscles.
• Pain, which is a common complication, often secondary to
shoulder subluxation, but also commonly associated with the
musculoskeletal changes caused by immobility.
These impairments make many ADLs difficult, especially those
activities that depend on co-ordination between both upper limbs
or fine finger movements. With time, the tendency is to use the
unaffected limb predominantly and to disregard the affected limb,
thereby developing learned non-use (Taub 2006). Mood and cog-
nitive ability can be adversely affected by stroke, further dimin-
ishing functional abilities, and arm motor impairment itself can
impact well-being. The ensuing loss of meaningful activity tends
to reduce participation in society.
Description of the interventions
Professionals responsible for the delivery of upper limb rehabilita-
tion interventions most commonly consist of physical therapists
and occupational therapists. However, other health professionals
(e.g. nurses, doctors) and non-health professionals (e.g. exercise
professionals, carers, family members) may also contribute to the
delivery of interventions (Coupar 2012; Harris 2010a). Therapy
is usually provided to patients during their period of hospitalisa-
tion, during early supported discharge at home or in outpatient
settings. In some countries, patients are admitted to rehabilitation
centres once they are medically stable. Therapy may be provided
individually or to groups of stroke survivors in classes.
Patients and carers frequently report that they feel they would
benefit from continued rehabilitation: Results of a survey of UK
stroke survivors indicate that 43% wanted additional therapy,
most commonly more physiotherapy (Stroke 2012). Similar un-
met needs have been reported for upper limb rehabilitation by
Canadian stroke survivors (Duxbury 2012; Vincent 2007). After
discharge from formal rehabilitation, stroke survivors may enrol
in fitness centres (Best 2012) or may utilise commercially available
gaming products to continue exercising for therapeutic purposes
(Anderson 2010; Elsworth 2008; Saposnik 2010; Yavuzer 2008).
Effective upper limb interventions that can be delivered across
the stroke pathway-in hospitals and rehabilitation, outpatient and
community settings-are clearly needed. In addition to interven-
tions that can be delivered by healthcare professionals, self-man-
agement strategies must be available to promote more indepen-
dent recovery among stroke survivors.
Generally, the interventions used by rehabilitation professionals
will consider each patient’s goals and will be selected after assess-
ment of a patient’s upper limb impairments, together with their
effects on activity and level of participation (Langhorne 2011).
However, upper limb rehabilitation interventions could also be
delivered as part of a group exercise class or circuit training. Ad-
ditional interventions may be selected by patients, for example,
commercial gaming devices or fitness equipment that can be used
at home or in fitness centres.
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A wide range of interventions can be delivered in an attempt to
improve the function of upper limbs after stroke. Such interven-
tions may be aimed at particular impairments (e.g. muscle weak-
ness) or functional movements (e.g. grasp and release). Upper limb
interventions may be used separately or may be combined so that
treatment addresses the multi-factorial nature of the deficits that
may follow stroke, integrating a number of techniques to address
problems and secondary complications. Therefore upper limb re-
habilitation after stroke is likely to involve a complex intervention
that requires the co-operation of patient, carers and the rehabili-
tation team.
Upper limb rehabilitation interventions may be delivered at differ-
ent doses, with ’dose’ referring to the intensity (effort), frequency
and duration (time) of an intervention (Bosch 2014; Cooke 2010;
Kwakkel 2006; Page 2012). The dose of an intervention is likely to
affect the outcome (Cooke 2010; Kwakkel 2006). (See Published
notes for full definitions of doses used within this Overview.)
Interventions relevant to this Cochrane overview include but are
not limited to the following, which are listed here in alphabetical
order.
Bilateral arm training
Simultaneous bilateral arm training uses activities for which both
arms perform identical movements at the same time (McCombe
Waller 2008; Mudie 2000; Stewart 2006). Different forms of si-
multaneous bilateral arm training are available. Some use ’free’
arm movements, and others use mechanical or robotic devices to
drive active or passive movement of the affected limb through
identical movement of the less-affected upper limb. The key in-
gredient of this form of intervention is interlimb coupling, which
is thought to rebalance interhemispheric inhibition, activate the
affected hemisphere (Stinear 2008) and improve motor control
within the affected limb (McDermott 2012).
Biofeedback
Biofeedback provides enhanced awareness of movement or func-
tion, with the goal of improving voluntary control of that move-
ment or function. Electromyographic (EMG) biofeedback pro-
vides information aboutmuscle activity, which is detected through
surface electrodes placed on the skin, or through needle or fine-
wire electrodes inserted into the muscle, and is fed back to the
patient via electrical activity displayed on a visual display unit or
by an auditory signal (Crow 1989; Wolf 1983).
Bobath approach
The Bobath approach, which is classed as a ’neurodevelopmental
technique,’ was originally thought to reduce abnormal tone by
positioning, while handling techniques are used to facilitate nor-
mal movement (Bobath 1990; Davies 1985; Davies 1990; Raine
2009). This approach has evolved over time (Lennon 2000) and
has recently been defined as “a problem solving approach to the
assessment and treatment of individuals with disturbances of func-
tion, movement, and postural control due to a lesion of the cen-
tral nervous system” (Kollen 2009). The content of interventions
based on the Bobath approach has beenwidely debated, and lack of
agreement on what constitutes ’Bobath’ poses challenges (DeJong
2004; Langhammer 2012; Mayston 2008; Tyson 2009).
Brain stimulation
Transcranial direct current stimulation (tDCS)
This is thought to have an effect similar to that of TMS (above),
but it is applied through two surface electrodes placed on the skull
(Dayan 2013; Hummel 2006).
Transcranial magnetic stimulation (TMS)
TMS involves stimulation of the brain applied via a wired coil
positioned on the head over the sensory motor area (Dayan 2013;
Hummel 2005). Rapidly changing magnetic fields, initiated by a
brief high-intensity electrical current, stimulate the central nervous
system. Repetitive pulse TMS (rTMS) is proposed as a treatment
for people with stroke, as it can be used to modulate excitability in
the cerebral cortex over longer periods of time than are required
by other types of TMS (Kagan 2012a).
Complementary interventions
Complementary therapies that can be used to promote upper
limb function after stroke include traditional Chinese therapies,
acupuncture and homeopathy. With acupuncture, needles are in-
serted at meridian points or trigger points with the objective of
improving neurological function after stroke (Wu 2009).
Constraint-induced movement therapy (CIMT)
InCIMT, or ’forced use therapy,’ the non-affected hand is placed in
an arm sling or,more commonly, in amitt that prevents its use dur-
ing fine movement (Page 2001; Page 2002; Taub 1993; Uswatte
2006; Wolf 2006). With the non-affected hand ’constrained,’ op-
erant conditioning (i.e. learning through consequences) is used to
increase task difficulty for the affected hand in small amounts, so
the stroke survivor can succeed in using the affected limb. Progres-
sion is therapeutically directed by using these shaping techniques,
thereby reducing learned non-use.
Electrical stimulation
Electrical stimulation involves stimulation applied to muscles
through surface electrodes or percutaneous electrodes (which pen-
etrate the skin). Electrical stimulation is usually delivered with
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the aim of strengthening a muscle contraction or improving vol-
untary motor control, or both. Functional electrical stimulation
(FES) involves stimulation aimed at replacing or assisting a vol-
untary muscle contraction during a functional task (Roy 2010).
Several stimulators are available; these provide single-channel or
multi-channel stimulation that can be programmed to an appro-
priate frequency, bandwidth and strength, to control the duration
of stimulation and the duration of intervals between stimulation.
Muscles can be stimulated cyclically, triggered by movement or
triggered electromyographically (by initiation of muscle activity
within themuscle to be stimulated). Electrical stimulation applied
to the whole hand through a glove may provide sensory stimula-
tion (Dimitrijevic 1996; Pomeroy 2006).
’Hands-on’ therapy (manual therapy techniques)
The arm and hand joints may be moved by a therapist, who may
provide partial or full assistance if the patient’s active control is
inadequate: Such movement may be aimed at maintaining joint
and soft tissue mobility. Passive or active movements of the wrist
and interphalangeal and metacarpophalangeal joints of the fingers
and thumb can be used to stretch the wrist and finger muscles
to their maximum pain-free range. Mobilisation of an accessory
movement of a small joint by a therapist may be applied to main-
tain or increase movement of these joints, or to treat joint pain.
Mental practice
Exercise-based and functional movement-based interventions can
involve overt as well as covert techniques to promote skill acquisi-
tion (Jeannerod 2005). Covert techniques commonly involve ob-
servational learning and mental practice. Mental practice, some-
times calledmental imagery ormotor imagery, is a trainingmethod
that involves no actual movement. However, during mental prac-
tice training, mental rehearsal is often combined with (or followed
by) physical practice when possible. Mental practice training may
focus on goal attainment or anxietymanagement, but the type used
most often in stroke rehabilitation involves cognitive rehearsal of
specific activities by imagining task performance (Page 2007).
Mirror therapy
Exercise-based interventions can use stimulation of other (non-
motor) pathways to promote functional movement (Johannson
2012). Mirror therapy is based on visual stimulation. In mirror
therapy, a mirror is placed in the patient’s sagittal plane, thus re-
flecting the non-affected side as if it were the affected side, so that
movements of the non-affected limb give the illusion that the af-
fected limb is moving (Michielsen 2010).
Music therapy
Music therapy may be used to stimulate movement, cognition and
speech, to enhance relaxation or to reduce pain; it is generally
delivered by certified/registered music therapists. Music therapy
interventions may include listening and moving to music, per-
forming, improvising or composing music, singing or performing
vocal activities. Music may be combined with other modalities.
Music can be used to cue rhythmical functional movement: This
is known as rhythmical auditory stimulation (Bradt 2010).
Pharmacological interventions
A number of systemic drugs (drugs that affect the whole body) are
generally used to reduce spasticity, including baclofen, diazepam
and dantrolene. Botulinum toxin can be injected to provide a focal
treatment when spasticity in a specific muscle or muscle group is
the cause of problems (Cousins 2010; Shaw 2011).
Repetitive task training
Repetitive task training involves the repeated practice of functional
tasks (whole task practice when possible), combining elements of
intensity of practice and functional relevance (French 2007) (see
also ’Task-specific training,’ below). Repetitive task training-when
progressed appropriately-is thought to reduce muscle weakness
and to form the physiological basis of motor learning (Butefisch
1995). Key components of skill acquisition, such as active cogni-
tive involvement, functional relevance of the task and knowledge
of results and performance, are hypothesised to enhance learning
during repetitive task training (Schmidt 2014). These components
are central to the so-called ’movement science’ approach to stroke
rehabilitation (Carr 1987; Carr 1990; Carr 1998).
Findings from animal research have shown that neuroplastic
changes emerge only after new skills are learned-not after repeti-
tive movement (Nudo 2000; Nudo 2003a; Nudo 2003b). Hence,
it is important to emphasise that the ’repetition’ within repetitive
task training refers to repeated practice of new functional skills-
not to the reproduction of identical movements per se.
Robotics
Electromechanical and robotic devices are devices that can move
passive limbs, while providing assistance or resistance to move-
ment of a single joint or control of intersegmental co-ordination
(Mehrholz 2012). Robotic devices may be used to deliver or en-
hance repetitive task training or task-specific training, and are
thought to support motor learning and increase motor control and
strength.
Sensory interventions (interventions to improve
sensory function)
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Movement and somatosensory awareness can be enhanced in sev-
eral ways, including techniques such as sensory reeducation, tac-
tile kinaesthetic guiding, repetitive sensory practice or desensiti-
sation (Doyle 2010). Sensory and positional awareness may be
stimulated by passive or active-assisted movement, as well as by
stimulatory techniques such as stroking and tapping.
Strength training
Muscle strength training is directed at working a specific muscle,
or group of muscles, by using voluntary control. Movement may
be assisted or resisted by a therapist or by gym equipment (Harris
2010b). Alternatively, exercises may be done in classes directed
by a therapist or exercise professional, may utilise various exercise
machines or may involve circuit training.
Stretching and positioning
Several techniques may be used to optimise joint position and
to maintain or regain soft tissue length. These techniques often
involve the use of assistive devices, such as supportive devices,
splints and orthoses. Shoulder subluxation has traditionally been
treated with supportive devices (Ada 2005). Splints are external
devices used to fix a joint in one position, often used to support
the hand or fingers in an optimal position. Orthoses are external
devices (similar to splints) applied to elbow, wrist and/or finger
joints to optimise position, provide stability and prevent, limit or
assist movement (Hoffman 2011; Lannin 2007). These may be
used alone or with electrical stimulation in a neuroprosthesis (an
orthotic device with prepositioned electrodes that assist function)
(Hendricks 2001).
Surgical interventions
Several different surgical interventions could be used to promote
upper limb function after stroke. For example, tendon surgery can
relieve shoulder pain and reduce spasticity in the upper limb after
stroke (Namdari 2012; Pomerance 1996), but it is not part of
routine clinical practice in the UK.
Task-specific training
Task-specific training, also referred to as functional task training,
involves practice of tasks relevant to daily life, including part-
and whole-task practice (Van Peppen 2004). The ’motor learning,’
’motor relearning’ or ’movement science’ approach involves func-
tional or task-specific training (Carr 1987; Carr 1990; Carr 1998)
and is often supplemented by other modalities, such as assistive
technologies (Timmermans 2009). Task-specific training may be
carried out as a form of repetitive task training (see above).
Reach-to-grasp exercise is a form of task-specific training, as reach-
to-grasp is a common functional task performed by the upper
limb.
Virtual reality
Virtual reality involves interactive simulations created with com-
puter hardware and software to provide a simulated practice en-
vironment, as well as feedback on movement execution or goal
attainment, or both (Laver 2011; Merians 2006). Virtual reality
enables people to engage in activities within an environment that
appears and feels similar to real-world objects and events, using
devices such as a keyboard and a mouse, or through multi-modal
devices such as a wired glove (Kagan 2012b). Virtual reality may
also be used with robotic devices that assist or resist movement
(see above).
How the intervention might work
Rehabilitation of the arm following stroke is a complex interven-
tion that integrates different modalities to address deficits that
are often multi-factorial, with clinicians individualising treatment
programmes in an attempt to optimise outcomes for patients. Un-
derstanding of the precise mechanisms of action for many of the
interventions delivered by clinicians is limited. The ways that in-
terventions are thought to work can be described by using several
different frameworks. The International Classification of Func-
tioning,Disability andHealth, knownmore commonly as the ICF,
can be used to describe whether treatments are aimed at reducing
impairments, increasing activity or increasing participation (ICF
2001). Alternatively, treatments can be described as being used to
prevent or reduce the development of complications (e.g. shorten-
ing of muscles (contractures)); to restore original status or to sub-
stitute with compensatory mechanisms (altered neural pathways
ormovements); or to utilise compensatory devices (e.g. neuropros-
theses) (Dobkin 2005). Treatments may also prime (act to pre-
pare the sensory motor system for practice) or augment (enhance
sensorimotor function during practice), thereby maximising the
benefits derived from task-specific practice (Pomeroy 2011).
For the purposes of this review, we have used a taxonomy of re-
habilitation interventions based on work arising from a major
multi-site stroke rehabilitation study (DeJong 2004). This taxon-
omy provides a model that describes key types of rehabilitation
interventions (Figure 1) and attempts to encapsulate the diver-
sity and complexity of rehabilitation treatments. This taxonomy
shows that neuromuscular and musculoskeletal interventions may
work by leading to and supporting the practice of functional ac-
tivities. Additional interventions using cognitive, perceptual and
sensory attributes can be used to enhance skill acquisition. Such
interventions may be delivered by the therapist with or without
devices (e.g. orthoses) or additional modalities (e.g. electrical stim-
ulation). These interventions may be delivered in various settings
that may impact the people available to provide the intervention
or the setting (e.g. hospital or home) of such work, and may in-
fluence motivation and integration with ADLs.
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Figure 1. Taxonomy of rehabilitation interventions used within this overview.Key: CIMT: constraint-induced
movement therapy; NDT: neurodevelopmental treatment; PNF: proprioceptive neuromuscular facilitation;
Tx: treatment.
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References relevant to the intervention mechanisms explained in
this section are cited within Description of the interventions. The
ways in which individual treatment components may work are
briefly outlined below.
Musculoskeletal interventions
Joint contractures and reduced range of motion at joints can re-
sult from various factors, including reduced muscle length and
increased stiffness of muscle and connective tissue. The tendency
toward progressive loss of range may be reduced by moving the
joints through a full range of motion with pressure at the end
of the range; stiffness may be reduced by repetitive movements.
Suchmotion can be delivered bymanual therapy or self-stretching.
Mechanical and electromechanical devices may provide or assist
movement, and electrical stimulation can cause muscle contrac-
tions that may also have the effect of lengthening the antagonist
of the stimulated muscles and causing joint motion.
Muscle weakness may be reduced through exercises that utilise
muscles or by electrical stimulation of muscles. Muscle can be
strengthened by graduated resistance exercises. When muscles are
unable to move the limb against gravity, manual support provided
by the therapist or a weight-relieving system (e.g. robot) allows
weakened muscles to produce limb movement. Electrical stimu-
lation can be used to strengthen muscles when the muscle con-
traction produced by stimulation is of adequate intensity. Some
improvements in muscle strength and endurance may be gained
during repetitive task training.
Neuromuscular interventions
Normal co-ordination can be impeded by stroke. Abnormalmove-
ment synergies may be seen (e.g. wrist flexion with finger flexion
when attempting to grasp), thus some practitioners consider that
movement needs reeducation.
Bilateral training is thought to utilise interlimb coupling, so that
the intact brain hemisphere facilitates activation of the damaged
hemisphere.
Repetitve task training may augment the activity of neural path-
ways that underlie specific functions and promote acquisition of
the tasks practised.
CIMT is used to overcome the acquired behaviour of non-use
of the affected arm after stroke. It focuses movement practice on
the affected arm and hand during prolonged periods of intense,
progressively structured activities, for which success is rewarded
with enthusiastic praise. Use of the non-affected arm and hand is
inhibited by use of a constraining device, such as a mitt or an arm
sling.
In mirror therapy, the same cortical areas of the brain are active
during action-and observation of action-of the reflected image of
unimpaired arm movement: This affects the excitability of the
motor area of the affected limb and limits the development of
learned non-use.
Mental practice has been used to enhance elite performance in
sports, dance and music, and thus has potential for benefit in the
rehabilitation context. A considerable body of evidence from non-
impaired people shows that similar areas of the brain are active
whether movement is actual, observed or imagined, with the ex-
ception of the areas responsible for execution of actual movement.
Assistive devices
Awrist orthosis can support the wrist in an extended position; this
may facilitate gripping. A neuroprosthesis comprises an orthosis
together with prepositioned electrodes that are stimulated to assist
grasp and release.
Assistive modalities
Proprioceptive and other sensory deficits reduce ’normal feed-
back.’ Biofeedback systems utilise signals produced by muscle ac-
tivity to inform the user about the extent and timing of muscle
activity by means of a visual or auditory display, or both. Elec-
tromechanical (robotic) systems use actuators (complex control
mechanisms) to assist and to provide feedback on limb movement
visual display units. Alternatively, a game scenario is used to pro-
vide feedback.
Electrical stimulation may be used to reeducate movement when
the stimulator has a number of channels that can be programmed
to stimulate muscles in the desired sequence.
Sensory awareness may be increased by tactile stimulation. Electri-
cal stimulation at a sensory level can be applied via a glove, again
increasing awareness.
Non-invasive brain stimulation (TMS and tDCS) can be used
to enhance motor skills, although the specific underlying mech-
anisms of stimulation-induced effects remain largely unknown
(Dayan 2013).
Virtual reality can offer the motivation for practising specific ac-
tions at the intensity required to induce cortical reorganisation.
Most systems provide knowledge of the result (i.e. whether or
not the outcome was successful), although there is the potential
for knowledge of performance (i.e. details of the effectiveness of
a movement, for example, through provision of kinematic feed-
back). Tasks can be graded by clinicians to provide a progressively
challenging practice that can be performed without direct clinical
supervision.
Such technologies may be used individually or integrated with
other therapeutic modalities (Burridge 2010).
Pharmacological interventions
Systemic antispasticity medications, such as baclofen and di-
azepam, act on the nervous system to reduce nerve signals to mus-
cles, thereby reducing spasticity. Dantrolene acts within the mus-
cle by interfering with calcium release from the sarcoplasmic retic-
ulum, weakening muscle contractile function and thus acting as a
muscle relaxant. Spasticity can also be treated focally with injec-
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tions of botulinum neurotoxin. Within muscles, this neurotoxin
inhibits the release of acetylcholine, thereby blocking nerve im-
pulses and limiting hyperactivity in treated muscles.
Complementary medicine
Acupuncture is thought to cause biological responses within a per-
son’s biochemistry or circulation. Sensory neurons may transmit
effects distal to the needle insertion site, thus affecting various
physiological systems.
Treatment setting
Services can be delivered at different locations thatmay affect treat-
ment through environmental and societal factors. Some stroke
survivors may be motivated by group sessions. In early supported
discharge, the rehabilitation team may be able to advise on how
to integrate rehabilitation activities into home life. Accessibility to
some interventions may be restricted within some treatment set-
tings as the result of resource issues such as equipment availability
or staff training or skills.
Why it is important to do this overview
Identifying the most effective upper limb rehabilitation interven-
tions is a recognised priority for stroke research. The Chartered
Society of Physiotherapy used amodifiedDelphi technique, which
identified the top priority question for physiotherapy research in
the field of neurology as this: “What is best practice in the reha-
bilitation of the upper limb in patients with stroke with respect
to timing, content and dosage?” (Rankin 2012). Furthermore, in
our James Lind Alliance priority setting project, which involved
equal involvement among stroke survivors, carers and healthcare
professionals, the question “What are the best treatments for arm
recovery and function?” was included in the Top 10 agreed upon
research priorities, out of 226 unanswered research questions iden-
tified as relating to life after stroke (Pollock 2012).
Given the importance of upper limb rehabilitation and associated
research, it is not surprising that a substantive and growing number
of randomised controlled trials (RCTs) are examining the effec-
tiveness of rehabilitation interventions aimed at promoting upper
limb recovery (Langhorne 2009). Evidence of the effectiveness of
many of these interventions has been synthesised and summarised
within several systematic reviews. The rapidly growing body of
systematic reviews can be overwhelming for decision makers and
healthcare practitioners who do not have time to keep up-to-date
with this evidence base (Bastian 2010). Furthermore, although
Cochrane systematic reviews have synthesised available RCT evi-
dence, these reviews of upper limb interventions generally explore
the effects of specific, single, interventions compared with placebo
or control interventions (e.g. French 2007; Laver 2011; Pomeroy
2006; Sirtori 2009). Arguably, synthesis of evidence related to sin-
gle, specific upper limb interventions fails to facilitate translation
of evidence into clinical practice or decision making for which the
relative effectiveness of different treatment options must be con-
sidered (Jansen 2013). A Cochrane overview of upper limb reha-
bilitation reviews will synthesise all high-quality evidence about
upper limb rehabilitation interventions into an accessible, com-
prehensive document, thus supporting clinicians and policy mak-
ers in decision making for stroke rehabilitation (Becker 2011).
O B J E C T I V E S
To carry out a Cochrane overview by synthesising systematic re-
views of interventions provided to improve upper limb function
after stroke.
M E T H O D S
Criteria for considering reviews for inclusion
We included all reviews that met our selection criteria and that
are published in the Cochrane Database of Systematic Reviews
(CDSR) or the Database of Abstracts of Reviews of Effects
(DARE).
It has been argued that, as the quality of Cochrane systematic
reviews has consistently been found to be better than that of
non-Cochrane reviews (Delaney 2007; Farmer 2012; Jadad 1998;
Jørgensen 2008; Moher 2007; Moja 2005; Olsen 2001), the pri-
mary aim of a Cochrane overview should be to summarise mul-
tiple Cochrane intervention reviews (Becker 2011). However, as
some time has passed since some Cochrane reviews were updated,
we anticipated that some non-Cochrane reviews may be more cur-
rent. We therefore believed it was essential to consider other high-
quality reviews to ensure that our overview is as comprehensive
and current as possible. Systematic reviews included in DARE,
which comprises the results of extensive searches carried out by
the Centre for Reviews and Dissemination, at the University of
York (DARE), have been independently assessed by two overview
authors to confirm that a number of key quality criteria are met.
This application of quality criteria ensures that systematic reviews
in DARE have (1) reported inclusion or exclusion criteria, (2) em-
ployed an adequate search strategy and (3) synthesised included
studies. In addition, to be included on DARE, a review must be
considered to have assessed the quality of the included studies or
provided sufficient details about individual included studies to en-
able assessment of quality by a reader.
To be eligible for inclusion, reviews had to meet the following
criteria.
• Included RCTs. If a review included quasi-RCTs (QRCTs)
as well as RCTs, we included data from the QRCTs if they had
been pooled with data from the RCTs. However, if it was
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possible to extract data pertaining only to the RCTs, we did this
in preference to including data from QRCTs. In the event that
we included evidence from QRCTs, we planned to highlight and
discuss the implications of including this evidence. If a review
included other studies in addition to RCTs (e.g. before-and-after
studies), we included the review, but did not include the
evidence from these other study types. We excluded reviews of
other study designs or of qualitative studies.
• Included studies in which the participants are adults with a
clinical diagnosis of stroke. We included reviews that included
studies with other participants in addition to people with stroke
(e.g. adults with other neurological diseases or traumatic brain
injury) when at least 75% of the participants were stroke
patients, or when data on stroke patients had been presented and
analysed as a separate subgroup; we will highlight when data are
reported from a mixed population.
• Investigated an intervention for which the primary aim is to
improve functional recovery or to reduce impairment-or both-of
the upper limb.
• Investigated the effects of interventions for the upper limb.
This may include comparisons of interventions with control,
placebo or standard care; comparisons of one active treatment
versus another active treatment; and comparisons of different
doses, intensities or timing of delivery of the same intervention.
Whenwe identified overlapping reviews (i.e. reviews exploring the
same participants, interventions, comparisons and outcomes), we
systematically identified the most up-to-date and comprehensive
review and excluded reviews that overlappedwith this.When itwas
unclear whether reviews overlapped, we systematically explored
methodological features of the reviews and reached consensus on
which reviews should be included or excluded to avoid overlap
(see Data extraction and management for additional details).
We included any review for which the primary aim of the interven-
tion was to improve functional recovery, or reduce impairment, of
the upper limb, regardless of the outcome measures reported.
Primary and secondary outcomes of interest to this overview are
as follows.
Primary outcome
The primary outcome for the overview involved upper limb func-
tion, including measures that examine active function, dexterity,
object manipulation and reach-to-grasp, grip or pinch. For syn-
thesis and analysis within the overview, we planned to group mea-
sures of upper limb function according to whether, primarily, they
assess function of the arm (including shoulder, elbow and wrist)
or function of the hand (including fingers). This outcome can be
measured by using a range of measures including, but not limited
to, those that follow.
Arm function
• Action Research Arm Test (ARAT) (Lyle 1981) or Upper
Extremity Function Test (Carroll 1967).
• Box and Block Test (Desrosiers 1994; Mathiowetz 1985).
• Wolf Motor Function Test (WMFT) (Wolf 2001).
• Frenchay Arm Test (Heller 1987).
• Functional Test of the Hemiparetic Upper Extremity
(Wilson 1984).
• Upper Extremity Performance Test for the Elderly
(TEMPA) (Desrosiers 1993).
• Sodring Motor Evaluation of Stroke Patients-arm section
(Sodring 1995).
• Chedoke Arm and Hand Activity Inventory (Barreca 2005).
• Motor Assessment Scale-hand movement or advanced hand
movement scores (Carr 1985).
Hand function
• ABILHAND (Gustafsson 2004).
• Jebsen Hand Function Test (Jebsen 1969).
• Nine-Hole Peg Test (Kellor 1971).
• Purdue Peg Test (Desrosiers 1995).
• Stroke Impact Scale (Duncan 1999).
Secondary outcomes
Secondary outcomes include measures of motor impairment, ac-
tive movement and co-ordination and performance of ADLs and
extended ADLs.
Motor impairment (including deficits in active movement
and co-ordination)
A wide range of methods, measures and tools can be used to as-
sess motor impairment. We planned to include assessments that
could be categorised into the following four motor impairment
outcomes, using one of the measures listed.
• Motor impairment scales.
◦ Fugl-Meyer Assessment of Sensorimotor Recovery
after Stroke (upper limb section) (Fugl-Meyer 1975).
◦ Wolf Motor Function Test (WMFT) (Wolf 2001).
◦ Motricity Index (Demeurisse 1980).
◦ Rivermead Motor Assessment (arm section) (Lincoln
1979).
◦ Motor Club Assessment (Ashburn 1982).
◦ Motor Status Score (Ferraro 2002).
• Measures of movement and co-ordination.
◦ Temporal measures.
⋄ Movement time for completion of various tasks.
⋄ Number of movements executed within stated
time.
⋄ Movement speed/velocity.
◦ Spatial outcomes.
⋄ Kinematic measures.
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⋄ Spatial accuracy.
• Strength outcomes.
◦ Grip strength.
◦ Medical Research Council (MRC) Scale (MRC 1975).
◦ Dynamometer scores (including Jamar) (Bohannon
1987).
• Muscle tone/spasticity.
◦ Ashworth Scale (Ashworth 1964), or Modified
Ashworth Scale (Bohannon 1987).
◦ Electromyographic (EMG) activity.
◦ Reflex activity (e.g. H reflex).
Performance of activities of daily living
We includedmeasures of performance of ADLs including feeding,
dressing, bathing, toileting, simple mobility and transfers. Com-
mon outcome measures include global measures of ADLs, such as
Barthel ADL Index (Mahoney 1965), RivermeadADLAssessment
(Whiting 1980), Rivermead Motor Ability Scale (Collen 1991),
Rankin Scale (Bonita 1988), Functional Independence Measure
(FIM) (Keith 1987), Katz Index of Activities of Daily Living (Katz
1970) andRehabilitationActivities Profile (Van Bennekom1995).
Performance of extended activities of daily living (ADLs)
Weplanned to includemeasures of performance of extendedADLs
including shopping and household tasks. Common outcomemea-
sures can be assessed by using the following tools.
• Nottingham Extended Activities of Daily Living (Nouri
1987).
• Rivermead Extended Activities of Daily Living (Rossier
2001).
• Frenchay Activities Index (Holbrook 1983).
We also documented other outcomes reported in included reviews,
including measures of participation, mood, adverse events and
quality of life.
Search methods for identification of reviews
We searched the Cochrane Database of Systematic Reviews
(CDSR) and the Database of Reviews of Effects (DARE) (The
Cochrane Library; searched 14 June 2013).
We developed a sensitive search strategy for The Cochrane Library
with the help of the Cochrane Stroke Group Trials Search Co-
ordinator (Appendix 1).
In an effort to identify ongoing systematic reviews, we searched
for protocols of Cochrane reviews in the CDSR (The Cochrane Li-
brary; searched 14 June 2013) and PROSPERO, an international
prospective register of systematic reviews (www.crd.york.ac.uk/
prospero/; searched11 June 2013) (Appendix 2).We contacted the
authors of protocols meeting our selection criteria and included
any reviews that were completed before the end of February 2014.
When protocol or review authors had indicated when a review
should be finished, we sent reminder emails in advance of this date
to check on progress.
To ensure that data included in the overview were as current as
possible, we contacted authors of relevant reviews to ascertain de-
tails of planned updates. We also contacted authors of all relevant
Cochrane reviews, Cochrane protocols and other reviews in an
effort to identify additional relevant systematic reviews.
We searched for relevant reviews in all languages and arranged
translation when necessary.
Data collection and analysis
Selection of reviews
Two overview authors (SF and AP) independently assessed titles
and abstracts of records identified by the electronic searches and
excluded obviously irrelevant reviews. We obtained the full text
of the remaining reviews, then two overview authors (SF and AP)
independently selected systematic reviews including trials thatmet
the following criteria.
• Included adults with a clinical diagnosis of stroke.
• Investigated any intervention targeted at improving
functional recovery of the upper limb.
• Assessed outcomes of upper limb motor function, ADLs,
motor impairment, extended ADLs, participation, quality of life
or adverse events.
If disagreement arose between these two overview authors, they
consulted a third overview author (FvW) to reach consensus
through discussion.
Two overview authors (FvW and JM) independently assessed ar-
ticles published in German, and we assessed articles published in
Chinese with the assistance of aChinese speaker with experience in
appraising stroke rehabilitation trials (Pei LingChoo).We planned
to seek translations of publications in other languages if this was
required.
Data extraction and management
Two overview authors (SF and AP) extracted data independently.
They resolved disagreements by discussion, with assistance from a
third overview author (FvW), if necessary. We used a data collec-
tion form thatwas specifically designed andpiloted by the overview
author team.
Onto this form, we extracted and recorded key features of each
review including details of the aims and rationale, types of studies,
participants, interventions, comparisons, outcomes assessed and
date of last search.
We systematically synthesised, using a spreadsheet, the studies in-
cluded within all identified reviews to explore whether any re-
views covered the same studies.When overlap between reviewswas
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noted, two overview authors (SF and AP) discussed the overlap
with consideration of each review question and comparisons ex-
plored, the date of the last search and key aspects of methodologi-
cal quality (e.g. types of studies included, risk of bias assessment).
We used these details to reach agreement regarding which of the
reviews should contribute data to the results (e.g. if two reviews
of similar methodological quality and with similar trials addressed
the same question, we would extract data only from the review
with the more up-to-date search strategy that had identified trials
published more recently).
For each comparison reported in each included review, one
overview author (SF) systematically extracted data on the risk of
bias (as documented in the published review) of trials within the
comparison and the results of anymeta-analyses performed. These
data were then checked by a second overview author (AP) with
reference to the published review.
Assessment of methodological quality of included
reviews
Quality of included reviews
Twooverview authors (SF andAP, FvW, JMorMB) independently
assessed the methodological quality of included reviews, basing
this assessment on the AMSTAR measurement tool (Shea 2007;
Shea 2009) and considering the following key domains.
• Clarity of review objective.
• Description of trial eligibility criteria.
• Extent of searching undertaken.
• Transparency of assessment process.
• Assessment of publication bias.
• Assessment of heterogeneity.
The AMSTAR measurement tool has been demonstrated to be
valid and reliable (Shea 2009).However, questionswithin the AM-
STAR tool are often multi-faceted, which complicates the rating
process. Univariable questions derived from these multi-faceted
questions have previously been used effectively to assess risk of
bias in review articles (Farmer 2012). Therefore we formulated
simple univariable questions for each of the AMSTAR questions/
criteria, so that we have an item-specific record of information
obtained from each review that we assessed. These questions are
outlined in Table 1, and additional clarification notes are pro-
vided in Appendix 3. For each of the questions within our mod-
ified AMSTAR (mAMSTAR) tool, two overview authors inde-
pendently documented each answer as ’yes,’ ’no,’ ’unsure’ or ’not
applicable,’ and provided relevant comments (in a similar format
to that used with the Cochrane ’Risk of bias’ tool). We developed
and implemented an objective algorithm to determine responses
to the original AMSTAR questions based on agreed mAMSTAR
responses (Appendix 3).
When overview authors were authors of an included review, they
were not involved in assessment of methodological quality of that
review, and this was done independently by two other overview
authors.
Note: See Differences between protocol and review for a descrip-
tion of amendments made to our modified AMSTAR during the
review process, including the introduction of objective criteria to
determine answers to the original AMSTAR questions based on
responses to our modified AMSTAR responses.
Quality of evidence in included reviews
We did not reassess the quality of individual studies included
within reviews but reported the quality of individual studies ac-
cording to the review authors’ assessment. We documented the
quality of evidence synthesised within the reviews based on criteria
consideredwithin theGRADE(Grading ofRecommendationsAs-
sessment, Development and Evaluation) approach (Guyatt 2008),
which includes the following.
• Risk of bias due to flawed design or conduct of studies.
• Imprecision (e.g. when confidence intervals for treatment
effect are wide).
• Inconsistency (e.g. when point estimates vary widely, I² is
large).
• Indirectness (e.g. variations in participants, interventions,
comparisons and outcomes).
• Publication bias (may be explored with the use of funnel
plots and classed as not suspected, suspected, strongly suspected
or very strongly suspected).
Two overview authors (SF and AP) assessed and documented risk
of bias related to study design, imprecision, inconsistency, indi-
rectness and publication bias for each outcome within compar-
isons presented in included reviews. Owing to the degree of sub-
jectivity required when the criteria above are considered and the
GRADE level of evidence determined, we developed objective cri-
teria to enable transparent, reproducible assignment of GRADE
levels of evidence. The criteria we used in our judgement of each
comparison presented within every included review were based on
systematic assessment of:
• the number of participants within the analysis;
• the risk of bias of trials contributing participants to the
analysis;
• heterogeneity within the analysis, as determined by I²; and
• the methodological quality of the review.
Two overview authors (SF and AP) worked together to ensure con-
sensus and consistency of entry of objective data pertaining to these
criteria onto a spreadsheet, and we used an objective algorithm
to determine whether evidence arising from each comparison was
classed as high, moderate, low or very low within GRADE, based
on the following definitions (Guyatt 2008).
• High quality: when further research is very unlikely to
change our confidence in the estimate of effect.
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• Moderate quality: when further research is likely to have an
important impact on our confidence in the estimate of effect and
may change the estimate.
• Low quality: when further research is very likely to have an
important impact on our confidence in the estimate of effect and
is likely to change the estimate.
• Very low quality: when we are very uncertain about the
estimate.
Details of the objective criteria and algorithm that we used to
determine the GRADE level of evidence are provided in Appendix
4.
Note: See Differences between protocol and review for a more
detailed description of why we developed these objective criteria.
Data synthesis
Two overview authors (SF and AP) independently extracted rel-
evant data from the reviews and systematically synthesised these
data within tables. In these tables, we documented the primary
and secondary outcomes of each intervention comparison in an
included review, as well as the number of studies and the number
of participants included in the comparison, and (when available
from the reviews) the mean difference (or standardised mean dif-
ference), 95% confidence intervals and I² statistic for heterogene-
ity (Deeks 2001). Comparisons were determined by data provided
in the included reviews. This table also synthesised key informa-
tion related to the quality of evidence, and documented eligibil-
ity criteria, study characteristics and the primary outcome of each
review.
Statistical analyses
Indirect comparisons are those made between interventions that
have not been compared directly with each other within the same
trial (Becker 2011).Wehadplanned to complete statistical analysis
using indirect comparisons of interventions included in different
reviews only if it was judged that trials included in the reviews
had a low level of clinical and methodological heterogeneity. To
judge clinical heterogeneity, we considered factors that are known
to predict upper limb recovery or response to rehabilitation after
stroke (Coupar 2011; Sunderland 1989).
If indirect comparisons had been possible, we had planned to eval-
uate differences between treatment and placebo/control/usual care
interventions, while preserving randomisation of the originally as-
signed participant groups. We planned to use the test for differ-
ences between subgroups in RevMan (RevMan 2012), with sub-
groups defined by the different comparisons made, and will esti-
mate differences between subgroups and will determine statistical
significance (Becker 2011). Differences between summary effects
in the two subgroups would have provided an estimate of the indi-
rect comparison of two interventions. We planned to not perform
indirect comparisons when studies performed direct comparisons,
or when the same studies were included within more than one re-
view. As indirect comparisons are not randomly assigned compar-
isons, we planned to apply caution when interpreting the results
of statistical analyses.
Note: Although we had planned for potential indirect compar-
isons, no indirect comparisons have been carried out. All available
outcome data comprised continuous data, generally pooling re-
sults from a variety of different outcome measures using standard-
ised mean differences, and statistical advice suggested that conse-
quently indirect comparisons were not appropriate. Subsequently,
we did not formally explore clinical and methodological hetero-
geneity with a view toward indirect comparisons; however in gen-
eral, we judged that levels of clinical and methodological hetero-
geneity within trials included in the reviewswere high. Rather than
performing indirect comparisons, when a comparison was judged
to have moderate-quality evidence related to the effect on our pri-
mary outcome of upper limb function, and the review reported
a standardised mean difference and 95% confidence intervals, we
plotted these results on a graph to provide a visual representation
of effect sizes.
Sensitivity analysis
We planned, when possible, to conduct sensitivity analyses based
on the methodological quality of included reviews, by compar-
ing results when all studies are included against those obtained
when evidence assessed to be of low quality or at high risk of
bias is excluded. We also planned to explore the results when only
Cochrane reviews are included versus when reviews from DARE
are included. (See Differences between protocol and review.)
R E S U L T S
Note: The main results, including a summary of included reviews,
interventions covered and implications for practice and research,
are summarised in Table 2 and Figure 2.
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Figure 2. Summary of findings.
Results of the search
Our search identified 1840 possible records (1451 from CDSR,
277 from DARE, 109 from PROSPERO and three from other
sources). After eliminating 1700 obviously irrelevant records on
the basis of titles, two independent overview authors assessed ab-
stracts for the remaining 140 reviews (Figure 3). They agreed that
35 studies did not meet the inclusion criteria, leaving 105, for
which we obtained full texts and then assessed for inclusion. We
excluded 52 of these: 37 because the review had clearly been super-
seded by a more up-to-date review addressing the same question,
or because the review clearly contained the same (or fewer) studies
of another review of similar (or better) quality; 14 because they did
not meet the selection criteria for the Overview; and one because
we were unable to locate the full-text paper. The remaining 53
reviews were eligible for inclusion in this Overview; however, 11
of these were identified to be ongoing, and two were references
to duplicate publications: Foongchomchaey 2005 was a duplicate
publication of Ada 2005; French 2010 was a duplicate publication
of French 2007, leaving 40 reviews to be included within the qual-
itative synthesis of reviews (Table 3). Nineteen of the 40 reviews
were Cochrane reviews, and 21 were non-Cochrane reviews.
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Figure 3. Study flow diagram.
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Details of the 11 ongoing reviews are provided in Table 4, and
reasons for exclusion of the 52 excluded reviews are provided in
the ’Characteristics of excluded reviews’ section (Table 5).
Thirty-one of the 40 included reviews contained data suitable for
inclusion within the quantitative synthesis of reviews; however
four of these contributed only data from subgroup analyses, as
the main analyses overlapped with other included reviews. Table
6 provides a summary of which reviews are included within the
qualitative and quantitative syntheses.
Description of included reviews
Types of studies
Thirty-one of the 40 reviews included RCTs and quasi-RCTs, and
nine of the reviews included non-randomised trials and other de-
signs as well as RCTs. Additional details are provided in Table
3. The 40 reviews contain 503 studies (18,078 participants), al-
though some overlap is evident in studies included in some of the
reviews, and some of these studies are non-randomised studies or
included populations other than people with stroke with upper
limb impairment. These overlaps and the types of studies included
are explored further in the description of types of interventions
provided in the included reviews.
Participants
Thirty-four of the 40 reviews included only participants with
stroke. Six reviews included mixed populations of participants:
Three included populations with neurological conditions (Bradt
2010 acquired brain injury; Braun 2013 stroke, Parkinson’s dis-
ease, multiple sclerosis; Demetrios 2013 adults and children with
stroke), and three included mixed neurological and non-neuro-
logical populations (Hijmans 2004 elbow conditions of any cause;
Katalinic 2010 contractures due to neurological conditions, ad-
vanced age, trauma or surgery, joint or muscle pathology; Singh
2010 shoulder pain of any cause).
Interventions
Thirty-seven of the 40 reviews focused on different types of in-
terventions for the upper limb. Thirty-five of these are focused
on single types of interventions, and two reviews (Farmer 2014;
Urton 2007) included a mixture of different single interventions.
Exploration of overlap between the reviews of single interventions
and these reviews, which include several different interventions,
led to the inclusion of each of these mixed intervention reviews
under one intervention only, with Farmer 2014 contributing data
related to electrical stimulation and Urton 2007 contributing data
related to reach-to-grasp exercise.
We identified reviews related to a total of 20 individual interven-
tion types (some with additional subcategories). However, for two
of these intervention types (acupuncture and self-management),
we identified no completed reviews (ongoing reviews only). There-
fore, we have identified evidence related to 18 different types of
interventions from these 37 reviews.
The remaining three of the 40 reviews examined factors in service
delivery, focusing on the dose or location of the intervention.
Comparisons
Included reviews explored comparisons of interventions with no
treatment, placebo, control, usual care, other interventions and
different doses of interventions. Comparison groups included
within each review are summarised in the ’Characteristics of in-
cluded reviews’ section (Table 3), and relevant comparison groups
are described in relation to the included reviews in the sections
below.
Outcomes
Included reviews covered a wide range of outcomes; these are sum-
marised in the ’Characteristics of included reviews’ section (Table
3). Further details of available data related to these outcomes are
provided below.
Description of included reviews related to individual
interventions
The 37 reviews related to each of the 18 types of interventions are
described below, in relation to each intervention.
Bilateral arm training
Two included reviews focused on bilateral training (Coupar 2010;
van Delden 2012). However, the focus of these reviews differed,
with Coupar 2010 comparing simultaneous bilateral arm training
versus usual care or control intervention, while van Delden 2012
included only studies that directly compared bilateral arm train-
ing with unilateral arm training. The methodological quality of
these two reviews was quite similar. The most recent search date
was provided by van Delden 2012 (June 2011), which also iden-
tified two RCTs that were published after the search of Coupar
2010 (August 2009). However, the wider scope of Coupar 2010
meant that a larger number of trials (18 trials, 549 participants)
were included compared with van Delden 2012 (nine trials, 452
participants).
Therefore, data from Coupar 2010 contributed to comparisons of
bilateral arm training versus usual care, and bilateral arm training
versus other interventions (with data available for arm function,
hand function, impairment and ADL outcomes), and data from
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van Delden 2012 contributed to comparisons of unilateral arm
training versus bilateral arm training (with data available for arm
function and impairment outcomes).
In addition, van Delden 2012 reported subgroup analyses explor-
ing the impact of severity of stroke on arm function outcomes.
Biofeedback
Two included reviews explored biofeedback (Molier 2010;
Woodford 2007). However, Molier 2010 investigated the effects
of any type of biofeedback on arm function (eight trials, 148 par-
ticipants), while Woodford 2007 included only studies of EMG
biofeedback (13 trials, 269 participants). Molier 2010 did not
carry out any meta-analysis and did not present data on effect
sizes; therefore this study contributed only qualitative information
(Table 7).
Woodford 2007 compared EMG biofeedback (combined with
physiotherapy) versus physiotherapy alone and provided data for
arm function, impairment and ADL outcomes. The search date
for Woodford 2007 was March 2006.
Bobath approach
One review investigated the effectiveness of the Bobath approach,
including five RCTs (209 participants), which compared upper
limb therapy based on the Bobath concept versus control inter-
vention (Luke 2004). Effect sizes were presented for two individ-
ual studies for upper limb function outcomes. The search date for
this review (2003) is considerably out-of-date.
(Note: We are aware of another review investigating the effective-
ness of the Bobath approach (Kollen 2009). At the time of our
search, this review was presented as a record only (i.e. no struc-
tured abstract) within DARE; subsequently this review was not
identified during the search and is not included in this overview.
In August 2013, a structured abstract was published on DARE
(DARE). This review included seven RCTs (392 participants) that
reported upper limb outcomes. No meta-analyses were reported,
and the abstract published by the Centre for Reviews and Dissem-
ination (CRD Kollen 2009) highlights issues related to method-
ological limitations of the review and the included RCTs.)
Brain stimulation
Two up-to-date reviews, both judged to be of highmethodological
quality, investigated different types of brain stimulation. Elsner
2013 explored the effects of tDCS compared with sham tDCS, no
intervention or conventional therapy and included 15 trials (455
participants). Hao 2013 investigated rTMS compared with sham
rTMS, sham rTMS plus other baseline intervention or baseline
intervention only and included 19 trials (588 participants).
Constraint-induced movement therapy (CIMT)
Among 11 systematic reviews related to CIMT, Corbetta 2010
(last search April 2010; 18 trials, 674 participants) was judged
to provide the most up-to-date and comprehensive inclusion of
relevant trials. However, Corbetta 2010 included only data on
two main comparisons: CIMT versus control for arm function
and ADL outcomes. Sirtori 2009 (last search June 2008; 19 trials,
619 participants), although not as up-to-date as Corbetta 2010,
provided subgroup comparisons related to time post stroke and
dose of intervention. We therefore planned to include data from
these subgroup analyses. However, only subgroup data related to
ADL outcomes were available; for our primary outcome of upper
limb function, these data could not be obtained.
Electrical stimulation
We included three reviews related to electrical stimulation (Farmer
2014; Meilink 2008; Nascimento 2014). Farmer 2014 focused
on neuromuscular electrical stimulation, Meilink 2008 on EMG-
triggered electrical stimulation and Nascimento 2014 on electrical
stimulation for improvingmuscle strength. Relatively few overlaps
were noted between trials included in these three reviews, and a
total of 37 electrical stimulation trials were included between the
reviews (13 of 18 electrical stimulation trials included by Farmer
2014 were ’unique’; six of eight included by Meilink 2008 were
’unique’; and 13 of 16 trials included by Nascimento 2014 were
’unique’).
Farmer 2014 (last search September 2011) provided data related to
neuromuscular electrical stimulation versus control for outcomes
of upper limb function, impairment and ADLs. However, Farmer
2014 provides the effect sizes of individual trials and has pooled no
data: 18 trials (706 participants) related to electrical stimulation
were included.
Meilink 2008 (last search June 2006) compared EMG-triggered
electrical stimulation versus cyclical electrical stimulation for out-
comes of arm function and impairment; investigators also com-
pared EMG-triggered electrical stimulation versus no treatment
for arm function outcomes. A total of eight trials (157 partici-
pants) were included.
Nascimento 2014 is the most up-to-date of these reviews (last
search December 2012) and was judged to be of high method-
ological quality. The primary aim of this review was to explore the
effect of electrical stimulation on muscle strength, but outcomes
related to arm function and ADLs were also included. Sixteen tri-
als (638 participants) were included.
’Hands-on’ therapy (manual therapy techniques)
One review investigated the effectiveness of hands-on therapeutic
interventions or manual therapy techniques, including three trials
(86 participants), each exploring different interventions (Winter
2011; last search March 2010). Data were not pooled, and this
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review is included within qualitative syntheses only. The small
number of studies and the methodological limitations make it
inappropriate to draw conclusions from this review.
Mental practice
Three reviews related to mental practice were included (Barclay-
Goddard 2011; Braun 2013; Wang 2011). All investigated tri-
als that delivered mental practice as an addition to conventional
exercise, compared with conventional exercise alone, or conven-
tional exercise plus a control or placebo intervention. We identi-
fied Braun 2013 as the most up-to-date review related to mental
practice (last search June 2012). However, we found that Wang
2011 (last search October 2010) included several Chinese lan-
guage publications that were not included by Braun 2013. Braun
2013 included 14 trials with stroke participants (421 participants),
and Wang 2011 included 16 trials (652 participants), of which
eight trials (461 participants) were published in Chinese language
journals and were not included within Braun 2013. We therefore
extracted data from both of these trials but explored where there
was overlap; we did not include any of the analyses presented by
Wang 2011 that did not include data from Chinese trials. Thus,
we extracted from Braun 2013 data related to the effects of mental
practice on arm function and activities of daily living and from
Wang 2011 data related to impairment .
Barclay-Goddard 2011 (last search November 2010; six trials, 119
participants) was superseded by Braun 2013. However, as neither
Braun 2013 nor Wang 2011 carried out any subgroup analyses,
we extracted from Barclay-Goddard 2011 data from the subgroup
analyses related to time post stroke and dose of intervention.
Mirror therapy
One Cochrane review, of high methodological quality, assessed
the effects of mirror therapy, compared with any other interven-
tion, for improving motor function, ADLs, pain and visuospatial
neglect (Thieme 2012; last search June 2011); it included 14 tri-
als (567 participants). Data were pooled from 10 trials (421 par-
ticipants), combining upper limb function and impairment out-
comes. Data from four trials (217 participants) related tomeasures
of ADL outcomes were pooled.
Music therapy
We found one review related to the effectiveness of music therapy
on a range of outcomes in participants with brain injury (Bradt
2010; last search February 2010). Only two trials (41 participants)
explored effectiveness on upper limb recovery, and data from these
studies were not pooled because of clinical differences between
these studies.
Pharmacological interventions
Pharmacological interventions for spasticity
Two reviews explored the effects of pharmacological interventions
on spasticity in participants with stroke (Elia 2009; Olvey 2010).
Elia 2009 (last search September 2006; 11 trials, 782 participants)
included only studies that investigated botulinum neurotoxin A or
B but included any studies (regardless of type of evidence) aimed
at improving spasticity (not limited to upper limb). Olvey 2010
(last search July 2010; 54 studies, 2327 participants, of which 23
studies (1039 participants) are trials) included any pharmacologi-
cal treatment for upper limb spasticity. However, almost all studies
included in Olvey 2010 investigated botulinum neurotoxin (51 of
54 included studies); subsequently substantial overlap is evident
between the studies included in these two reviews. No data were
pooled within Olvey 2010; therefore only data from Elia 2009
are included within the quantitative results. Of 11 trials included
by Elia 2009, spasticity in the upper limb was measured by the
Ashworth Scale in two trials (142 participants) of botulinum toxin
(Dysport), and three trials (185 participants) investigated the ef-
fects of botulinum toxin (Botox). Nine trials measured disability,
but no meta-analysis was carried out because of the nature of the
measurement scales reported.
Multi-disciplinary rehabilitation following pharmacological
interventions
One review investigated the effects of multidisciplinary rehabilita-
tion following botulinum toxin, comparedwithmulti-disciplinary
rehabilitation alone, in improving activity limitation (Demetrios
2013; last search September 2012). This review included both
adults and children with poststroke spasticity. Three trials (91 par-
ticipants) were included, but no data were pooled because of het-
erogeneity. This review is therefore included within the qualitative
synthesis only.
Pharmacological interventions for shoulder pain
One review investigated the effects of botulinum toxin on shoulder
pain, spasticity and shoulder range of movement, in participants
with shoulder pain (including poststroke shoulder pain) (Singh
2010; last search January 2010). Six studies (164 participants)were
included, of which five (109 participants) examined poststroke
shoulder pain.
Repetitive task training
The same group of authors published two reviews (French 2007
with dual publication French 2010; and French 2008), both of
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which explored the effects of repetitive task training on functional
ability in people with stroke. French 2007 (last search October
2006) defined repetitive task training as “an active motor sequence
(multi joint motion) performed repetitively” and identified 14 tri-
als (659 participants), of which eight trials (412 participants) as-
sessed the impact of repetitive task training on upper limb func-
tion. Six (274 participants) of these eight trials explored upper
limb training, and two (138 participants) investigated global func-
tional activities. Data related to effects on measures of arm and
hand function were pooled, and subgroup analyses related to time
post stroke and dose of intervention were carried out.
French 2008 (last search September 2006) combined trials of
repetitive upper limb training identified in French 2007 with trials
of constraint-induced movement therapy. As a result of overlap
between included trials, this review is included within our qualita-
tive synthesis only (Table 7). French 2008 pooled data from 18 tri-
als (634 participants) related to the effects of repetitive functional
task practice on arm function; eight of these (467 participants)
are trials of repetitive task training, and 10 (167 participants) are
trials of CIMT.
Robotics
Two reviews explored the effects of robot-assisted arm training
(Mehrholz 2012; Norouzi-Gheidari 2012). Mehrholz 2012 (last
search August 2011) was judged to bemost up-to-date and to be of
the highest methodological quality. However, Norouzi-Gheidari
2012 (last search July 2010) reported a number of subgroup anal-
yses that we considered relevant to this overview. Therefore, we
extracted data from Mehrholz 2012 (19 trials, 666 participants)
for the main analyses but used data from Norouzi-Gheidari 2012
(12 trials, 383 participants) in relation to the subgroup analy-
ses. However, although Norouzi-Gheidari 2012 explored different
subgroups on the basis of time after stroke (acute and subacute or
chronic) and the comparison investigated (additional robotic ther-
apy or same duration of conventional therapy), no tests for sub-
group differences were provided, and differences must be inferred
from reported effect sizes. Mehrholz 2012 compared robotic ther-
apy versus any comparator, including other rehabilitation, placebo
or no treatment, although Norouzi-Gheidari 2012 included only
comparisons with conventional rehabilitation.
Sensory interventions (interventions to improve sensory
function)
Two reviews investigated the effectiveness of interventions that
aim to train sensory function in participants with stroke (Doyle
2010; Schabrun 2009). Doyle 2010 (last search September 2009)
investigated “interventions hypothesised to remediate sensory im-
pairment after stroke,” and divided included trials into those in-
vestigating “sensory re-training” (which included active training or
exercises, such as mirror therapy, discrimination activities, tactile
recognition tasks and motor imagery) and “sensory stimulation”
(which included interventions such as electrical stimulation, mag-
netic stimulation, intermittent pneumatic compression, tensive
mobilisations of peripheral nerves). Schabrun 2009 (search date
not reported) similarly dened two groups of interventions: “active
sensory training” (“exercises specifically designed to train sensory
function, for example, practice localising and detecting position
of body parts in space”) and “passive sensory training” (“electrical
stimulation to produce activation of cutaneous nerves in the ab-
sence of muscle contraction”). Doyle 2010 included 13 trials (467
participants), three (71 participants) of which investigated sensory
retraining and 10 (396 participants) of which investigated sensory
stimulation. Schabrun 2009 included 14 studies (of any design;
296 participants), six (101 participants) of which were classed as
active sensory retraining and eight (195 participants) as passive
sensory retraining.Despite the similarity of interventions included
within these two reviews, no overlap of trials was noted. Doyle
2010 is focused specifically on the upper limb and includes only
RCTs, and nine of the 14 studies included by Schabrun 2009 were
specific to the upper limb (four lower limb; and one both upper
and lower limb); only five were assessed to be “properly designed”
RCTs.
Doyle 2010 presented effect sizes related to arm function and
impairment outcomes from trials that compared treatment for
sensory impairment versus no additional treatment (both treat-
ment groups could receive conventional or routine therapy) and
from trials that compared treatment for sensory impairment ver-
sus placebo or attention control treatment. However, no data were
pooled “due to clinical and methodological diversity.” Data were
extracted from individual trials for reported effect sizes. One of the
included trials investigated mirror therapy; as the effect of mirror
therapy has been investigated by another review (Thieme 2012; see
’Mirror Therapy’), data from this single trial were not extracted.
Schabrun 2009 states that data were insufficient to enable pooling
of data related to active sensory training, and no effect sizes were
presented for any of the studies focused on the upper limb. There-
fore, no data from Schabrun 2009 related to active sensory train-
ing interventions were extracted. Schabrun 2009 presents pooled
data for three studies (participant numbers unclear) that investi-
gate passive sensory training (electrical stimulation), although the
comparison group is not clearly reported. Only one of these three
studies was assessed by the review authors to be a “properly de-
signed” RCT.
Strength training
One non-Cochrane review investigated the effect of strength train-
ing for the affected upper limb, in which strength training was
defined as voluntary exercise against resistance (Harris 2010; last
search April 2009). Thirteen trials (517 participants) were in-
cluded, and data were pooled for outcomes of upper limb func-
tion, grip strength and ADLs. Subgroup analyses are reported for
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subgroups of participants with subacute or chronic stroke, with
mild or moderate impairment. However, no test for subgroup dif-
ferences was reported.
(Note: We are aware of another review investigating the effective-
ness of strength training interventions (Ada 2006). This reviewwas
presented as a record with DARE only (i.e. no structured abstract);
subsequently this review was not identified during the search and
is not included in this overview. However, peer review comments
related to this overview have highlighted this review. This review
does not present information related to upper limb interventions
separately, so it would be difficult to extract data related to effects
of strength training on the upper limb. This review is considered
as ’awaiting assessment’ for inclusion within this overview.)
Stretching and positioning
Katalinic 2010 (last search April 2009) investigated the effects of
stretch for contractures, defined a stretching intervention as one
that “aimed to maintain or increase the mobility of any synovial
joint,” with a criterion for study inclusion stating: “the stretch
needed to sustain the soft tissues in a lengthened position for a
minimum of 20 seconds on more than one occasion.” This review
included participants from a wide range of populations at risk
of muscle contracture at the shoulder; a total of 35 trials (1391
participants) were included; 24 of these trials (782 participants)
included populations of people with neurological conditions, in-
cluding stroke. The interventionswere focused on a range of joints,
both lower limb (eight trials) and upper limb (16 trials). Types
of stretch administered included “passive stretching (self-adminis-
tered, therapist-administered and device-administered), position-
ing, splinting and serial casting.” Meta-analyses within this review
present data from the subgroup of participants with neurologi-
cal conditions, but data related to limb or type of intervention
are pooled and no subgroups are presented. Furthermore, pooled
comparisons included trials with any type of control group inter-
vention, including no intervention, usual care or other active in-
terventions such as physiotherapy, passive stretching or botulinum
toxin.
Positioning of the shoulder
Borisova 2009 (last search June 2005) reviewed trials that investi-
gated positioning of the shoulder. All included trials had to have a
measure of shoulder range of motion as an outcome measure. All
of the five trials (126 participants) included in Borisova 2009 are
also included in the review of stretching interventions by Katalinic
2010. However, pooled analysis of the trials of positioning pre-
sented by Borisova 2009 effectively forms a subgroup (based on
joint and type of intervention) of the trials included by Katalinic
2010; therefore we extracted data from the range of movement
outcome presented by Borisova 2009.
Hand splinting
One review synthesised studies, of any methodological design, in-
volving hand splinting to prevent contracture and reduce spastic-
ity (Lannin 2003; last searchMay 2003). Twenty-one studies (230
participants) were included, of which five (participant numbers
unclear) were RCTs. No overlap was noted between the trials in-
cluded by Lannin 2003 and those included within Katalinic 2010,
although one of the included trials was excluded from Katalinic
2010, and Katalinic 2010 includes several more recently published
trials that investigate wrist and hand splints. However, Katalinic
2010 does not present these data as a separate subgroup analy-
sis. Lannin 2003 presents data for comparisons of hand splints
versus no splint or hand splint versus a 30-minute stretch, and
we extracted these data. Comparisons of dorsal and volar hand
splints and length of time wearing finger spreaders are also pre-
sented within the review, but we did not extract these data.
Elbow orthoses
One non-Cochrane review, which is considerably out of date
(Hijmans 2004; last search June 2003), investigated elbow or-
thoses.However, only one trial (18 participants) was included, and
this trial was excluded from the review by Katalinic 2010 (which
also identified more recent trials focused on the elbow). No data
were presented within this review, and it is included within the
qualitative synthesis only.
Shoulder supports
One Cochrane review, which is considerably out-of-date (Ada
2005; last search March 2004), investigated the effectiveness of
supportive devices in preventing subluxation, repositioning the
head of the humerus, decreasing pain or increasing function fol-
lowing stroke. Four trials (142 participants) were included, all of
which investigated shoulder strapping or the hemi-sling for pre-
venting or reducing shoulder subluxation. No overlap is evident
between the trials included byAda 2005 and those includedwithin
Katalinic 2010.
Task-specific training
Reach-to-grasp exercise
Two reviews that investigated reach-to-grasp exercise-related in-
terventions were included (Pelton 2012; Urton 2007). However,
both are included within the qualitative synthesis only, as neither
provided data suitable for extraction. Pelton 2012 (last search April
2010) investigated interventions aimed at improving co-ordina-
tion of the arm and hand during the reach-to-grasp movement.
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Eight studies (155 participants) were included, but these included
a variety of study designs. Urton 2007 (last search June 2005; 11
studies, 269 participants) included a mixture of different inter-
ventions, including ’goal-directed reaching’ and ’reach-to-grasp’
interventions. However, the methodological quality of this review
was judged to be poor, so it is not appropriate to draw conclusions
from it.
Virtual reality
One Cochrane review investigated the effects of virtual reality and
interactive video-gaming on function after stroke (Laver 2011; last
search March 2010). Of a total of 19 included trials (565 partici-
pants), eight (240 participants) were focused on upper limb func-
tion. Data were extracted for comparisons of virtual reality versus
any other intervention, for a mixed upper limb function and im-
pairment outcome and for grip strength. Subgroup analyses based
on time post stroke (more or less than 6 months post stroke) and
length of intervention (more or less than 15 hours) are presented,
along with a test for subgroup differences.
Description of included reviews related to factors in service
delivery
The three reviews related to different factors in service delivery are
described below.
Dose of intervention
Cooke 2010 (last search October 2009) was judged to be the
review with the most up-to-date evidence related to intensity of
the intervention. It included trials that investigated the effects of
additional, augmented or increased duration or effort of exercise
therapy comparedwith a lesser dose. Seven trials (680 participants)
were included; however, only three of these trials (258participants)
investigated increased intensity of dose for the upper limb.
Service location
Home-based therapy
One Cochrane review, of high methodological quality, investi-
gated the effects of home-based therapy programmes on upper
limb recovery (Coupar 2012; last search May 2011); it included
four trials (166 participants). Three of the four trials (156 partic-
ipants) compared home-based therapy versus usual care; pooled
data related to outcomes of arm function, ADLs, extended ADLs
and impairment were extracted; the intervention in two of these
three trials consisted of an upper limb programme of exercise, and
in the other trial, the intervention comprised virtual reality deliv-
ered via telerehabilitation. One of the four trials (10 participants)
compared upper limb therapy (based on virtual reality) provided
at home (delivered via telerehabilitation) versus the same inter-
vention provided in hospital; data were available for measures of
impairment only.
Telerehabilitation
One Cochrane review, of high methodological quality, investi-
gated the effects of telerehabilitation services for people with stroke
(Laver 2013; last search July 2013). This review included 10
trials (933 participants) covering a wide range of telerehabilita-
tion services; only four of these trials (87 participants) investi-
gated interventions that aimed to improve upper limb function,
all of which comprised customised computer-based training pro-
grammes.Data could be pooled for only two of these trials (46 par-
ticipants) for ameasure of upper limb function. Both of these trials
were also included in the review of home-based therapy (Coupar
2012; see above) and contributed to pooled data related to impair-
ment outcomes (but not to the outcome of arm function, ADLs
or extended ADLs).
Reviews incorporating evidence related to a mixture of
different interventions
As described above, two reviews incorporated evidence related to
a mixture of different interventions (Farmer 2014; Urton 2007).
A brief description of these reviews is provided below.
Farmer 2014 included trials of ’assistive technologies’ including
studies of electrical stimulation (17 RCTs), CIMT (12 RCTs),
biofeedback (two RCTs), robotics (sevenRCTs), brain stimulation
(one RCT), virtual reality (one RCT) and stochastic resonance
(one RCT). This review did not pool data from any of the trials
but presented effect sizes for individual trials and outcomes; this
limited our ability to extract data from this review. Eleven trials
that were not included within other reviews of single interventions
were included in Farmer 2014; 10 of these trials investigated elec-
trical stimulation (of which one described ’stochastic resonance,’
rather than ’electrical stimulation’) and one CIMT. As we had
identified a large number of reviews ofCIMTand twohigh-quality
reviews that pooled the data from trials of CIMT (Corbetta 2010;
Sirtori 2009), we made the decision to not extract from Farmer
2014 data related to CIMT. However, it is important to note that
Farmer 2014, which includes a more recent search, did identify
one additional trial of CIMT. We had identified two other trials
related to electrical stimulation; however, each of these trials had a
different focus, and Farmer 2014 explored trials of neuromuscu-
lar electrical stimulation and stochastic resonance; data related to
trials have therefore been included within the section on electrical
stimulation.
Urton 2007 stated that these investigators included studies of “ef-
fective interventions for upper extremity hemiparesis following
stroke.” The 11 included trials investigated augmented exercise
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therapy, electrical stimulation, goal-directed reaching and reach-
to-grasp movements. As a result of poor methodological quality
and absence of data presented within the review, this review is
included only within the qualitative synthesis. It was considered
to contribute unique trial data related to ’reach-to-grasp’ exercise
only, and therefore is discussed under this heading only. Inter-
ventions of augmented exercise therapy and electrical stimulation
were judged to be coveredmore comprehensively by other reviews.
Methodological quality of included reviews
Figure 4 provides details of judgements for themodifiedAMSTAR
andAMSTARassessment questions, and summarises the responses
arising fromCochrane and non-Cochrane reviews for each of these
questions; Table 8 provides results for the AMSTAR assessment
only.
Figure 4. AMSTAR and mAMSTAR results (AMSTAR in shaded columns; mAMSTAR in unshaded columns).
The table below summarises the number of ’yes’ responses as-
signed to each of the 40 included reviews for the 11 AMSTAR
questions, where 11 ’yes’ responses represent a judgement of the
highest methodological quality.
23Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
AMSTAR number of ’yes’ responses Cochrane reviews Non-Cochrane reviews
11 Elsner 2013
French 2010
Hao 2013
Katalinic 2010
Mehrholz 2012
10 Coupar 2012
Laver 2011
Laver 2013
Thieme 2012
French 2008*
Nascimento 2014
9 Barclay-Goddard 2011;
Bradt 2010*
Coupar 2010
Demetrios 2013
Doyle 2010
Winter 2011
Braun 2013
8 Singh 2010
Sirtori 2009
Woodford 2007
7 Ada 2005 Cooke 2010
van Delden 2012
6 Corbetta 2010
Elia 2009
Pelton 2012*
Schabrun 2009
5 Harris 2010
Lannin 2003
Molier 2010*
Norouzi-Gheidari 2012
4 Luke 2004*
Meilink 2008
Wang 2011
3 Olvey 2010*
2 Borisova 2009
Hijmans 2004*
Farmer 2014
1
0 Urton 2007*
24Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
*Reviews included in qualitative synthesis only.
1. Was an ’a priori’ design provided?
We judged 36 of the 40 reviews to have provided ’a priori’ design,
establishing the research questionbefore the reviewwas conducted.
The four reviews judged not to provide ’a priori’ design were all
non-Cochrane reviews, with three judged not to pre-describe the
outcomes (Hijmans 2004; Meilink 2008; Olvey 2010) and one
judged not to pre-describe the intervention (Urton 2007). In addi-
tion, nine of the non-Cochrane reviews were judged not to specify
the comparison of interest, and this was judged to be unclear for
a further two reviews (one Cochrane; one non-Cochrane).
2. Was there duplicate study selection and data
extraction?
We judged that 23 of the 40 reviews had appropriate study selec-
tion and data extraction; eight reviews were judged not to have ap-
propriate study selection and data extraction; and this was unclear
for nine reviews. All eight of the reviews judged not to have ap-
propriate study selection and data extraction were non-Cochrane
reviews, with three reviews judged not to have two independent
review authors for study selection or data extraction (Lannin 2003;
Olvey 2010; Urton 2007); two judged not to have two indepen-
dent review authors for data extraction (Borisova 2009; Hijmans
2004); and three judged to have two independent review au-
thors but no clear procedure for resolving disagreements (Corbetta
2010; Farmer 2014; Luke 2004). Three of the nine reviews that
judged this to be unclear were Cochrane reviews, with one unclear
for all parameters (Singh 2010); one unclear in relation to the use
of two independent review authors for data extraction (Ada 2005);
and one unclear in relation to the procedure for resolving disagree-
ments (Woodford 2007). The six non-Cochrane reviews judged to
be unclear were all-at a minimum-unclear in relation to whether
two independent review authors were involved in data extraction
(Elia 2009; Harris 2010; Meilink 2008; Norouzi-Gheidari 2012;
Schabrun 2009; Wang 2011).
3. Was a comprehensive literature search performed?
We judged that 31 of the 40 reviews performed a comprehensive
literature search; seven non-Cochrane reviews were judged not to
report a comprehensive literature search; and this was unclear for
two non-Cochrane reviews. The most common reason for not
being judged to report a comprehensive literature search was that
the search strategy was not available, or it was unclear (Borisova
2009; Corbetta 2010; Elia 2009; Harris 2010; Urton 2007;Wang
2011). Three reviews did not supplement electronic searches with
searching of other resources (Farmer 2014; Luke 2004; Urton
2007), and one did not report dates of searches (Schabrun 2009).
4. Was the status of publication (i.e. grey literature)
used as an inclusion criterion?
We judged that 19 of the 40 reviews searched for reports regardless
of publication type or language; 16 of these were Cochrane reviews
and three were non-Cochrane reviews (Corbetta 2010; French
2008; Nascimento 2014). This information was unclear for three
of the 19 Cochrane reviews, primarily because of the absence of
a statement related to language of publication (Coupar 2010;
Singh 2010; Sirtori 2009). For most (19/21) of the non-Cochrane
reviews, this information was not provided or was unclear.
5. Was a list of studies (included and excluded)
provided?
Twenty-nine of the 40 reviews provided a list of included and
excluded studies. All 40 of the included reviews provided a list of
included studies, but 11 non-Cochrane reviews did not provide
a list of excluded studies (Borisova 2009; Corbetta 2010; Farmer
2014;Harris 2010; Luke 2004;Meilink 2008;Molier 2010;Olvey
2010; Pelton 2012; Urton 2007; Wang 2011). Thirteen of the 19
Cochrane reviews (Ada 2005; Barclay-Goddard 2011; Bradt 2010;
Coupar 2010; Coupar 2012; Doyle 2010; Hao 2013; Katalinic
2010; Laver 2011; Mehrholz 2012; Sirtori 2009; Thieme 2012;
Woodford 2007) and eight of the 21 non-Cochrane reviews (
Borisova 2009; Corbetta 2010; Elia 2009; Lannin 2003; Luke
2004; Olvey 2010; Schabrun 2009; Urton 2007) did not provide
a flow diagram illustrating study selection.
6. Were the characteristics of included studies
provided?
We judged that 27 of the 40 reviews provided adequate de-
tails of the characteristics of included studies. Eighteen of the
19 Cochrane reviews were judged to provide adequate details,
and details were unclear for one Cochrane review (Woodford
2007). Eleven of the 12 non-Cochrane reviews were judged
not to provide adequate details related to the included partici-
pants (Borisova 2009; Braun 2013; Cooke 2010; Farmer 2014;
Hijmans 2004; Lannin 2003; Meilink 2008; Norouzi-Gheidari
2012; Olvey 2010; Urton 2007;Wang 2011), and one was judged
not to provide adequate details related to outcomes (Corbetta
2010).
7. Was the scientific quality of included studies
assessed and documented?
We judged that 30 of the 40 reviews adequately assessed and doc-
umented the scientific quality of included studies; these included
17 Cochrane reviews and 13 non-Cochrane reviews. Informa-
tion about whether scientific quality was assessed by two inde-
pendent review authors was unclear for two of the 19 Cochrane
reviews (Ada 2005; Sirtori 2009), was not reported or was judged
to be unclear for seven of the non-Cochrane reviews (Elia 2009;
Harris 2010; Hijmans 2004; Molier 2010; Norouzi-Gheidari
2012; Olvey 2010; Urton 2007) and was judged to have been as-
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sessed but not documented for two of the non-Cochrane reviews
(Farmer 2014; Schabrun 2009).
8. Was the scientific quality of included studies used
appropriately in formulating conclusions?
We judged that 29 of the 40 reviews used the scientific qual-
ity of studies appropriately in formulating conclusions; these in-
cluded 17 Cochrane reviews and 12 non-Cochrane reviews. Two
Cochrane reviews were judged not to appropriately consider the
methodological rigour of the included studies in the review anal-
yses (Ada 2005; Barclay-Goddard 2011); nine non-Cochrane re-
views were judged to not use this appropriately or to be unclear in
the use of scientific quality within the analyses or in formulating
conclusions (Borisova 2009; Cooke 2010; Farmer 2014; Hijmans
2004; Molier 2010; Norouzi-Gheidari 2012; Urton 2007; van
Delden 2012; Wang 2011).
9. Were methods used to combine the findings of
studies appropriate?
We judged that 27 of the 40 reviews used appropriate methods for
combining the results of studies; however, 11 were judged not to
have combined the results of studies, and one was unclear on this.
One review was judged not to have reported appropriate methods
for combining the results of studies (Luke 2004).
10. Was the likelihood of publication bias assessed?
We judged that eight of 40 reviews assessed publication bias.
Five of these were Cochrane reviews (Elsner 2013; French 2010;
Hao 2013; Katalinic 2010; Mehrholz 2012), and three were non-
Cochrane reviews (Braun 2013; French 2008; Wang 2011).
11. Was the conflict of interest stated?
Thirty of 40 reviews included a conflict of interest statement; these
included all 19 Cochrane reviews and 11 of 21 non-Cochrane
reviews. Eleven of the non-Cochrane reviews were judged not to
have a conflict of interest statement or to provide unclear infor-
mation on this. The Cochrane review of virtual reality was judged
to have a potential conflict of interest, as one of the review authors
was a “co-owner of a company that develops virtual reality for
rehabilitation” (Laver 2011).
Reviews included in data synthesis
Nine of the 40 reviews (three Cochrane and six non-Cochrane)
are included within a synthesis of qualitative data only. Details of
these reviews, their reported results and the reasons for inclusion
only in qualitative synthesis are provided in Table 7.
Data from the remaining 31 reviews are included in our synthesis
of quantitative data. However, some overlap was noted between
data included within some reviews; to avoid inclusion of duplicate
comparisons, only subgroup comparisons were considered for four
reviews (see Table 9 for further information).
Data from two reviews related to mental practice were included,
as considerable differences were noted in the included trials, with
Wang 2011 including several non-English papers not included by
Braun 2013, and Braun 2013 including some English-language
publications not included in Wang 2011. It should be noted that
some overlap is evident in the trials contributing data within these
reviews.
Outcome comparisons included in data synthesis
From the 31 reviews within our synthesis of quantitative data, we
extracted data related to the results of 127 comparisons of mea-
sures of upper limb function, impairment or ADLs. Ninety-one of
these comparisons were performed immediately at the end of the
intervention, and 20 at a follow-up assessment; 16 of these 127
comparisons were subgroup comparisons. Further details related
to the number of reviews contributing to these comparisons and
the outcome data extracted are briefly described as follows.
Upper limb function: immediate outcome
We extracted data related to our primary outcome of upper limb
function as related to 29 comparisons, presented by 19 reviews,
immediately at the end of intervention. Of these 29 comparisons,
18 comprised outcomes within our prestated category of ’arm
function’ and five outcomes within our prestated category of ’hand
function.’ Two combined both arm and hand function outcomes,
which we refer to as ’upper limb function.’ Two comparisons com-
bined arm function outcomes with measures of ADL, and two
combined upper limb function outcomes with measures of motor
impairment, but we judged these combined outcomes to be most
relevant to our upper limb function category.
Upper limb function: follow-up outcome
Data suitable for extraction related to follow-up outcomes of upper
limb function were available from only two reviews (three com-
parisons). Two of these comparisons were related to measures of
arm function, assessed at less than and more than six months post
stroke (Cooke 2010). The third comparison combined both arm
and hand function outcomes to form a pooled measure of upper
limb function (French 2007).
Impairment: immediate outcome
We extracted data from 21 reviews related to 44 comparisons as
related to measures of impairment immediately at the end of the
intervention.Of these 44 comparisons, 19weremeasures of ’motor
impairment’ (16 were assessed using the Fugl-Meyer Assessment),
nine were measures of range of movement, eight were measures of
spasticity, seven were measures of strength and one was a measure
of sensory impairment.
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Impairment: follow-up outcome
Seven reviews contributed follow-up data related to 11 compar-
isons with measures of impairment: three motor impairment,
one strength, two spasticity and five range of movement. Most
reviews pooled data from any follow-up period, which gener-
ally occurred over three months following intervention, although
Katalinic 2010 presented data for follow-up measures of 24 hours
to one week and longer than one week.
Activities of daily living: immediate outcome
We extracted data related to 18 comparisons from 13 reviews as re-
lated to measures of ADLs. Thirteen of the comparison outcomes
comprised generic ADL assessments, most commonly Barthel In-
dex and Functional Independence Measure. Four comprised as-
sessments of activity, as measured by the Motor Activity Log. One
comparison pooled data from generic ADL assessments with mea-
sures of upper limb function (Mehrholz 2012); as these were prin-
cipally measures of ADLs, this information is presented with the
ADL outcomes.
Activities of daily living: follow-up outcome
Four reviews contributed follow-up data related to five compar-
isons, all of which included measures of generic ADLs. As in the
follow-up assessment of impairment, most reviews pooled data
from any follow-up period, but Katalinic 2010 presented data for
follow-up measures of 24 hours to one week and longer than one
week.
Quality of evidence within reviews included in
data synthesis
This section describes judgement of the quality of evidence for
each of the 127 comparisons for which data were extracted. Qual-
ity is described as high, moderate, low or very low, as derived us-
ing the objective criteria and algorithm presented in Assessment
of methodological quality of included reviews and Appendix 4.
It is important to note that this statement and categorisation of
the quality of evidence do not reflect the effectiveness of the in-
terventions in any way. The effect of interventions is reported in
the section Effects of interventions.
Table 10, Table 11, Table 12, Table 13, Table 14 and Table 15
detail comparisons judged to provide moderate- (or high-) quality
evidence; Table 16, Table 17, Table 18, Table 19, Table 20 and
Table 21 detail comparisons judged to provide low- or very low-
quality evidence. Table 22 presents data for the subgroup compar-
isons.
Quality of evidence related to effects of interventions on
upper limb function
High-quality evidence: upper limb function
No high-quality evidence was related to the effects of intervention
on upper limb function.
Moderate-quality evidence: upper limb function
Twelve of the 127 comparisons provided moderate-quality
GRADE evidence related to the effects of intervention on upper
limb function. These 12 comparisons came from nine different
reviews: five Cochrane reviews and four non-Cochrane reviews.
Ten of these comparisons related to the effects of intervention
on upper limb function immediately at the end of intervention,
providing moderate-quality evidence in relation to:
• bilateral arm training (compared with unilateral arm
training) (van Delden 2012);
• CIMT (Corbetta 2010);
• repetitive task training (French 2010);
• mental practice (Braun 2013);
• mirror therapy (Thieme 2012);
• treatment for sensory impairment (Doyle 2010);
• virtual reality (Laver 2011);
• factors in service delivery: dose of intervention (augmented
exercise) (Cooke 2010); and
• factors in service delivery: location (home-based therapy)
(Coupar 2012).
(See Table 10.)
Two of these comparisons were related to follow-up measures of
upper limb function, providing moderate-quality evidence in rela-
tion to repetitive task training (French 2010) and factors in service
delivery: dose of intervention (augmented exercise) (Cooke 2010)
(Table 11).
Low- or very low-quality evidence: upper limb function
Twenty of the 127 comparisons provided low- or very low-quality
GRADE evidence related to the effects of intervention on upper
limb function. These 20 comparisons came from 11 different re-
views. Nineteen comparisons were related to outcomes immedi-
ately at the end of the intervention (Table 16), and one to a follow-
up assessment (Table 17). A summary of the quality criteria that
led to the downgrading of each comparison to low or very low is
provided in these tables.
Quality of evidence related to effects of interventions on
upper limb impairment
High-quality evidence: upper limb impairment
No high-quality evidence was related to the effects of intervention
on upper limb impairment.
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Moderate-quality evidence: upper limb impairment
Seventeen of the 127 comparisons provided moderate-quality
GRADEevidence related to the effects of interventiononmeasures
of upper limb impairment. These 17 comparisons came from 10
different reviews: sevenCochrane reviews and three non-Cochrane
reviews.
Thirteen of these comparisons were related to the effects of in-
tervention on upper limb impairment immediately at the end of
intervention, providing moderate-quality evidence in relation to:
• bilateral arm training (compared with unilateral arm
training) (van Delden 2012);
• brain stimulation-tDCS (Elsner 2013);
• mental practice (Wang 2011);
• robotics (Mehrholz 2012);
• treatment for sensory impairment (Doyle 2010);
• stretching and positioning (Katalinic 2010);
• virtual reality (Laver 2011);
• factors in service delivery: dose of intervention (augmented
exercise) (Cooke 2010);
• factors in service delivery: location (home-based therapy)
(Coupar 2012); and
• factors in service delivery: location (telemedicine) (Laver
2013).
(See Table 12.)
Four comparisons were related to follow-up measures of upper
limb impairment, providingmoderate-quality evidence in relation
to stretching and positioning (Katalinic 2010; three comparisons)
and factors in service delivery: location (home-based therapy) (
Coupar 2012; one comparison) (Table 13).
Low- or very low-quality evidence: upper limb impairment
Thirty-nine of the 127 comparisons provided low- or very low-
quality GRADE evidence related to the effects of interventions on
upper limb impairment. These 39 came from 13 different reviews,
with 31 related to outcomes measured immediately at the end of
intervention (Table 18) and eight related to outcomes measured
at follow-up (Table 19). A summary of the quality criteria that led
to downgrading of each comparison to low or very low is provided
in these tables.
Quality of evidence related to effects of interventions on
ADL outcomes
High-quality evidence: ADL outcomes
High-quality evidence was related to one comparison exploring
the effects of tDCS on ADLs (Elsner 2013; a Cochrane review).
No other high-quality evidence was related to ADL outcomes.
Moderate-quality evidence: ADL outcomes
Ten comparisons provided moderate-quality GRADE evidence
related to the effects of intervention on measures of ADLs. These
10 comparisons came from six reviews: four Cochrane reviews and
two non-Cochrane reviews.
Seven of these comparisons were related to the effects of interven-
tion on ADL outcomes immediately at the end of intervention,
providing moderate-quality evidence in relation to:
• bilateral arm training (compared with unilateral arm
training) (van Delden 2012);
• mental practice (Braun 2013);
• mirror therapy (Thieme 2012);
• robotics (Mehrholz 2012);
• stretching and positioning (Katalinic 2010); and
• factors in service delivery: location (home-based therapy)
(Coupar 2012).
(See Table 14.)
Three comparisons were related to follow-up measures of ADL
outcomes, providing moderate-quality evidence in relation to
stretching and positioning (Katalinic 2010; two comparisons) and
factors in service delivery: location (home-based therapy) (Coupar
2012, one comparison) (Table 15).
Low- or very low-quality evidence: ADL outcomes
Twelve of the 127 comparisons provided low- or very low-quality
GRADEevidence related to the effects of interventiononmeasures
of ADL. These 12 comparisons came from eight different reviews,
with 10 comparisons related to ADL measures immediately at the
end of intervention (Table 20) and two related to follow-up ADL
assessments (Table 21). A summary of the quality criteria that led
to downgrading of each comparison to low or very low is provided
in these tables.
Quality of evidence related to other outcomes
Few data related to other outcomes defined as of interest to this
reviewwere available; consequently these are not reported in tables,
but when quality of evidence is judged to be moderate, these data
are described in relation to each individual intervention or factor
in service delivery.
Quality of evidence related to subgroup analyses
Data from 16 subgroup comparisons were extracted; these were
related to severity of stroke (three subgroup comparisons; van
Delden 2012); time post stroke (seven subgroup comparisons;
Barclay-Goddard 2011; French 2007; Laver 2011); and dose of
intervention (six subgroup comparisons; Barclay-Goddard 2011;
French 2007; Laver 2011). Ten of these subgroup comparisons
were judged to provide moderate-quality GRADE evidence, and
six to provide low-quality GRADE evidence (Table 22).
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Effect of interventions
Table 2 and Figure 2 provide a summary of the evidence of effects
of interventions; further details on the effects of each individual
intervention and factors in service delivery are provided as follows.
Individual interventions
Bilateral arm training
Moderate-quality evidence shows that unilateral arm training was
more beneficial than bilateral arm training for improving upper
limb function (six trials, 375 participants) and ADLs (three trials,
146 participants), but no difference was noted between unilateral
and bilateral arm training for measures of impairment (four trials,
228 participants) (van Delden 2012).
Only low-quality evidence was related to bilateral arm training
compared with usual care or other interventions for upper limb
function, impairment and ADL outcomes (Coupar 2010).
Biofeedback
Up-to-date data related to biofeedback were absent. Low-qual-
ity evidence compared EMG biofeedback with physiotherapy
(Woodford 2007).Qualitative information suggests that low-qual-
ity evidence was related to biofeedback, with some suggestion that
biofeedback may have some beneficial impact (Molier 2010).
Bobath approach
Only very low-quality evidence was related to the effectiveness of
the Bobath approach, and data from individual trials had not been
pooled (Luke 2004). The review search is considerably out-of-date
(last search 2003). (Note: Evidence from Kollen 2009, which was
not identified for inclusion in this overview, would also be judged
to be of low or very low quality.)
Brain stimulation
tDCS
No evidence related to the impact of tDCS on measures of upper
limb function was available.
High-quality evidence indicated that tDCS resulted in no benefit
or harm for ADL outcomes compared with placebo or control
intervention; this was based on a pooled analysis of five trials (286
participants). Moderate-quality evidence showed a beneficial im-
pact on measures of impairment, based on data from seven trials
(304 participants) comparing tDCS versus placebo or control in-
tervention (Elsner 2013).
Some evidence was related to follow-up ADL and impairment
outcomes, but this evidence was of low quality, primarily because
of the small number of trials that provided follow-up data (Elsner
2013).
rTMS
Data from upper limb function outcomes were combined with
pooled data from four trials (73 participants), providing low-qual-
ity evidence related to the impact of rTMS on upper limb func-
tion. However, data from one trial (15 participants) related to the
ARAT were classed as providing moderate-quality evidence and
demonstrated no significant benefit or harm of rTMS (standard-
ised mean difference (SMD) 0.19, 95% confidence interval (CI)
-0.84 to 1.23) (not shown in tables) (Hao 2013).
Data from two trials (183 participants) measuring ADL outcomes
were pooled, providing low-quality evidence related to the impact
of rTMS on ADL outcomes (Hao 2013).
Constraint-induced movement therapy (CIMT)
Moderate-quality evidence showed a beneficial effect of CIMT
on measures of upper limb function; this evidence came from
data pooled from 14 trials (477 participants) comparing CIMT
versus any control. Evidence related to measures of ADL outcome
was classed as of low quality, although the low-quality grading
was largely influenced by methodological limitations within the
systematic review (Corbetta 2010).
Electrical stimulation
Only low-quality evidence was related to the effectiveness of elec-
trical stimulation. Despite relatively large numbers of trials, dif-
ferences between interventions and outcomes prevented pooling
of a large portion of the data. Farmer 2014 made the decision to
not pool data from any included trials; Nascimento 2014 pooled
available data, but most studies were judged to be at high risk of
bias. Small study size and limitations with the systematic review
contributed to low-quality GRADE evidence fromMeilink 2008.
Hands-on therapy (manual therapy techniques)
Lack of trial evidence means that evidence was insufficient to per-
mit any conclusions related to the effectiveness of hands-on ther-
apy techniques (Winter 2011; qualitative synthesis only).
Mental practice
Moderate-quality evidence showed a beneficial effect of mental
practice (provided in addition to conventional exercise-based in-
terventions) on arm function (data from Braun 2013; seven trials,
197 participants) and impairment (data fromWang 2011; five tri-
als, 216 participants). The impairment outcome was based on an
analysis of trials that delivered a four-week intervention; pooled
evidence related to the effects of a six-week or eight-week inter-
vention was of very low quality (four trials, 90 participants) and
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of low quality (six trials, 282 participants), respectively.Moderate-
quality evidence showed no benefit or harm of mental practice for
ADL measures, but evidence related to follow-up measures was of
low quality, largely because of low participant numbers at follow-
up (Braun 2013).
Mirror therapy
Moderate-quality evidence showed a beneficial effect of mirror
therapy compared with any other treatment on a combined up-
per limb function and impairment outcome (10 trials, 421 par-
ticipants) and on ADL outcomes (four trials, 217 participants)
(Thieme 2012).
Music therapy
Lack of trial evidence means that evidence was insufficient to per-
mit any conclusions related to the effectiveness of music therapy
on upper limb outcomes (Bradt 2010).
Pharmacological interventions
Pharmacological interventions for spasticity
Low- and very low-quality evidence was related to the effects of bo-
tulinum toxin onmeasures of spasticity after stroke (data fromElia
2009). This is supported by evidence, which has been synthesised
narratively only, from Olvey 2010, which concludes that findings
related to the effects on upper limb function of botulinum toxin
in participants with spasticity are “inconsistent.” Methodological
limitations are seen in these reviews, and available trial evidence is
limited.
Multi-disciplinary rehabilitation following pharmacological
interventions
Demetrios 2013, a review includedwithin the qualitative synthesis
only, concludes that evidence is of low quality and that high-
quality trials are needed.
Pharmacological interventions for shoulder pain
Low- and very low-quality evidence was related to the effectiveness
of pharmacological interventions (botulinum toxin) on measures
of spasticity and shoulder range of movement in participants with
poststroke shoulder pain (data from Singh 2010; five trials, 109
participantswith stroke). Themethodological quality of the review
and the volume of participants were key contributors to the quality
of the evidence.
Repetitive task training
Moderate-quality evidence showed no benefit or harm for upper
limb function as a result of repetitive task training, immediately
at the end of intervention or at longer-term follow-up (data from
French 2007; eight trials, 412 participants). Subgroup analyses
revealed differences between subgroups related to time post stroke
and dose of intervention (see below).
’Repetitive functional task practice’ (repetitive task training
and constraint-induced movement therapy)
Pooling of data from trials of repetitive task training and con-
straint-induced movement therapy provides moderate-quality ev-
idence of a beneficial effect of repetitive functional task practice
on arm function (SMD 0.24, 95% CI 0.06 to 0.42) and a non-
significant trend towards benefit for hand function (SMD 0.19,
95% CI -0.03 to 0.42) (French 2008; data not reported in tables).
Robotics
Moderate-quality evidence showed a beneficial effect of robotics
compared with any comparison intervention (other rehabilita-
tion, placebo or no treatment) on measures of impairment (Fugl-
Meyer) (16 trials, 586 participants) and ADLs (13 trials, 552 par-
ticipants), and moderate-quality evidence indicated no benefit or
harm for measures of strength (10 trials, 321 participants) (data
from Mehrholz 2012).
In contrast, subgroup analyses reported byNorouzi-Gheidari 2012
demonstrated moderate-quality evidence of no benefit or harm of
robotics, compared with the same duration of conventional re-
habilitation, on the Fugl-Meyer Assessment (six trials, 204 par-
ticipants; SMD 0.17, 95% CI -0.14 to 0.48). Evidence related
to the effects of additional robotic therapy (delivered in addition
to conventional rehabilitation), compared with conventional re-
habilitation, demonstrated benefit but was judged to be of low
quality (four trials, 158 participants; SMD 0.46, 95% CI 0.14
to 0.78) (data not reported in tables). Norouzi-Gheidari 2012 re-
ported the same subgroup comparisons (i.e. same duration or ad-
ditional robotic therapy) for outcomes of ADLs and motor power,
but these comparisons are judged to be of low quality, and no tests
for subgroup differences are reported. The methodological quality
of this review is judged to have a key impact on the quality of this
evidence.
Sensory interventions (interventions to improve sensory
function)
Moderate-quality evidence, arising from one single, small, well-
conducted RCT (29 participants), showed that sensory stimula-
tion (thermal stimulation) had a beneficial effect on arm function,
when compared with no treatment. Moderate-quality evidence
arising from the same RCT suggested that sensory stimulation
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was more beneficial than no treatment in improving impairment
as measured by the recovery rate of the Brunnstrom assessment
(Doyle 2010).
Evidence from other small single trials of sensory stimulation or
passive sensory training was judged to be of low or very low quality
(Doyle 2010; Schabrun 2009; qualitative analysis only).
Strength training
Data for pooled comparisons of all outcomes for comparisons of
strength training with control interventions were judged to be
of low quality. However, it is important to note that the quality
judgement was downgraded for risk of bias of included trials, but
that this was based on absence of information rather than evidence
of high risk within included trials, as the review provided only
total Physiotherapy Evidence Database (PEDro) scores, and the
component scores were not available.
Low-quality evidence showed a beneficial effect of strength train-
ing on upper limb function, based on data from 11 trials (465 par-
ticipants), and of a beneficial effect on grip strength, based on data
from six trials (306 participants). Low-quality evidence showed
no benefit or harm of strength training on ADLs (five trials, 210
participants) (Harris 2010).
(Note: Ada 2006 is currently awaiting assessment for inclusion
within this review and contains evidence related to the effects of
strength training.)
Stretching and positioning
One high-quality review (Katalinic 2010) provided moderate-
quality evidence suggesting no benefit or harm of stretching com-
pared with any other intervention for measures of impairment
(joint mobility and spasticity) and ADLs. This finding pertains
to measures taken within 24 hours of the end of the interven-
tion, those taken between 24 hours and one week after the inter-
vention and those taken more than one week after the interven-
tion. However, this review pools data from trials including a wide
range of populations, interventions and comparison groups, and-
other than presenting data from the subgroup of trials with partic-
ipants with neurological conditions-no subgroup data related to
these variables are presented. Three other reviews (Borisova 2009;
Hijmans 2004; Lannin 2003) provide what is effectively subgroup
comparisons of the populations, interventions and comparisons
included by Katalinic 2010; however, all of these reviews are out-
of-date (search dates May 2003 to June 2005) and have several
methodological limitations. Evidence arising from these reviews
is judged to be of low or very low quality, and evidence is limited
by the small numbers of participants within the comparisons ex-
plored and by the methodological quality of the reviews.
Shoulder supports
Low-quality evidence, derived from an out-of-date review, show
no benefit of shoulder supports on arm function (one trial, 83
participants), shoulder external rotation (one trial, 14participants)
and contracture (one trial, 81 participants) (Ada 2005).
Task-specific training
Reach-to-grasp exercise
Evidence was insufficient to permit conclusions related to the ef-
fectiveness of reach-to-grasp exercise, as no high-quality systematic
review has explored this intervention (Pelton 2012; Urton 2007;
both in qualitative synthesis only).
Virtual reality
Moderate-quality evidence shows a beneficial effect of virtual real-
ity from a pooled analysis including measures of both upper limb
function (ARAT,WMFT) and impairment (Fugl-Meyer outcome)
(seven trials, 205 participants). Moderate-quality evidence also
suggests a beneficial effect on the Fugl-Meyer outcome alone (five
trials; 171 participants; all of these data were included within the
pooled analysis of upper limb function and impairment). Moder-
ate-quality evidence, based on two trials (44 participants), further
shows no benefit or harm of virtual reality on grip strength (Laver
2011).
Factors in service delivery
Dose of intervention
Moderate-quality evidence from three trials (258 to 319 partici-
pants) showed no benefit or harm of increased dose of interven-
tion for arm function or strength. Moderate-quality evidence also
suggested no benefit or harm for arm function at six-month fol-
low-up, although evidence at shorter follow-up length was of low
quality. Evidence related to impairment outcomes at follow-up
was of low quality (Cooke 2010).
Evidence from subgroup analyses
Evidence related to dose of intervention was extracted from sub-
group analyses within reviews related to CIMT (Sirtori 2009),
mental practice (Barclay-Goddard 2011), repetitive task training
(French 2007) and virtual reality (Laver 2011).
Moderate-quality evidence was related to the subgroups of trials
that delivered between 0 and 20 hours or more than 20 hours of
repetitive task training, with evidence that the subgroup receiv-
ing more than 20 hours had a beneficial effect (three trials, 113
participants). However, a significant subgroup difference between
these groups based on dose of intervention was not reported (P
31Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
value 0.31) (data from French 2007). Similarly, moderate-qual-
ity evidence was related to the subgroups of trials that delivered
more or less than 15 hours of virtual reality, with evidence that
the subgroup receiving more than 15 hours had a beneficial effect
(five trials, 171 participants), but no significant subgroup differ-
ence between these groups was reported (P value 0.87) (data from
Laver 2011).
Subgroup analyses related to the dose of CIMTwere extracted only
for our secondary outcome of ADL measures. A non-significant
(P value 0.07) trend towards a greater effect was noted with a
CIMT dose less than or equal to 30 hours (Sirtori 2009; data not
entered in tables; more than 30 hours of exercise, two trials, 73
participants; SMD 0.02, 95% CI -0.44 to 0.49; 30 hours or less
of exercise, four trials, 111 participants; SMD 0.58, 95% CI 0.20
to 0.97).
Subgroup analyses related to dose of mental practice were of low
quality and did not indicate a difference between participants who
received more or less than 360 minutes (P value 0.30) (Barclay-
Goddard 2011).
Service location
Home-based therapy
For the comparison of home-based therapy programmes for up-
per limb recovery versus usual care, moderate-quality evidence
showed no benefit or harm for measures of upper limb function
immediately after intervention (one trial, 100 participants); ADL
outcomes, both immediately after intervention (two trials, 113
participants) and at longer-term follow-up (one trial, 80 partici-
pants); and extended ADL outcomes, both immediately after in-
tervention (two trials, 113 participants; mean difference (MD)
0.83, 95% CI -0.51 to 2.17) and at longer-term follow-up (one
trial, 80 participants; MD 0.80, 95%CI -0.96 to 2.56) (data from
extended ADLs not provided in data tables). For measures of im-
pairment based on the Fugl-Meyer Assessment, moderate-quality
evidence similarly showed no benefit or harm immediately after
intervention (three trials, 156 participants); however, at follow-up
moderate-quality evidence of benefit favoured home-based ther-
apy (one trial, 36 participants) (Coupar 2012).
Evidence related to the comparison of upper limb therapy deliv-
ered at home versus in hospital was of low quality. Data were avail-
able for only one trial (10 participants), which was judged to be
at high risk of bias (Coupar 2012).
Telerehabilitation
No data related to the primary outcome of upper limb function
were presented in the available review (Laver 2013). Data from
two small trials (46 participants) provided moderate-quality evi-
dence related to upper limb impairment, as measured by the Fugl-
Meyer Scale, demonstrating that telerehabilitation (comprising a
computer-based training programme) resulted in no benefit or
harmwhen compared with usual care (MD 3.65, 95%CI -0.26 to
7.57). These data also contribute to themoderate-quality evidence
showing no benefit or harm of home-based upper limb therapy
for measures of impairment (see above).
Severity of stroke
Evidence from subgroup analyses
Evidence related to severity of stroke was extracted from sub-
group analyses within reviews related to bilateral arm training (van
Delden 2012) and strength training (Harris 2010). No significant
subgroup differences related to stroke severity in terms of improve-
ments in upper limb function occurred as a result of bilateral arm
training versus unilateral arm training (P value 0.60).
Harris 2010 presents a meta-analysis for subgroups of participants
who have moderate or mild impairment after stroke. However,
no test for subgroup differences is reported, limiting the ability to
draw conclusions from these data (data not provided in tables).
Time post stroke
Evidence from subgroup analyses
Evidence related to time post stroke was extracted from sub-
group analyses within reviews related to CIMT (Sirtori 2009),
mental practice (Barclay-Goddard 2011), repetitive task training
(French 2007), robotics (Norouzi-Gheidari 2012), strength train-
ing (Harris 2010) and virtual reality (Laver 2011).
Subgroup analyses related to the effects of time post stroke follow-
ing CIMTwere extracted only for our secondary outcome of ADL
measures. No significant subgroup differences related to time post
stroke were noted for improvements in ADL outcomes as a result
of CIMT (P value 0.39) (Sirtori 2009; data not presented in ta-
bles).
Subgroup analyses related to effects of time post stroke on mental
practice outcomes were of low quality and showed no differences
between participants who weremore and less than six months post
stroke (P value 0.78) (Barclay-Goddard 2011).
Subgroup analyses comparing trials with participants who were
zero to 15 days, 16 days to six months or more than six months
post stroke found no significant subgroup differences between
groups for measures of arm function (P value 0.98), and all groups
demonstrated no benefit or harm from the repetitive task training
intervention (data from French 2007). Similarly, subgroup anal-
yses of participants who were more or less than six months post
stroke found no significant subgroup differences between groups
for a composite upper limb function and impairment measure (P
value 0.37), although both groups demonstrated a beneficial effect
of the virtual reality intervention (data from Laver 2011).
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Both Norouzi-Gheidari 2012 and Harris 2010 reported meta-
analysis results for subgroups of participants in the acute/subacute
or chronic phase after stroke. However, no test for subgroup dif-
ferences is reported in either of these trials, limiting the ability to
draw conclusions from these data, which relate to robotics and
strength training, respectively (data not provided in tables).
Farmer 2014 explored intervention effect size (from trials of assis-
tive technologies, which primarily included electrical stimulation,
CIMT, biofeedback and robotics) in relation to time post stroke,
providing some very limited evidence that the greatest effects are
achieved with treatment in the acute phase after stroke. Farmer
2014 also reported evidence from an individual trial that early
treatment with CIMT may cause adverse effects in some groups
of stroke patients.
Indirect comparisons between interventions
As stated in the methods (Data collection and analysis), although
we had planned for potential indirect comparisons, no indirect
comparisons have been carried out because different outcomemea-
sures were combined with the use of SMDs and levels of hetero-
geneity were judged to be high between trials within reviews. In-
stead, when a comparison was judged to yield moderate-quality
evidence related to the effects on our primary outcome of upper
limb function, and when the review reported an SMD and 95%
CIs, we plotted these results on a graph to provide a visual repre-
sentation of effect sizes. This is presented in Figure 5. We recom-
mend that no conclusions should be drawn related to differences
in effect sizes between these interventions, as evidence varies in
relation to key parameters such as dose of intervention and time
post stroke.
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Figure 5. Effects of interventions: upper limb function. Moderate-level GRADE evidence (comparisons
reporting standardised mean differences only).Comparison of intervention versus any other control (including
no treatment, control or usual care), unless otherwise stated (as in the comparison of bilateral arm training vs
unilateral arm training).Favours intervention if to the right of the zero line (for comparison of bilateral vs
unilateral arm training-favours unilateral arm training).
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D I S C U S S I O N
This overview included 40 reviews related to interventions for
improving upper limb function after stroke, with some areas of
overlap noted between the trials included within these reviews.
However, it is important to note that we specifically excluded 37
additional reviews because they had been superseded by a later
review, or contained no additional trials compared with a review of
similar, or higher,methodological quality. Identifying themost up-
to-date evidence related to interventions to improve upper limb
function is clearly challenging because of overlap between reviews.
The quality of the included reviews varied substantially.
Overlap between reviews and methodological limitations within
some reviews present significant challenges to clinicians and policy
makers seeking synthesised evidence to aid clinical decision mak-
ing.
We identified reviews related to 18 different individual interven-
tions, many of which included several subcategories of interven-
tion types; this further confirms the challenges involved in identi-
fying the best intervention for an individual patient. This overview,
therefore, has an important role in synthesising best evidence on
upper limb rehabilitation interventions into a single, accessible,
comprehensive document, thus supporting clinicians and policy
makers in clinical decision making for stroke rehabilitation.
Summary of main results
High-quality evidence
High-quality evidence related to the effectiveness of interventions
in improving upper limb function is absent, and evidence is in-
sufficient to permit confident recommendations regarding specific
interventions for routine use in clinical practice.
The only high-quality evidence identified within this overview
demonstrated that tDCS had no beneficial effect (or harm) for
ADL outcomes. This finding leads us to recommend that tDCS
should not be introduced into routine clinical practice. However,
moderate-quality evidence of a beneficial effect of tDCS on upper
limb impairment indicates that tDCS does merit further investi-
gation within clinical trials.
Moderate-quality evidence related to a relatively small number
of interventions can be used to support clinical decision making.
Current evidence is insufficient to enable indirect comparisons of
the relative effects of different interventions; consequently, selec-
tion of interventions must be based on expert clinical reasoning
and judgement following assessment of an individual patient and
with due consideration for the patient and patient goals, prefer-
ences and setting.
Individual interventions with moderate-quality
evidence of effect
Moderate-quality evidence suggests that CIMT, mental practice,
mirror therapy and virtual reality may be beneficial in the treat-
ment of upper limb function after stroke, but adequately powered,
high-quality RCTs are required to confirm the benefits of these
interventions.
Moderate-quality evidence suggests that robotics may be effective
in improving upper limb impairment and ADL outcomes. How-
ever, robotics may not be more beneficial than conventional ther-
apy at the same dose. Further research is required to explore this,
and all trials should be careful to control for the effects of dose
when exploring novel interventions and assistive modalities. We
recommend further research into robotics before robotic devices
are introduced into routine clinical practice.
In relation to the dose of intervention, moderate-quality evidence
indicates that repetitive task training provided no benefit or harm;
however, the subgroup with the greatest number of repetitions
showed beneficial effects. We recommend that the current review
of repetitive task training be updated and large-scale RCTs carried
out to explore the effects of dose, including number of repetitions
during repetitive task training. Further research may be required
to explore the impact of different treatment parameters to inform
the development of large-scale RCTs related to the effects of dose.
Somemoderate-quality evidence is related to one formof interven-
tion for sensory impairment; however, this evidence came from just
one high-quality RCT, and further high-quality trials are therefore
recommended.We do not recommend changes to clinical practice
based on this single RCT; however, interventions for sensory im-
pairment are already used widely within routine clinical practice.
Moderate-quality evidence suggests that bilateral arm training is
not as effective as unilateral arm training. This evidence shows that
further research investigating bilateral arm training as a generic
intervention for the population of people with impaired arm func-
tion after stroke may not represent an efficient use of resources.
However, current reviews synthesise a clinically diverse range of
bilateral arm training interventions, tend to use outcomemeasures
designed to assess unilateral arm function (i.e. function of the im-
paired limb) and tend to not assess function using both arms to-
gether. Consequently, future research into bilateral arm training
interventions may be justified if a sound theoretical rationale can
be provided for both the intervention and the outcome measure.
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Individual interventions with moderate-quality
evidence of no benefit or harm
Moderate-quality evidence shows no benefit or harm associated
with repetitive task training. However, as stated above, evidence
shows a dose response, and further research into the issue of dose
is essential (see below). It is essential that future trials of repeti-
tive task training achieve what is proposed to be minimum num-
bers of repetitions for successful skill acquisition. Current evidence
shows that an average of more than 300 repetitions per practice
session may be required to achieve improvements in arm function
(Birkenmeier 2010).
Moderate-quality evidence also shows no benefit or harm associ-
ated with stretching and positioning interventions. However, this
evidence was derived from a wide range of populations with var-
ied intervention and comparison groups. We recommend further
exploration to investigate the effects of clearly targeted interven-
tions on specific groups of participants. The issue of dose of inter-
vention (including duration, frequency and joint angle) is likely
to be central to the effect of stretching and positioning interven-
tions, and we urge researchers to ensure that research protocols
comprise doses that are theoretically predicted to effect change.
High-quality up-to-date reviews are required for all stretching and
positioning interventions.
Individual interventions with low-quality
evidence
Up-to-date reviews required
Evidence related to the following interventions is currently of low
quality; high-quality, up-to-date reviews are recommended to ad-
equately inform the current state of evidence.
• Biofeedback.
• Bobath therapy. (Note: A Cochrane review is currently
exploring the effectiveness of the Bobath approach but excludes
trials focused only on the upper limb (Pollock 2014). A review
similar to this is needed but should include upper limb trials. As
in Pollock 2014, the challenge of defining the Bobath concept
would have to be addressed within any review of upper limb
trials.)
• Electrical stimulation. (Note: An ongoing review is related
to functional electrical stimulation (Howlett (Ongoing)), but this
is unlikely to cover all evidence related to electrical stimulation.)
• Strength training. (See also recommendations for high-
quality RCTs, below.)
• Task-specific training. (Note: An ongoing review is related
to reach-to-grasp exercise-Diermayr (Ongoing).)
• Pharmacological interventions. (Note: We are aware of at
least one phase III RCT that has not been included within
current reviews (Shaw 2011); updating of current reviews is
required to include this trial evidence.)
In addition, subgroup analyses are recommended to explore dif-
ferent populations, interventions and comparisons in relation to
stretching and positioning interventions. An ongoing review is re-
lated to assistive devices for contractures and may explore some of
these recommended subgroups (Meeran (Ongoing)). An update
of the review of repetitive task training is recommended, as are
high-quality analyses related to the effects of CIMT on measures
of impairment and ADL outcomes.
High-quality RCTs required
Despite high-quality systematic reviews, evidence in relation to
many interventions remains of low quality, and high-quality RCTs
are recommended.We support recommendations for further high-
quality RCTs, as provided within up-to-date high-quality system-
atic reviews. Interventions for which further RCTs are recom-
mended include rTMS (Hao 2013), hands-on therapy (Winter
2011), music therapy (Bradt 2010) and pharmacological interven-
tions (Demetrios 2013).
For interventions for sensory impairment (Doyle 2010), we deter-
mined that some moderate-quality evidence currently shows ben-
efit in trials synthesised within high-quality reviews, but further
high-quality RCTs with appropriate attention controls are recom-
mended.
Although we recommend an up-to-date systematic review related
to upper limb strength training (see above), we do consider that
current evidence is sufficient to justify (see, for example, Ada 2006)
support of recommendations for high-quality RCTs.
Factors in service delivery
Dose of intervention
Moderate-quality evidence from a systematic review of trials of
increased dose of exercise shows that increased dose of interven-
tion provides no benefit or harm (Cooke 2010). However, some
evidence from subgroup analyses indicates that a greater effect size
may occur with increased dose of an individual intervention.Mod-
erate-quality evidence from subgroup analyses comparing greater
and lesser doses ofmental practice (Barclay-Goddard 2011), repet-
itive task training (French 2007) and virtual reality (Laver 2011)
demonstrates a beneficial effect for the group given the greater
dose, but not for the group given the smaller dose. However, in
none of these cases does a test for subgroup differences suggest
a statistically significant difference between groups. The issue of
dose is central to establishing meaningful high-quality evidence
related to rehabilitation interventions, and we recommend that:
• all reviews of upper limb interventions should explore
subgroups based on dose of intervention;
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• RCTs of upper limb interventions should consider the
impact of dose and, when appropriate, ensure that control
interventions are matched for dose; and
• RCTs related to dose of upper limb intervention should be
carried out. These should consider length of treatment sessions,
number of treatment sessions and length of treatment period, as
well as intensity of interventions (including number of
repetitions and, when appropriate, resistance applied).
We identified two ongoing reviews that may further inform
the evidence base related to dose of intervention (Galvin 2012
(Ongoing); Schneider (Ongoing)).
Location of intervention
Some evidence has been found for the effectiveness of home-based
therapy programmes (Coupar 2012) and telemedicine (Laver
2013) in improving upper limb function. However, interpreta-
tion of this evidence is limited by the intervention delivered to
the control group, which was often “usual care,” rather than a
comparison with another service location. Furthermore, the evi-
dence base is limited by the fact that overlap is evident between
the trials included within the reviews of home-based therapy and
telemedicine, with both including the same trials of a computer-
based intervention. If trials, or reviews, related to the location of
the intervention are to be carried out, we recommend that the
question to be answered should be clearly defined, and if the ques-
tion relates to comparison of outcomes when rehabilitation is pro-
vided in one setting (e.g. home) versus another (e.g. hospital), tri-
als/reviews should be planned accordingly.
Time post stroke and severity of impairment
All evidence related to the influence of time post stroke and severity
of initial upper limb impairment on the effect of interventions is
of low quality. We recommend that the issue of the best time at
which to offer rehabilitation interventions for the upper limb, and
to which participants, is explored within high-quality RCTs, and
that all RCTs of upper limb interventions consider the impact of
these issues. We also recommend that all reviews of upper limb
interventions, when possible, explore subgroups based on time
post stroke and severity of initial upper limb impairment.
Overall completeness and applicability of
evidence
Completeness of evidence within reviews
Review evidence related to interventions to improve upper limb
function after stroke is not complete.We have identified several re-
views that require updating and for which methodological limita-
tions need to be addressed. We did identify some ongoing reviews
that were relevant to these areas. In addition, we identified two
individual interventions (acupuncture and self-management) for
which there is currently only an ongoing review (Kidd (Ongoing);
Liang 2011 (Ongoing)). There may be additional interventions
for which no review, or no registered ongoing review, has been
conducted; it is therefore impossible to be entirely confident that
all relevant upper limb interventions are covered by at least one
review and included within this overview. However, we did iden-
tify some reviews that covered a broad mixture of different inter-
ventions; we considered all interventions covered by these reviews,
and we believe this increases the chance that we will have success-
fully identified all interventions for which some primary research
evidence is available in the form of RCTs.
The search dates of included reviews, as illustrated in Figure 6,
range from December 2003 to July 2013. The mean search date
is around February 2010. We recommend urgent updating for re-
views on three topics for which the longest time since last search
has passed; these include biofeedback, Bobath therapy and repet-
itive task training. Updating of reviews is clearly a challenge, but
it is essential to the completeness of the evidence base. Decisions
to update must be made with consideration of the priority of the
review topic, the likelihood of new high-quality trials and the cur-
rent quantity and quality of evidence within the review. A high-
quality up-to-date review of an intervention should be prepared
before any further RCTs are undertaken, so that primary research
can be appropriately informed by the current evidence base.
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Figure 6. Date of last search for evidence for identified interventions.
For some interventions and topics, we have identified a large num-
ber of overlapping reviews, and determining themost comprehen-
sive and up-to-date review was complex. We urge researchers to
take action to avoid publication of overlapping or similar reviews
by searching for reviews and protocols before initiating a review,
by publishing review protocols and by clearly highlighting when
a new publication supersedes previous publications. Registration
and publication of Cochrane reviews is designed to avoid the
challenges associated with overlapping reviews, and the Cochrane
Stroke Review Group takes steps to ensure that no overlap occurs
between Cochrane reviews. When a Cochrane review is out-of-
date, researchers interested in an updated review on that topic or
intervention are encouraged to contact the Cochrane Stroke Re-
viewGroup to discuss collaboration on updating the review, rather
than preparing an alternative journal publication.
Applicability of evidence
The aim of this overview was to synthesise best evidence on upper
limb rehabilitation interventions into a single, accessible, compre-
hensive document, thus supporting clinicians and policy makers
in clinical decision making for stroke rehabilitation. However, the
aim was not to bring together all evidence required to make an
individual treatment decision about an individual patient within
a specific setting. This overview serves to signpost clinicians and
policy makers toward relevant systematic reviews to support clin-
ical decisions. It is the nature of stroke rehabilitation research and
clinical practice that the application of evidence to an individual
patient or healthcare setting will depend on the specific details of
that patient or setting, and that clinical decisions require expert
clinical reasoning and judgement if available evidence is to be in-
terpreted and applied effectively. Before any evidence is applied,
we therefore recommend that clinicians and policy makers are
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guided to the appropriate review, and that they consider carefully
the details of the trials synthesised within that review, specifically
reflecting on the relevance of the participant population, trial set-
ting and context, interventions delivered and outcomes assessed in
relation to the clinical decision to be made. We believe that, given
the large volume of overlapping evidence and the variable quality
of this evidence, this overview can serve to efficiently guide clini-
cians and policy makers to the most appropriate review evidence.
Within this overview, in addition to variations among participants,
interventions, setting and context, we specifically found that the
dose of interventions, outcomes and comparisons were central
to assessment of the potential applicability of evidence. Further
discussion related to the impact of these on the applicability of
evidence is provided in Appendix 5.
Quality of the evidence
Assessment of quality of included reviews
We assessed the quality of included reviews using a modified ver-
sion of the AMSTAR tool to derive answers to the original AM-
STAR questions (Table 1). Despite a number of challenges associ-
ated with development and use of the mAMSTAR and AMSTAR
tools (see Appendix 3 for further discussion and details), we be-
lieve that our use of mAMSTAR questions has provided substan-
tial benefit, and that our clear reporting of agreed upon responses
(in Figure 4) enhances the transparency of our judgements and
provides the reader with a detailed overview of methodological
components of each review.
Quality of included reviews
We have provided a detailed, transparent assessment of the qual-
ity of included reviews in Figure 4 and Table 8 and have de-
scribed issues related to each of the 11 AMSTAR questions in
Methodological quality of included reviews. There is clearly a dif-
ference in the number of ’yes’ responses betweenCochrane reviews
and non-Cochrane reviews. However, the data demonstrate that
many of these differences are accounted for by poor reporting of
information within some of the non-Cochrane reviews (i.e. lack
of ’yes’ responses reflects an absence of, or unclear, information,
rather than reflecting poor methods per se).
Within the included reviews, we have identified various methods
of assessing and reporting the quality of included studies. These
are briefly summarised and discussed in Table 23.
In the past, full and adequate reporting of methodological de-
tails of reviews has been challenging because of the word restric-
tions of a journal publication. However, this should no longer be
a limitation of adequate reporting, now that most journals pro-
vide opportunities for publication of online supplementary ma-
terial (Hoffmann 2014a). Despite opportunities for online ma-
terial, we found less comprehensive reporting in non-Cochrane
reviews, which, for example, rarely reported details of excluded
studies. For reviews to be useful and inform clinical decisions, ad-
equate reporting of methods is essential. We urge review authors
and journal editors to ensure that minimum reporting standards
are achieved. As guidelines and checklists are increasingly used by
journal editors in considering study and review methodology, this
endeavour should support improved reporting.
Many reviews of stroke rehabilitation interventions will include
trials that explore a wide range of diverse interventions, partici-
pants and outcome measures. This diversity presents additional
challenges to review quality. If reviews are to inform clinical prac-
tice, it is essential that they contain adequate descriptions of inter-
ventions investigated and participants included. We believe that
further work is required to enhance reporting and assessment of
these details in a systematic and clinically relevant way, and that
this will be supported by the use of tools such as the recently de-
veloped template for intervention description and replication (TI-
DieR) checklist (Hoffmann 2014b). Often review authors make
important decisions related to whether to pool (or to not pool)
data arising from relatively diverse trials. Such decisions should
always be fully explored and discussed to highlight the benefits
and limitations associated with the decision, and appropriate steps
should be taken by review authors to avoid the introduction of bias
at this stage of the review process. We believe that further work
is required to establish transparent methods designed to avoid in-
troduction of bias at the stage of decision making related to meta-
analyses of data related to diverse interventions.
Assessment of quality of evidence in included reviews
Systematically establishing the quality of evidence has been central
to this overview, and considerable work has gone into ensuring
objective and consistent application of GRADE levels of evidence
to all comparisons contributing data to this review. Our methods
of objectively determining GRADE levels of evidence, based on
assessment of the quality of included reviews and the quality of
trials within the included reviews, are described in the methods
section, and further details are provided in Appendix 4.
Further work is clearly required to explore our methods of ap-
plying GRADE levels of evidence. However, in the absence of
this, we believe that our objective application and determination
of GRADE levels of evidence provide substantial benefit to our
overview. We have assessed the quality of evidence using a trans-
parent, objective process, with consideration of both the quality of
the review and the trials included within the review, while remov-
ing potential risk of bias associated with subjective interpretation
and application of this evidence. Further discussion related to our
method of objectively determining GRADE levels of evidence is
provided in Appendix 4.
Quality of evidence in included reviews: GRADE levels of
evidence
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Details of GRADE levels of evidence applied to comparisons
within this overview are presented in the section ’Quality of
the evidence within reviews included in data synthesis’ within
Methodological quality of included reviews. Only one of the 127
included comparisons was judged to provide high-level GRADE
evidence. Just over one-third of the comparisons were judged to
provide moderate-level GRADE evidence (49/127), and the re-
maining two-thirds (77/127) were judged to present low- or very
low-quality GRADE evidence. Reasons for judging evidence as
low or very low were related to all criteria judged in assessment
of the evidence-number of participants, risk of bias of included
trials, heterogeneity within analyses andmethodological quality of
the review. As most evidence related to interventions to improve
upper limb function after stroke is of low quality, this will have a
significant impact on clinical decision making; consequently, con-
siderable expertise is required to enable clinical decisions. Expert
clinical judgement will be a key component of any decision-mak-
ing process. Further research is urgently required to improve the
quality of evidence available to support clinical decisions related to
upper limb rehabilitation after stroke. Specific recommendations
have been made regarding future research related to the individual
interventions assessed. These recommendations include full-scale
definitive RCTs for those interventions for which current evidence
of benefit is of moderate quality; and for interventions with low-
quality evidence, updated high-quality reviews or further primary
research will contribute to an existing review.
Potential biases in the overview process
We identified reviews for inclusion by searching CDSR, DARE
andPROSPERO.We also included other relevant reviews ofwhich
review teammembers were aware.We agreed on a cutoff point and
did not include reviews published after this date. The extent of our
search, the inclusion of reviews of which review team members
were aware and the introduction of a cutoff potentially introduced
biases to the reviews selected for inclusion. However, we did ensure
that the decision to include any identified reviews was based on
an independent assessment by two overview authors, with discus-
sion involving a third overview author when disagreement arose.
We also used two independent review authors at all stages of as-
sessment of the quality of included reviews. When one member
of our overview team was an author of an identified review, that
person was not involved in assessment of that review. When data
were extracted from a review, one overview author extracted these
onto a spreadsheet, and a second overview author checked each
entry against the original review. We used objective criteria to (1)
determine the AMSTAR responses from the mAMSTAR, and (2)
allocate a GRADE level of evidence from quality assessment of the
review and of the trials included in the review. Although we recog-
nise that potential biases exist at all stages of the overview process,
we believe that we have taken appropriate steps to reduce these
biases throughout the process. In particular, we believe that our
use of objective criteria to apply the GRADE level of evidence has
substantially reduced potential subjectivity and bias at this stage,
has resulted in a transparent and reproducible system and is a key
strength of this overview.
Our search of DARE may have failed to reveal some potentially
relevant non-Cochrane reviews; this was particularly the case for
reviews for which a record but no structured abstract was avail-
able. In these cases, our search was limited to the review title and
assigned medical subject heading (MeSH) terms. When reviews
were not specifically focused on the upper limb, it is likely that
our search strategy will have failed to identify them as potential
reviews. Subsequent to our search, we have identified two reviews
for which records, but no structured abstracts, were available on
DARE at the time of our search (Ada 2006; Kollen 2009). Neither
of these reviews included terms relevant to the upper limb within
the review title or assigned MeSH terms, yet they are potentially
relevant to this overview. We will assess these reviews for inclu-
sion in future updates of this overview. Ideally, non-Cochrane re-
views would be identified through complete searches of electronic
databases (including MEDLINE, EMBASE, the Cumulative In-
dex to Nursing and Allied Health Literature (CINAHL) and the
Physiotherapy Evidence Database (PEDro)), using a comprehen-
sive systematic review methodology filter.
The quality of the reviews included in this overview and the quality
of the studies included within these reviews have varied substan-
tially. We did not exclude reviews on the basis of methodological
quality or the quality of included studies. However, we have taken
steps to reflect any limitations in the quality of the evidence by
considering key quality components in our assessment and judge-
ment of the quality of evidence. It is clear that methodological lim-
itations within both the reviews and the studies included within
the reviews mean that all evidence within this overview should be
interpreted with caution, as several biases may exist.
We systematically explored overlap between the studies included
within reviews; we then made judgements as to which was the
most up-to-date or comprehensive review in relation to each in-
tervention. We attempted to do this in a rigorous, transparent
manner; however, we were required to make a number of complex
decisions. The decision whether one review was more up-to-date
or more comprehensive than another was often complicated by
the fact that some reviews included studies other than RCTs, some
included participant populations other than those with stroke and
some included studies related to a mixture of different interven-
tions (so the number of included studies alone was not a reflection
of the relevant high-quality evidence associated with one inter-
vention). In making decisions about whether one review had been
superseded by another, we considered themAMSTAR assessment,
but we did not have objective criteria on which to base these de-
cisions, and each decision was made through discussion between
overview authors. Therefore, potential risk of bias was associated
with decisions made by the overview authors in relation to which
reviews were included.
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Several potential biases were associated with data related to com-
parisons presented within the tables of ’Effects of interventions’
(Tables 9 to 21) and summarised within Figure 2 and Table 2. In
particular, we have provided few details related to the content of
the comparison group, and these details are often unclear within
the reviews.Many review authorsmake decisions to pool data from
trials that include a range of diverse comparison groups, includ-
ing no treatment, control and attention control, usual care and
other alternative interventions. This introduces a potential risk of
bias, and the ’alternative’ intervention should always be considered
when clinical decisions are made on the basis of available evidence.
In addition, although we took substantial steps to avoid inclusion
of reviews with overlapping studies, there remain some studies that
contribute to more than one included review. We have attempted
to highlight all situations in which this occurred, but this remains
a potential bias within this overview.
Agreements and disagreements with other
studies or reviews
We are unaware of any other overviews or reviews of reviews ex-
ploring the evidence related to upper limb rehabilitation.
After the cutoff date for inclusion within this overview, a large
review of RCTs of physical therapy interventions was published
(Veerbeek 2014). The aim of that review was to synthesise evi-
dence and carry out meta-analyses related to “stroke rehabilitation
interventions in the domain of physical therapy.” This review cov-
ers physical interventions to improve upper limb function that are
also included in this overview. Pharmacological and brain stimula-
tion interventions included within this overview are not included.
A summary of the characteristics of this review is available in
Appendix 6, along with our assessment (based on assessments by
two independent overview authors) of the methodological quality
of this review using mAMSTAR.
The key difference between our overview and this large review
by Veerbeek 2014 is that Veerbeek 2014 has based assessments of
the evidence on RCTs, but we have used only reviews of RCTs.
Furthermore, Veerbeek 2014 assessed the quality of RCTs using
the PEDro score and considered any trial with a score greater
than or equal to 4 to be of “high quality.” This assessment of
“high quality” does not take into consideration criteria such as
volume of evidence or heterogeneity of pooled data (although this
information is reported). Clearly some advantages are associated
with using RCT evidence directly, rather than reviews of RCTs,
as this avoids the potential risks of bias associated with review
methods and reporting.
The conclusions from both our overview and the review of
Veerbeek 2014 are in agreement that evidence suggests a benefi-
cial effect (on outcomes of upper limb function, impairment and/
or ADLs) for CIMT, mental practice, robotics, interventions for
sensory impairment and virtual reality.
It is important to note that Veerbeek 2014 reported a significant
increase in upper limb muscle tone among participants receiving
virtual reality interventions.
Our overview of evidence also concluded that moderate-quality
evidence suggests a beneficial effect of mirror therapy. In contrast,
meta-analyses performed by Veerbeek 2014 demonstrated a non-
significant effect on outcomes or motor function and arm-hand
activities. Veerbeek 2014 reported no significant effect of bilateral
training; this is consistent with our findings when bilateral arm
trainingwas comparedwith usual care or other control, but we also
concluded that moderate-quality evidence shows that unilateral
arm training was more beneficial than bilateral arm training.
We concluded that an up-to-date systematic review of RCTs re-
lated to electrical stimulation is needed, and, based on the lack
of review evidence, we judged evidence related to electrical stim-
ulation to be low-quality GRADE evidence. Veerbeek 2014 has
carried out a series of meta-analyses of RCT data related to electri-
cal stimulation, which demonstrate that neuromuscular stimula-
tion of the wrist/finger flexors/extensors has a significant beneficial
effect on measures of upper limb function, motor function (im-
pairment) and muscle strength (22 trials, 894 participants). Elec-
tromyography-triggered neuromuscular stimulation of the wrist/
finger extensors showed a significant beneficial effect on measures
of upper limb impairment (25 trials, 492 participants). No evi-
dence revealed an effect of transcutaneous electrical nerve stimu-
lation (TENS) (four trials, 484 participants).
Veerbeek 2014 concluded that significant benefit is associatedwith
high-intensity exercise or practice (effect size 0.21, 95% CI 0.02
to 0.39). We found evidence from subgroup analyses of benefit
associated with higher doses or greater intensity of interventions.
However, we found no evidence of a beneficial effect in reviews
that provided pooled data related to intensity or dose.
In conclusion, comparison of this overview with the review of
RCTs by Veerbeek 2014 revealed the following.
• Broad agreement regarding the level of evidence, and, when
evidence of benefit is apparent, for most interventions, it is
agreed that CIMT, mental practice, robotics, interventions for
sensory impairment and virtual reality are potentially beneficial
interventions.
• Broad agreement regarding evidence demonstrating the
benefit of increased dose of intervention, although our overview
is cautious about drawing conclusions based on this evidence.
• Disagreement regarding evidence related to mirror therapy,
with our overview concluding that there is evidence of benefit,
and Veerbeek 2014 concluding that there is no evidence of
benefit;we recommend further exploration of RCT data related
to mirror therapy.
• We have recommended an updated review and meta-
analysis of evidence related to electrical stimulation; Veerbeek
2014 reports the results of analysis of evidence related to
electrical stimulation, suggesting that this intervention may
provide beneficial effects.
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• Broad agreement regarding interventions for which low-
quality evidence is currently available and further research is
required.
A U T H O R S ’ C O N C L U S I O N S
Large numbers of overlapping reviews are related to interven-
tions to improve upper limb function following stroke, and this
overview serves to signpost clinicians and policy makers toward
relevant systematic reviews to support clinical decisions, providing
a single, accessible, comprehensive document that brings together
all relevant reviews (see Table 2 for a brief summary of results and
implications). This overview should also play a key role in research
prioritisation, ensuring effective use of resources, promoting col-
laborative working toward shared priorities and avoiding duplica-
tion of effort.
High-quality evidence related to the effectiveness of interventions
to improve upper limb function is urgently needed, as is effective
collaboration to support large, robust RCTs of interventions cur-
rently used routinely within clinical practice. There is a particular
need to establish evidence related to dose of interventions, as this
has widespread implications for clinical practice, organisation of
rehabilitation services and future research.
Implications for practice
A diverse range of interventions are aimed at improving upper
limb function after stroke. In general, evidence is of low qual-
ity and does not support clear clinical decisions. However, some
moderate-quality evidence suggests that CIMT, mental practice,
mirror therapy, interventions for sensory impairment, virtual re-
ality and a relatively high dose of repetitive task practice may be
effective interventions. These interventions should be considered
for this patient group. However, clinical application of evidence
will depend on specific details of an individual patient or setting,
or both, and clinical decisions will require expert clinical reason-
ing and judgement if available evidence is to be interpreted and
applied effectively.
For interventions that are currently used routinely in clinical prac-
tice, evidence is insufficient to support a change in clinical prac-
tice, and we recommend that healthcare professionals continue to
select and implement these interventions on the basis of individual
patient assessment and expert clinical reasoning and judgement.
However, research evidence is also available that is related to sev-
eral interventions not yet widely used in routine clinical practice.
These interventions include brain stimulation techniques (tDCS
and rTMS) and robotic devices. On the basis of current evidence,
we do not recommend the introduction of these emerging inter-
ventions into clinical practice at this stage. High-quality evidence
suggests that tDCS does not provide benefit (or harm) in terms of
ADL outcomes; therefore we do not currently recommend the in-
troduction of tDCS into routine clinical practice. Although some
moderate-quality evidence shows a beneficial effect of robotics, no
evidence from systematic reviews suggests that this has been estab-
lished in comparison with the same dose of conventional therapy;
therefore we do not recommend the introduction of new robotic
devices into routine clinical practice at this stage. Currently only
low-quality evidence related to rTMS is available, and we sup-
port the review authors in concluding that rTMS should not be
introduced into clinical practice at this time. Further research is
required before implications for practice related to these emerging
therapies are apparent.
Implications for research
Further research is urgently required to establish high-quality ev-
idence related to interventions to improve upper limb function
after stroke. In particular, arising from (but not limited to) the
results of this overview, we support recommendations for the fol-
lowing.
• High-quality RCTs related to dose of intervention. The
issue of dose of intervention is clearly central to establishment of
meaningful high-quality evidence related to upper limb
rehabilitation. Dose should always be carefully considered when
primary and secondary research is planned and performed.
• Full-scale (phase III) RCTs to confirm the benefits of
CIMT, mental practice, mirror therapy and virtual reality.
• High-quality up-to-date reviews to synthesise current
evidence on biofeedback, Bobath therapy, electrical stimulation,
reach-to-grasp exercise, repetitive task training, strength training
and stretching and positioning interventions.
• High-quality RCTs to establish effectiveness of rTMS,
hands-on therapy, music therapy, pharmacological interventions
and interventions for sensory impairment.
To ensure efficiency of future research, it is important that system-
atic reviews are updated to incorporate new RCTs, and that fur-
ther RCTs are planned with consideration of the evidence within
relevant up-to-date systematic reviews and with knowledge of on-
going RCTs. We urge researchers to ensure that details of ongoing
RCTs are registered on relevant databases.
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A D D I T I O N A L T A B L E S
Table 1. AMSTAR and mAMSTAR assessment questions
AMSTAR questions/criteria Dichotomous questions used to assess quality of reviews
1. Was an ’a priori’ design provided?
The research question and inclusion criteria should be established
before the conduct of the review
1.1 Were review subjects clearly defined?
1.2 Were review interventions described?
1.3 Were review comparisons specified?
1.4 Were review outcomes specified?
2. Was there duplicate study selection and data extraction?
There should be at least two independent data extractors, and a
consensus procedure for disagreements should be in place
2.1Were studies assessed for inclusion by two independent review
authors?
2.2 Were data extracted by two independent review authors?
2.3 Was there a clear procedure for resolving any disagreements?
3. Was a comprehensive literature search performed?
At least two electronic sources should be searched.The reportmust
include years and databases used (e.g. CENTRAL, EMBASE,
MEDLINE). Key words and/or MeSH terms must be stated and,
where feasible, the search strategy should be provided. All searches
should be supplemented by consulting current contents, reviews,
textbooks, specialised registers or experts in the particular field of
study, and by reviewing the references in the studies found
3.1 Were at least two major databases searched?
3.2 Were dates searched reported?
3.3 Were key words stated?
3.4 Were MeSH terms stated?
3.5 Was the search strategy provided or available on request?
3.6 Were searches supplemented by consulting current contents,
reviews, textbooks, specialised registers or experts in the particular
field of study, and by reviewing the references in the studies found?
4. Was the status of publication (i.e. grey literature) used as an
inclusion criterion? The review authors should state that they
searched for reports regardless of their publication type. The re-
view authors should state whether or not they excluded any reports
(from the systematic review), based on their publication status,
4.1 Were studies searched for and included regardless of their
publication type?
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Table 1. AMSTAR and mAMSTAR assessment questions (Continued)
language, etc
4.2 Were papers included regardless of language of publication?
5. Was a list of studies (included and excluded) provided?
A list of included and excluded studies should be provided.
5.1 Was there a list of included studies?
5.2 Was there a list of excluded studies?
5.4 Was there a flow diagram?
6. Were the characteristics of the included studies provided?
In an aggregated form such as a table, data from the original
studies should be provided on the participants, interventions and
outcomes. The ranges of characteristics in all the studies analysed
(e.g. age, race, sex, relevant socioeconomic data, disease status,
duration, severity, other diseases) should be reported
6.1 Were details provided on the participants of included studies
(including age, gender, severity of stroke, time since stroke)?
6.2Were details provided on the interventions of included studies?
6.3 Were details provided on the outcomes reported by included
studies?
7. Was the scientific quality of the included studies assessed and
documented? ’A priori’ methods of assessment should be provided
(e.g. for effectiveness studies if the author(s) chose to include only
randomised, double-blind, placebo-controlled studies, or alloca-
tion concealment as inclusion criteria); for other types of studies,
alternative items will be relevant
7.1 Was the scientific quality of included studies assessed?
7.2 Was this done by at least two independent review authors?
7.3 Was the scientific quality of studies documented?
8. Was the scientific quality of the included studies used appro-
priately in formulating conclusions? The results of the method-
ological rigour and scientific quality should be considered in the
analysis and the conclusions of the review, and explicitly stated in
formulating recommendations
8.1 Were the results of methodological rigour of the included
studies considered in the analysis of the review?
8.2Were the results of the scientific quality of the included studies
considered in the conclusions and/or recommendations of the
review?
9. Were the methods used to combine the findings of studies
appropriate? For the pooled results, a test should be done to ensure
the studies were combinable, to assess their homogeneity (i.e. Chi
2 test for homogeneity, I2). If heterogeneity exists, a random-
effects model should be used and/or the clinical appropriateness
of combining should be taken into consideration (i.e. Is it sensible
to combine?)
9.1 Were the methods used to combine the findings of studies
clearly described or referenced to appropriate text, or both?
9.2 If results are pooled, are the mean and confidence intervals (or
equivalent data) reported?
9.3 If results are pooled, is a test of heterogeneity reported?
9.4 Have the review authors stated a definition of statistical het-
erogeneity?
9.5 If statistical heterogeneity is present or suspected, has a ran-
dom-effects model been used?
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Table 1. AMSTAR and mAMSTAR assessment questions (Continued)
10. Was the likelihood of publication bias assessed?
An assessment of publication bias should include a combination
of graphical aids (e.g. funnel plot, other available tests) and/or
statistical tests (e.g. Egger regression test)
10. Was the likelihood of publication bias assessed?
11.Was the conflict of interest stated? Potential sources of support
should be clearly acknowledged in both the systematic review and
the included studies
11.1 Was there a conflict of interest statement?
11.2 Was the review free of any conflicts of interest?
Table 2. Summary of results and implications
Intervention Included re-
views
Moderate-
quality ev-
idence of ef-
fect on upper
limb function
Moderate-
quality ev-
idence of ef-
fect on upper
limb impair-
ment
Moderate-
quality ev-
idence of ef-
fect on ADL
outcomes
Low- or very
low-quality
evidence
Implica-
tions for clin-
ical practice
Recommen-
dations for
research
Bilateral arm
training
Coupar 2010
(vs usual care
or control)
van Delden
2012 (vs
unilateral arm
training)
Unilateral
arm training
more effec-
tive than bilat-
eral arm train-
ing
(6 trials, n =
375)
No difference
be-
tween unilat-
eral arm train-
ing and bilat-
eral arm train-
ing (4 trials, n
= 228)
Unilateral
arm training
more effec-
tive than bilat-
eral arm train-
ing
Low-quality
evidence for
bilat-
eral arm train-
ing compared
with usual care
or other inter-
ventions
Evidence does
not
support bilat-
eral arm train-
ing as a re-
placement for
unilateral arm
training
A sound theo-
retical
rationale is es-
sential to jus-
tify further re-
search into bi-
lateral arm
training
Biofeedback Woodford
2007 (EMG
biofeedback)
Molier
2010 (qualita-
tive data only)
Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
Up-to-date re-
views required
Bobath ther-
apy
Luke 2004 Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
Up-to-date re-
views required
Brain stimu-
lation: tDCS
Elsner 2013 tDCS benefi-
cial for
impairment (7
trials, n = 304)
High-quality
evidence of no
bene-
fit or harm of
Ev-
idence insuffi-
cient to sup-
port introduc-
High-quality
RCTs required
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Table 2. Summary of results and implications (Continued)
tDCS (5 trials,
n = 286)
tion into rou-
tine clinical
practice
Brain stimu-
lation: rTMS
Hao 2013 Current ev-
idence of low
quality
In-
sufficient evi-
dence to sup-
port introduc-
tion into rou-
tine clinical
practice
High-quality
RCTs required
Constraint-
in-
duced move-
ment therapy
(CIMT)
Corbetta
2010 (sub-
group analy-
ses)
Sirtori 2009
CIMT bene-
ficial when
compared
with control
(14 trials, n =
477)
Evidence
of low qual-
ity for mea-
sures of ADLs
(because of
methodologi-
cal limitations
within review)
Moder-
ate-quality ev-
idence that
CIMT may be
effective inter-
vention for se-
lected patients
Phase III
RCTs recom-
mended Dose
must be con-
sidered
Electrical
stimulation
Farmer 2014
Nascimento
2014
Meilink 2008
Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
Meta-anal-
ysis of current
trials/comple-
tion of ongo-
ing review re-
quired
(Howlett)
“Hands-on”
ther-
apy (manual
therapy tech-
niques)
Winter
2011 (qualita-
tive data only)
in Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
High-quality
RCTs required
Mental prac-
tice
Barclay-
Goddard
2011 (sub-
group analy-
ses)
Braun 2013
Wang 2011
(includes Chi-
nese trials)
Mental prac-
tice beneficial
when given in
ad-
dition to con-
ventional in-
terventions (7
trials, n = 197)
Mental prac-
tice beneficial
when given in
ad-
dition to con-
ventional in-
terventions (5
trials, n = 216)
No benefit or
harm of men-
tal practice
Moder-
ate-quality ev-
idence that
mental
practice may
be effective in-
tervention for
some patients
Phase
III RCTs rec-
ommended
Mirror ther-
apy
Thieme 2012 Mirror
therapy bene-
ficial (10 tri-
(see upper limb
function)
Mirror ther-
apy beneficial
(4 trials, n =
Moder-
ate-quality ev-
idence that
Phase
III RCTs rec-
ommended
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Table 2. Summary of results and implications (Continued)
als, n = 421):
combined up-
per limb func-
tion and im-
pairment out-
comes
217) mirror
therapy may
be effective in-
tervention for
some patients
Music
therapy
Bradt 2010 Lack of trial
evidence
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
High-quality
RCTs required
Pharmaco-
logical inter-
ventions
Elia 2009 (bo-
tulinum toxin
for spasticity)
Olvey 2010
(botulinum
toxin for spas-
ticity; qualita-
tive data only)
Demetrios
2013 (multi-
dis-
ciplinary reha-
bilitation fol-
lowing phar-
macolog-
ical interven-
tions; qualita-
tive data only)
Singh 2010
(pharmaco-
logical in-
terventions for
shoulder pain)
Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
Reviews
require updat-
ing
High-quality
RCTs required
Repetitive
task training
(RTT)
French 2007
French 2008
No benefit or
harm of RTT
(8 trials, n =
412)
Beneficial ef-
fect
when dose >
20 hours (3
trials, n = 113)
Moder-
ate-quality ev-
idence that a
higher dose of
RTT
may be benefi-
cial
Review re-
quires updat-
ing
Large-scale
RCTs to ex-
plore dose is a
research prior-
ity, including
number
of repetitions
during RTT
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Table 2. Summary of results and implications (Continued)
Robotics Mehrholz
2012
Norouzi-
Gheidari 2012
Beneficial ef-
fect
of robotics as
compared
with
any compar-
ison on im-
pairment
scales (16 tri-
als, n = 586)
No benefit or
harm as com-
pared with
the same du-
ration of con-
ventional
therapy (6 tri-
als, n = 204)
No benefit or
harm on mea-
sures
of strength (10
trials, n = 321)
Beneficial ef-
fect
of robotics as
compared
with any com-
par-
ison on ADLs
(13 trial, n =
552)
Cur-
rent evidence
does not sup-
port Introduc-
tion into rou-
tine clinical
practice
High-qual-
ity RCTs re-
quired,
includ-
ing considera-
tion of dose
Sensory
interventions
Doyle 2010
Schabrun
2009 (qualita-
tive data only)
Beneficial ef-
fect of sensory
stimulation as
compared
with no treat-
ment (1 trial,
n = 29)
Beneficial ef-
fect of sensory
stimulation as
compared
with no treat-
ment (1 trial,
n = 29)
Low-quality
evidence for
all other inter-
ventions
Current evi-
dence does not
support
any change in
current clini-
cal practice
High-quality
RCTs required
Strength
training
Harris 2010 Low-quality
evidence of a
beneficial ef-
fect on upper
limb function
(11 trials, n =
465) and grip
strength (6 tri-
als, n
= 306). (Qual-
ity judgement
influenced by
poor reporting
within review)
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
High-
quality up-to-
date review re-
quired
High-quality
RCTs required
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Table 2. Summary of results and implications (Continued)
Stretching
and position-
ing
Katalinic
2010 (stretch-
ing and posi-
tioning)
Borisova 2009
(positioning
of shoulder)
Ada 2005
(shoulder sup-
ports)
Lannin 2003
(hand splint-
ing)
Hijmans 2004
(elbow
orthoses; qual-
itative data
only)
No benefit or
harm of
stretch-
ing as com-
paredwith any
other in-
tervention on
joint mobility
and spasticity
No benefit or
harm of
stretch-
ing as com-
paredwith any
other in-
tervention on
ADLs
Low-quality
evidence of
no benefit of
shoulder sup-
ports
Current evi-
dence does not
support
any change in
current clini-
cal practice
High-
quality up-to-
date review re-
quired
Es-
sential that re-
search proto-
cols comprise
doses that are
the-
oretically pre-
dicted to effect
change
Task-
specific train-
ing (reach-to-
grasp
exercise)
Pelton
2012 (qualita-
tive data only)
Urton
2007 (qualita-
tive data only)
Current ev-
idence of low
quality
Insuffi-
cient evidence
to support any
change in cur-
rent clinical
practice
High-
quality, up-to-
date review re-
quired
Virtual real-
ity
Laver 2011 Virtual
reality bene-
ficial (7 tri-
als, n = 205):
combined up-
per limb func-
tion and im-
pairment out-
comes
(see upper limb
function)
No benefit or
harm for grip
strength (2 tri-
als, n = 44)
Moder-
ate-quality ev-
idence that
virtual reality
may be effec-
tive interven-
tion for some
patients
Phase
III RCTs rec-
ommended,
includ-
ing considera-
tion of dose
Summary of results and implications related to individual interventions.
ADLs: Activities of daily living.
EMG: Electromyography.
RCTs: Randomised controlled trials.
rTMS: Repetitive transcranial magnetic stimulation.
tDCS: Transcranial direct current stimulation.
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Table 3. Characteristics of included reviews
Review
(source)
Interven-
tion
Date of
search
Objective
(as stated
within re-
view)
Types of
studies in-
cluded
Partic-
ipants in-
cluded
Interven-
tions
included
Compar-
isons
included
Outcomes
(as
defined
within re-
view)
Number
of studies
included
(number
of partic-
ipants in-
cluded)
Ada 2005
(CDSR);
Foong-
chom-
chaey
2005
(DARE)
Stretch or
position-
ing
22/03/
2004
To investi-
gate the ef-
fects
of support-
ive devices
in prevent-
ing sublux-
ation,
reposi-
tioning the
head of the
humerus
in
the glenoid
fossa,
decreasing
pain,
increasing
function
and ad-
versely in-
creasing
contrac-
ture in the
shoulder
after stroke
RCTs,
quasi-ran-
domised
and con-
trolled tri-
als
Stroke Supportive
devices
Alter-
native sup-
portive de-
vice or no
support
Distance
of subluxa-
tion (from
x-ray),
pain, func-
tion, con-
tracture
4 (142)
Barclay-
Goddard
2011
(CDSR)
Mental
practice
24/11/
2010
To
determine
whether
men-
tal practice
im-
proves the
outcomes
of upper
extrem-
ity rehabil-
itation for
individuals
RCTs Stroke, UL
functional
deficits
Mental
practice of
upper ex-
tremity
move-
ments or
tasks alone
or in com-
bination
with other
therapies
No inter-
vention;
conven-
tional in-
tervention;
placebo
mental
practice; or
other novel
therapies
Upper
extremity
func-
tion: Arm
and hand-
e.
g. Box and
Block Test,
Test Evalu-
ant des
Membres
Supérieurs
6 (119)
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Table 3. Characteristics of included reviews (Continued)
living with
the effects
of stroke
des Person-
nes Agées
(TEMPA),
Action Re-
search Arm
Test, Mo-
tor Assess-
ment
Scale, up-
per
extrem-
ity compo-
nent, Fren-
chay Arm
Test,
Wolf Mo-
tor Func-
tion
Test, com-
ponents of
the Barthel
Index or
the Func-
tional In-
depen-
dence
Mea-
sure. Hand
function-
Jebsen Test
of Hand
Func-
tion, Mo-
tor Assess-
ment Scale
Hand
Borisova
2009
(DARE)
Stretch or
position-
ing
30/06/
2005
To as-
sess the ef-
fective-
ness of po-
sitioning
on range of
motion of
the paretic
shoul-
der follow-
ing stroke
RCTs Stroke Position-
ing
Control Range of
motion
5 (126)
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Bradt
2010
(CDSR)
Music
therapy
25/02/
2010
To exam-
ine the ef-
fects of
mu-
sic therapy
with stan-
dard
care versus
standard
care alone
or standard
care com-
bined with
other ther-
apies
on
gait, upper
extremity
func-
tion, com-
munica-
tion, mood
and emo-
tions, so-
cial skills,
pain, be-
havioural
outcomes,
activities of
daily
living and
adverse
events
RCTs,
quasi-
RCTs
Acquired
brain
injury
Music
therapy
Standard
care
or standard
care with
other ther-
apies
Upper ex-
tremity
function:
measured
by
hand grasp
strength,
frequency
and dura-
tion
of identi-
fied hand
function,
spatiotem-
poral arm
control
Secondary
outcomes:
Commu-
nication,
mood and
emotions,
social skills
and inter-
actions,
pain, be-
havioural
outcomes,
activities of
daily living
Adverse
events (e.g.
death, fa-
tigue, falls)
7 (184)
Braun
2013
(DARE)
Mental
practice
01/06/
2012
To investi-
gate
the benefi-
cial and ad-
verse
effects
of a mental
practice in-
tervention
on activi-
ties, cogni-
tion
and emo-
RCTs Stroke,
Parkinson’s
or multiple
scle-
rosis (but
no studies
with
partic-
ipants with
multi-
ple sclero-
sis found)
Mental
practice as
therapy or
embedded
in therapy
Control
that allows
assessment
of the pos-
sible effects
of mental
practice
Measures
of func-
tion, activ-
ity
and partic-
ipation
Stroke-14
(421)
Parkin-
son’s-2(60)
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tion in pa-
tients after
stroke, pa-
tients with
Parkinson’s
disease
or multiple
sclerosis
Cooke
2010
(DARE)
Exercise
therapy
01/10/
2009
To deter-
mine the
strength of
current ev-
idence for
provision
of a
higher
dose of the
same types
of exercise-
based ther-
apy to en-
hance mo-
tor re-
covery af-
ter stroke
RCTs or
quasi-
RCTs
Stroke Experi-
mental and
con-
trol group
interven-
tions iden-
tical
except for
dose de-
scribed by
duration
and effort.
Therapy
dose could
be de-
scribed in
terms
of
time spent
in therapy
and/
or of effort
expended
See previ-
ous col-
umn-ex-
ercises but
without
increased
duration
Motor im-
pairment:
Motric-
ity Index,
muscle
tone, joint
range of
motion;
co-ordi-
nation, re-
action time
Motor ac-
tivity:
Modified
Rivermead
Mobil-
ity Index,
Action Re-
search Arm
Test,
Functional
Ambu-
lation Cat-
egories,
Nine-Hole
Peg Test
7 (680)
Corbetta
2010
(DARE)
CIMT
(con-
straint- in-
duced
movement
therapy)
01/04/
2010
This arti-
cle aims to
present an
up-
date of the
Cochrane
review and
to assess
the effects
of CIMT,
modi-
fied CIMT
and forced
RCTs
and quasi-
RCTs
Stroke CIMT,
modified
CIMT or
forced use
Usual care Disability:
Functional
Indepen-
dence
measure,
Barthel In-
dex
Arm mo-
tor
function:
Action Re-
search Arm
18 (674)
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use on dis-
ability and
arm motor
function
Test, Wolf
Mo-
tor Func-
tion Test,
Emory
Function
Test, Mo-
tor Assess-
ment Scale
Coupar
2010
(CDSR)
Bi-
lateral arm
training
28/08/
2009
To
determine
the effects
of simulta-
ne-
ous bilat-
eral train-
ing for im-
proving
arm func-
tion after
stroke
RCTs Stroke Simultane-
ous bilat-
eral train-
ing
Control,
usual care
Perfor-
mance in
ADLs:
functional
movement
of the up-
per limb;
Perfor-
mance in
extended
activi-
ties of daily
living: mo-
tor impair-
ment of
the arm
18 (549)
Coupar
2012
(CDSR)
Service de-
livery
21/05/
2011
To
determine
the effects
of home-
based ther-
apy pro-
grammes
for
upper limb
recovery in
pa-
tients with
upper limb
impair-
ment fol-
lowing
stroke
RCTs Stroke Home-
based ther-
apy for UL
rehabilita-
tion
Placebo,
no inter-
vention or
usual care
ADLs and
functional
move-
ment, ex-
tended
ADLs,mo-
tor impair-
ment
4 (166)
Demetrios
2013
(CDSR)
Pharmaco-
logical
01/09/
2012
To as-
sess the ef-
fectiveness
of multi-
disci-
RCTs Adults and
children
with post-
stroke
Multi-dis-
ciplinary
rehabili-
tation after
Multi-dis-
ciplinary
rehabilita-
tion
Pas-
sive func-
tion: Leeds
Arm Spas-
3 (91)
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plinary re-
habili-
tation, fol-
lowing bo-
tulinum
neurotoxin
and other
focal intra-
mus-
cular treat-
ments such
as phenol,
in improv-
ing
ac-
tivity limi-
tations and
other out-
comes in
adults and
children
with post-
stroke
spasticity.
To explore
what set-
tings, types
and inten-
sities
of rehabili-
tation pro-
grammes
are
effective
spastic-
ity (clinical
diagnosis)
botulinum
neu-
rotoxin or
other focal
intramus-
cular treat-
ments
tic-
ity Impact
Scale, Dis-
ability As-
sessment
Scale,
ArmActiv-
ity
Measure
Active
function of
the upper
limb: e.g.
Motor Ac-
tivity Log
(MAL) or
Action Re-
search Arm
Test
Active
function of
the lower
limb: e.g.
tests
of walking
speed, bal-
ance and
gait
pattern
Impair-
ments-
pain,
spasm fre-
quency,
joint range
of move-
ment, in-
volun-
tary move-
ments,
measures
of spastic-
ity (Mod-
ified Ash-
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worth
Scale,
Tardieu
Scale)
Partici-
pation and
impact on
caregivers:
WHO
QoL-
BREF,
Caregiver
Strain
Index
Adverse
events
Doyle
2010
(CDSR)
Sensory in-
tervention
16/09/
2009
To
determine
the effects
of inter-
ventions
that target
upper limb
sensory
impair-
ment after
stroke
RCTs and
controlled
clinical tri-
als
Stroke For sen-
sory im-
pairment
No
treatment,
conven-
tional
treatment,
attention
with
placebo or
with other
interven-
tions
for sensory
impair-
ment
Func-
tional use
of the up-
per limb:
including
Jebsen
Taylor
Hand
Function
Test, Fugl-
Meyer,
Modified
Motor As-
sessment
Scale,
Chedoke-
McMaster
Motor Ac-
tivity
Log Scales
(iden-
tifying per-
ceived level
of
use
and satis-
faction
with level
and quality
13 (467)
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of upper
limb use)
Ac-
tivity limi-
tations:
Barthel In-
dex; Func-
tional In-
depen-
dence
Mea-
sure; Fren-
chay Ac-
tivites In-
dex; global
depen-
dency
scales
Participa-
tion:
Stroke Im-
pact Scale,
quality
of life mea-
sures
Elia 2009
(DARE)
Botulinum
toxin in-
jection by
any route,
includ-
ing but not
limited
to intra-
muscular,
subcuta-
neous, in-
tradermal
and intra-
articular
routes
01/09/
2006
The aim of
this sys-
tematic re-
view was to
determine
whether
botulinum
neu-
rotoxin re-
duces spas-
ticity
or
improves
function in
adult
patients af-
ter stroke
All levels of
evidence
Stroke Intramus-
cular injec-
tions, bo-
tulinum
neuro-
toxin A or
botulinum
neurotoxin
B
Ashworth
Scale, Im-
provement
of
Global As-
sessment
Scale (area
under the
curve of
Ashworth
scores),
functional
disability,
pain
and quality
of life mea-
sured by
validated
scales; oc-
currence of
seri-
ous adverse
events
11 (782)
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Elsner
2013
(CDSR)
Tran-
scranial di-
rect cur-
rent stimu-
lation
(tDCS)
May 2013 To assess
the effects
of tDCS
on generic
activities of
daily living
and motor
function in
people
with stroke
RCTs, first
pe-
riod of ran-
domised
cross-over
trials
Stroke Active
tDCS
Placebo,
sham
tDCS, no
interven-
tion
or conven-
tional
rehabilita-
tion
Pri-
mary out-
come: Ac-
tivities
of daily liv-
ing-Fren-
chay Activ-
ities Index,
Barthel In-
dex, River-
mead Ac-
tivities of
Daily Liv-
ing Assess-
ment,
Modified
Rankin
Scale
and Func-
tional In-
depen-
dence
Measure
Secondary
outcomes:
Upper limb
function-
Action Re-
search Arm
Test, Fugl-
Meyer
Score,
Nine-Hole
Peg Test or
Jeb-
sen Taylor
Hand
Function
Test
Mus-
cle strength-
grip force
or motric-
ity index
Lower limb
function
15 (455)
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Farmer
2014 (per-
sonal com-
munica-
tion)
Assistive
technolo-
gies,
includ-
ing electri-
cal stimu-
lation
01/09/
2011
To identify
and
explore ev-
idence for
use of assis-
tive tech-
nologies in
poststroke
upper limb
rehabilita-
tion
RCTs Stroke Assistive
technolo-
gies
includ-
ing electri-
cal stimu-
lation
(An assis-
tive tech-
nology was
defined
as “a me-
chanical
or electri-
cal device
used in a
functional
task ori-
entated
training
process
which will
have a
systematic
or reha-
bilitative
effect on
a person”
and stated
to include
biofeed-
back, brain
stimu-
lation,
constraint-
induced
move-
ment,
neuro-
muscular
electrical
stimu-
lation
(NMES)
, robotics
and virtual
reality.)
Placebo,
alterna-
tive treat-
ments,
usual care
Impair-
ment:
Range
of motion,
grip
strength,
subjec-
tive assess-
ment of
strength,
Fugl-
Meyer
Activity:
Action Re-
search Arm
Test and
Wolf Mo-
tor Func-
tion Test
Partci-
pation:
Motor Ac-
tivity Log
Amount
of Use;
Motor Ac-
tivity Log
Quality
of Move-
ment;
Functional
Indepen-
dence
Measure;
Barthel
index;
Rankin
Score and
Stroke
Impact
Scale
11 (474)
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French
2007
(CDSR)
; French
2010
(DARE)
Repetitive
task train-
ing
16/10/
2006
To de-
termine
whether
repeti-
tive task
training
after stroke
improves
global,
upper
or lower
limb func-
tion, and
whether
treatment
effects are
dependent
on the
amount,
type or
timing of
practice
RCTs,
controlled
clinical tri-
als
Stroke Repetitive
tasks train-
ing; an ac-
tive motor
sequence
(multi-
joint mo-
tion) per-
formed
repetitively
Attention
con-
trol, recre-
ation, cog-
nitive ther-
apy, upper
limb versus
lower limb
Arm
function:
Motor As-
sessment
Scale-Up-
per Limb
Com-
ponent,
Action
Research
Arm Test,
Frenchay
Arm Test,
Wolf
Motor
Function
Test,
Functional
Test of
the Hemi-
paretic
Upper
Extremity,
Box and
Block Test,
Southern
Motor
Group As-
sessment
Hand
func-
tion: Mo-
tor Assess-
ment Scale
Hand; Jeb-
sen Test of
Hand
Function,
Peg Test
Sitting bal-
ance/
reach:
Reach-
14 (659)
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ing Perfor-
mance
Scale,
Functional
Reach.
Lower
limb
function:
walking
distance,
walking
speed,
functional
ambu-
lation,
Timed Up
and Go
Test/Sit
to Stand;
Rivermead
Motor As-
sessment,
Sodring
Motor
Evaluation
Scale
Standing
Balance/
Reach:
Berg Bal-
ance Scale,
Sitting
Equi-
librium
Index,
Standing
Equi-
librium
Index,
Functional
Reach
Global
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motor
function:
Motor As-
sessment
Scale,
Rivermead
Motor As-
sessment
Scale, So-
dring Mo-
tor Evalua-
tion Scale
Activi-
ties of daily
living mea-
sures:
Barthel In-
dex, Func-
tional In-
depen-
dence
Measure,
Modified
Rankin
Scale,
GlobalDe-
pendency
Scale
Measures
of task per-
formance
or impair-
ment:
Motricity
In-
dex, Fugl-
Meyer As-
sess-
ment, So-
dring Mo-
tor Evalu-
ation Scale
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Leg and
Arm Sub-
scales,
Trunk
Control
Test
Measures
of qual-
ity of life,
health sta-
tus,
user satis-
faction,
carer bur-
den, moti-
va-
tion or per-
ceived im-
prove-
ment:e.g.
Notting-
ham
Health
Profile, SF-
36, Dart-
mouthCo-
operative
Chart
Adverse
outcomes
French
2008
(DARE)
Repetitive
task train-
ing
01/09/
2006
To
determine
whether
repetitive
func-
tional task
practice
(RFTP) af-
ter stroke
improves
limb-
specific or
global
functionor
activities of
daily
RCTs,
quasi-
RCTs,
cross-over
trials (first
part)
Stroke Repetitive
task train-
ing
Usual
practice or
attention
control, al-
ternative
training
Arm func-
tion:
Action Re-
search Arm
Test; Mo-
tor Assess-
ment
Scale-
Upper
Limb
Compo-
nent, Fren-
chay Arm
Test, Wolf
Motor
31 (1078)
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living, and
whether
treatment
effects
are depen-
dent on
the
amount of
practice, or
the type or
timing of
the
interven-
tion. Also
to
provide es-
timates of
the cost-ef-
fectiveness
of RFTP
Function
Test, Func-
tional Test
of
the Hemi-
paretic
Upper Ex-
tremity,
Box and
Block Test,
Test Evalu-
ant des
Membres
Supérieurs
des Person-
nes Agées,
University
of Mary-
land Arm
Question-
naire
for Stroke,
Motor Ac-
tivity Log
Hand
function:
Motor As-
sesse-
ment Scale
Hand; Jeb-
sen Test of
Hand
Function;
Peg Test,
Purdue
Pegboard.
Sitting
Balance/
Reach-
Reach-
ing Perfor-
mance
Scale,
Functional
Reach
Hao 2013
(CDSR)
Repetitive
transcra-
nial mag-
23/04/
2012
To as-
sess the ef-
RCTs Stroke
(any age)
rTMS,
rTMS
Sham
treatment,
ADLs:
Barthel In-
19 (588)
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netic stim-
ulation
(rTMS)
ficacy and
safety of
rTMS for
improving
function in
people
with stroke
added
to standard
treatment
sham treat-
ment
added
to baseline
treatment,
base-
line treat-
ment alone
dex, Func-
tional In-
depen-
dence
Measure,
Modified
Rankin
Motor
function:
Upper limb
function-
Motor As-
sessment
Scale,
Action
Research
Arm Test,
Nine-Hole
Peg Test.
Lower limb
function-
changes
in stride
length
or speed,
Timed
Up and
Go Test,
Rivermead
Motor As-
sessment
Scale.
Global
motor
function-
Motor As-
sessment
Scale,
Rivermead
Motor
Assess-
ment Scale
Death or
disability
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Any other
impair-
ment im-
provement
(e.g. visual,
perceptual,
depres-
sion, cog-
nition, etc)
Harris
2010
(DARE)
Exercise 04/2009 To exam-
ine the evi-
dence
for
strength
training of
the paretic
upper limb
in improv-
ing
strength,
upper limb
function
and ADLs
RCTs Stroke Strength
train-
ing (volun-
tary exer-
cise against
resistance)
No
treatment,
placebo,
non-
strength-
ening in-
tervention
Upper
limb
strength,
upper limb
functionor
ADLs
13 (517)
Hijmans
2004
(DARE)
Stretch or
position-
ing
01/06/
2003
To as-
sess the sci-
entific base
of elbow
orthoses
All designs
considered
Elbow
condition
Splinting No
compar-
isons pre-
specified
Range
of motion,
pain, grip
strength
Stroke
RCT-1
(18),
Cohort-1
(16)
Katalinic
2010
(CDSR)
Stretch or
position-
ing
01/04/
2009
To
determine
the effects
of stretch
on con-
tractures in
peo-
ple with, or
at risk of,
contrac-
tures
RCTs and
controlled
clinical tri-
als; paral-
lel-group
designs,
within-
subject
designs or
cross-over
designs
•
Neurolog-
ical condi-
tions (e.g.
stroke,
multiple
sclerosis,
spinal cord
injury,
traumatic
brain in-
jury, Guil-
lain-Barré
syndrome,
Parkinson’s
disease)
• Ad-
Stretch,
stretch
plus co-in-
tervention
No stretch,
placebo or
sham
stretch, co-
interven-
tion
Range of
motion,
torques,
QoL,
SF-36,
Tardieu,
Modified
Ashworth
Scale,
Functional
Indepen-
dence
Measure,
motor
ability
score
35 (1391)
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vanced age
(e.g.
frailty);
• History
of trauma
or surgery
(e.g. burns,
joint re-
placement
surgery)
• Underly-
ing joint or
muscle
pathology
and disease
processes
(e.g.
inflamma-
tory arthri-
tis, os-
teoarthri-
tis)
Lannin
2003
(DARE)
Stretch or
position-
ing
26/05/
2003
To as-
sess the ef-
fectiveness
of hand
splint-
ing on the
hemiplegic
upper ex-
trem-
ity follow-
ing stroke
All designs
considered
Stroke Splinting No
compar-
isons pre-
specified
Func-
tional use
of hand,
range
of motion,
tone, spas-
ticity,
oedema,
pain
21 (230)
Laver 2011
(CDSR)
Virtual re-
ality
30/03/
2010
To evalu-
ate the ef-
fects of vir-
tual reality
and inter-
active
video gam-
ing on up-
per limb,
lower limb
and global
motor
function
after stroke
RCTs Stroke Immersive
or non-im-
mer-
sive virtual
reality
Alterna-
tive inter-
vention,
no Inter-
vention
Upper
limb func-
tion and
activity:
Arm func-
tion and
activity-
Motor As-
sessment
Scale (Up-
per Limb),
Action Re-
search
19 (565)
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Arm Test,
Wolf Mo-
tor Func-
tion Test;
Hand func-
tion
and activ-
ity-Nine-
Hole Peg
Test, Box
and Block
Test.
Gait and
bal-
ance func-
tion and
activity:
Lower limb
function
and activ-
ity-walking
distance,
walk-
ing speed,
Commu-
nity
Walk
Test, func-
tional am-
bulation,
Timed
Up and Go
Test;
Standing
reach-Berg
Bal-
ance Scale
and labo-
ratory-
based force
plate mea-
sures
Global
motor
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func-
tion: Mo-
tor Assess-
ment Scale
Secondary
outcomes:
Cog-
nitive func-
tion-Trail
Making
Test, Use-
ful Field of
View Test;
Activity
limitation-
Functional
Indepen-
dence
Measure
(FIM),
Barthel In-
dex,
Activities-
Specific
Bal-
ance; Con-
fidence
Scale, On-
Road
Driving
Test;
Participa-
tion restric-
tion
and quality
of life-SF-
36,
EQ5D,
Stroke Im-
pact Scale
or other
patient-
reported
outcomes;
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Func-
tional mag-
netic reso-
nance
imaging
(MRI)
Adverse
events:
mo-
tion sick-
ness, pain,
injury, falls
and death
Laver 2013
(CDSR)
Service de-
livery
09/07/
2013
To evaluate
the effects
of telereha-
bilitation,
in compar-
ison with
in-
person or
no rehabil-
itation, on
activities of
daily living
for people
after
stroke.
Sec-
ondary ob-
jectives in-
cluded de-
termining
the effects
of telereha-
bilitation
on mobil-
ity, health-
re-
lated qual-
ity of life,
upper
limb func-
tion, cog-
nitive
functionor
functional
RCTs Stroke Telereha-
bilitation
“In-Person
Rehabil-
itation” or
no rehabil-
itation or
alternative
method of
delivering
telereha-
bilitation
Primary
outcomes:
Activities of
daily liv-
ing-Func-
tional In-
depen-
dence
Measure;
Notting-
ham Ex-
tended Ac-
tivities of
Daily Liv-
ing
Secondary
outcomes:
Self-care
and domes-
tic life;
mobility (e.
g. Timed
Up and Go
Test, walk-
ing
speed,
functional
ambu-
lation cate-
gory);
Patient sat-
isfaction
10 (933)
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communi-
cation
with the in-
tervention-
self-
reported
health-re-
lated qual-
ity of life;
upper limb
function
(e.g.
Action Re-
search Arm
Test, Wolf
Motor
Function
Test, Fugl-
Meyer Up-
per
Extremity
Measure)
; cognitive
function
(e.g. Mini
-Mental
State
Examina-
tion, spe-
cific mea-
sures such
as tests of
attention
or exec-
utive func-
tion-
ing); Func-
tional com-
munica-
tion; Cost-
effective-
ness.
Adverse
events
Luke 2004
(DARE)
Exercise
therapy
2003 To
determine
the effec-
tiveness of
the Bobath
concept in
RCTs,
cross-over
and single
case series
Stroke Stated use
of the Bo-
bath con-
cept
or
neurode-
A control
for Bobath
interven-
tion in the
form of a
group with
Any
outcome
measure
reflecting
change in
upper limb
RCTs-5
(209)
Cross-
over-1
(131)
Single-
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reducing
upper limb
impair-
ments, ac-
tivity limi-
tations and
partic-
ipation re-
strictions
after stroke
velopmen-
tal therapy
in isolation
no
interven-
tion or a
group with
a compar-
ison inter-
vention,
or a base-
line phase
impair-
ment,
activ-
ity limita-
tion or par-
ticipation
restriction
case study-
2 (34)
Mehrholz
2012
(CDSR)
Robotics 01/08/
2011
To assess
the effec-
tiveness of
electrome-
chanical
and robot-
assisted
arm train-
ing
in improv-
ing generic
activi-
ties of daily
living, arm
function
and arm
muscle
strength in
patients af-
ter stroke
RCTs Stroke Electrome-
chanical
and robot-
assisted
arm train-
ing for re-
cov-
ery of arm
function
Other re-
habil-
itation or
placebo in-
terven-
tions, or no
treatment
ADLs
(Barthel
Index,
Functional
Indepen-
dence
Measure)
, Fugl-
Meyer,
Motricity
Index
and other
measures
of arm
function
or strength
19 (666)
Meilink
2008
(DARE)
Electros-
timulation
01/06/
2006
To assess
whether
EMG-trig-
gered neu-
romus-
cular elec-
trical
stimula-
tion
(EMG-
NMES)
applied to
the exten-
sormuscles
of the fore-
arm
improves
RCTs Stroke EMG-
NMES
Usual care Reaction
time, Fugl-
Meyer
Assess-
ment, Box
and Block
Test, peak
velocity,
decelera-
tion time,
Functional
Indepen-
dence
Measure
(self-care)
, Action
8 (157)
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Table 3. Characteristics of included reviews (Continued)
hand func-
tion after
stroke.
Research
Arm
Test, grip
strength,
Motricity
Index,
pinch
and grip
strength,
elbow
flexion/
shoulder
abduction,
goniome-
try
Molier
2010
(DARE)
Biofeed-
back
01/03/
2009
To investi-
gate the ef-
fects of dif-
fer-
ent aspects
and types
of aug-
mented
feedback
on motor
functions
and motor
activities of
the hemi-
paretic arm
after stroke
All levels of
evidence
Stroke Interven-
tion aug-
mented
by biofeed-
back
Compar-
isons were
not de-
fined a pri-
ori but in-
cluded
practis-
ing move-
ments
without
feedback
or robotic
guidance
Fugl-
Meyer,
Compos-
ite Spastic-
ity Index,
Ashworth
Scale,
Test Evalu-
ant des
Membres
Supérieurs
des Per-
sonnes
Agée,
Block and
Box Test,
Motor
Power
Score,
Motor
Status
Score,
Motor As-
sessment
Scale,
Jebsen
Taylor
Hand Test,
ABIL-
HAND,
23 (328):
RCTs-8
(148)
Cohort-10
(106)
Matched
pairs-2
(52)
Not ran-
domised-1
(16)
Observa-
tional
study-1 (5)
Single case
study-1 (1)
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Purdue
Pegboard
Test,
Chedoke
McMaster,
Wolf
Motor
Function
Measure,
Stroke
Impact
Scale,
Functional
Test of
the Hemi-
paretic
Upper
Extremity
Nasci-
mento
2014
(PROS-
PERO)
Elec-
trical stim-
ulation
December
2012
To de-
termine
whether
electrical
stimu-
lation is
effective in
increasing
strength
after
stroke, and
whether
any ben-
efits are
main-
tained
beyond the
interven-
tion period
or carried
over to
activity
RCTs and
controlled
trials
Stroke Cycli-
cal electri-
cal stimu-
lation for
strength-
ening
1. No
treatment,
placebo,
non-
strength-
en-
ing inter-
ventions
2. Other
strength-
en-
ing inter-
ventions
3. Differ-
ent modes
of electri-
cal stimu-
lation
Strength:
peak force
generation
Activity:
Block and
Box Test,
Action Re-
search Arm
Test
Gen-
eral activ-
ity: Barthel
Index
16 (638)
Norouzi-
Gheidari
2012
(DARE)
Robotics 01/07/
2010
To find ev-
idence re-
garding the
effective-
ness
of
robot ther-
RCTs Stroke Robot
therapy
Conven-
tional ther-
apy
Fugl-
Meyer,
Functional
Indepen-
dence
Mea-
sure, Mo-
12 (383)
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apy com-
pared with
conven-
tional ther-
apy in im-
proving
motor
recovery
and func-
tional abil-
ities of the
paretic up-
per limb of
patients
with stroke
tor Power
Scale, Mo-
tor Status
Scale
Olvey
2010
(DARE)
Pharmaco-
logical
01/07/
2010
To review
studies fo-
cusing on
contempo-
rary phar-
macolog-
ical thera-
pies
for upper
limb spas-
ticity after
stroke
RCTs,
open-
labelled
non-ran-
domised
or observa-
tional
studies
Stroke Pharmaco-
log-
ical treat-
ments for
spasticity
Dose com-
parisons or
placebo
with
or without
other treat-
ment
Spasticity
(Ashworth
Scale or
Modified
Ashworth
Scale or
Tardieu
Scale),
pain, Fugl-
Meyer As-
sessment,
Functional
Indepen-
dence
Measure,
Barthel
Index,
Disability
Assess-
ment
Scale,
range of
motion,
health-
related
quality of
life
RCTs-23
(1039)
Other-31
(1288)
Pelton
2012
(DARE)
Exercise 04/2010 To identify
all existing
interven-
tions tar-
geted at co-
ordination
All types of
study
design
Stroke Treatment
to develop
co-or-
dination of
hand and
Spe-
cific mea-
sures of co-
ordination
such
8 (155)
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Table 3. Characteristics of included reviews (Continued)
of arm and
hand seg-
ments
for reach-
to-grasp
follow-
ing stroke.
To deter-
mine the
effective-
ness of cur-
rent treat-
ments for
improv-
ing co-or-
dination of
reach-to-
grasp
after stroke
armduring
reach-to-
grasp
as
movement
veloc-
ity, acceler-
ation, de-
celeration
and move-
ment
duration,
maximum
hand aper-
ture and
reaction
time; Fugl-
Meyer As-
sessment
Schabrun
2009
(DARE)
Sensory
training
Not
reported
We exam-
ined
the volume
and quality
of the evi-
dence
available
for
both
passive and
active sen-
sory train-
ing follow-
ing stroke
All types of
study
design
Stroke Sensory re-
training
Jeb-
sen Taylor
Hand
Function,
Action Re-
search Arm
Test, Mod-
ified Ash-
worth As-
sessment
Scale,
Mod-
ified Mo-
tor Assess-
ment Scale
14 (296)
Singh
2010
(CDSR)
Pharmaco-
logical
22/01/
2010
To assess
the bene-
fits and sa-
fety of bo-
tulinum
toxin com-
pared with
placebo or
alterna-
tive treat-
ments in
adults with
shoulder
RCTs Shoulder
pain
Botulinum
toxin in-
jection by
any route,
includ-
ing but not
limited
to intra-
muscular,
subcuta-
neous, in-
tradermal
and intra-
Placebo in-
jection or
another ac-
tive treat-
ment
Pain: mea-
sured on a
visual ana-
logue scale,
numerical
rating scale
or semi-
quan-
titative de-
scriptive
scale
Adverse ef-
6 (164)
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pain articular
routes
fects
Function
or disabil-
ity: mea-
sured using
validated
shoulder-
specific
instru-
ments (e.g.
Constant
Score,
University
of
Cal-
ifornia and
Los Ange-
les Shoul-
der Scale
(UCLA) or
American
Shoulder
and Elbow
Surgeons
Shoul-
der Score,
Western
Ontario
Os-
teoarthri-
tis of the
Shoulder)
General
disability
mea-
sures: e.g.
Health As-
sessment
Question-
naire
Joint range
of motion
Quality of
life: e.g.
Short-
Form 36
(SF-36)
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Sirtori
2009
(CDSR)
Con-
straint-
induced
movement
therapy
(CIMT)
01/06/
2008
To assess
the efficacy
of CIMT,
modi-
fied CIMT
(mCIMT)
or
forced use
(FU) for
arm man-
agement in
hemi-
paretic pa-
tients
RCTs
and quasi-
RCTs
Stroke CIMT,
mCIMT
or forced
use
Other re-
habilita-
tion tech-
niques or
none
Arm mo-
tor func-
tion: per-
ceived
arm motor
func-
tion, arm
impair-
ment, dex-
ter-
ity, quality
of life
19 (619)
Thieme
2012
(CDSR)
Sensory in-
tervention
08/06/
2011
To sum-
marise the
effec-
tiveness of
mirror
therapy for
improv-
ing motor
function,
activi-
ties of daily
living, pain
and
visuospa-
tial neglect
in patients
after stroke
RCTs and
ran-
domised
cross-over
trials
Stroke Mirror
therapy
Any
control in-
tervention
Upper
limb and
hand func-
tion: Fugl-
Meyer,
Action Re-
seach Arm
Test, Wolf
Motor
Function
Test,
Brunnstrom
Stages of
Upper
Extremity,
Motricity
Index
Lower
limb func-
tion: Func-
tional In-
depen-
dence
Measure,
Barthel In-
dex
14 (567)
Urton
2007
(DARE)
Mixed 06/2005 To crit-
ically anal-
yse the lit-
erature on
effec-
tive inter-
ventions
RCTs and
CCTs
Stroke For upper
limb hemi-
paresis
Fugl-
Meyer As-
sessment,
Box and
Block Test,
Purdue
11 (269)
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for upper
extremity
hemipare-
sis follow-
ing stroke
Pegboard
Test,
Action
Research
Arm Test,
Functional
Indepen-
dence
Measure,
TEMPA,
Wolf
Motor
Function
Test, grip
strength,
Caregiver
Strain
Index,
Geriatric
Depres-
sion Score,
Ashworth
Scale,
Motor
Activity
Log and
other
study-
specific
measures
van
Delden
2012
(DARE)
Bi-
lateral arm
training
01/06/
2011
To com-
pare the ef-
fects
of unilat-
eral and bi-
lateral
training on
upper limb
function
after
stroke with
regard to 2
key factors:
severity of
upper limb
paresis and
time of in-
tervention
RCTs Stroke up
to 1month
= acute, 1-
6months =
sub-
acute, after
6months =
chronic
Unilateral
arm train-
ing; bi-
lateral arm
training
Alternative
treatment
Wolf
Motor
Function
Measure,
Canadian
Occupa-
tional Per-
formance
Measure,
Fugl-
Meyer As-
sessment,
Functional
Indepen-
dence
Measure,
Motor Ac-
9 (452)
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post stroke tivity Log,
Stroke
Impact
Scale,
Action
Research
Arm Test,
Rivermead
Motor As-
sessment,
Nine-Hole
Peg Test,
Modified
Barthel In-
dex, Not-
tingham
Health
Profile,
Hospital
Anxiety
and De-
pression
Scale, Mo-
tor Status
Scale,
Motor As-
sessment
Scale,
dynamom-
etry, Reha-
bilitation
Activities
Profile,
fMRI,
additional
kinematics
Wang
2011
(DARE)
Mental
practice
10/2010 To evaluate
men-
tal imagery
on rehabil-
itation of
func-
tions in pa-
tients with
stroke
RCTs Stroke Mental
practice or
mental im-
agery.
Other clin-
ical and re-
habilita-
tive treat-
ments were
the same as
control
group
Conven-
tional
stroke re-
habilita-
tion meth-
ods (such
as physio-
therapy
and occu-
pational
therapy)
Upper
limb func-
tion: Up-
per Limb
Section of
Fugl-
Meyer As-
sessment
of Motor
Recovery,
Action Re-
16 (652)
(191 total
partic-
ipants for
English pa-
pers, 461
to-
tal partic-
ipants for
Chinese
papers)
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search Arm
Test
Other
outcomes:
Motor As-
sessment
Scale,
Modified
Ashworth
Scale,
Upper
Extremity
Function
Test,
Functional
indepen-
dence
Measure,
Motor
Activity
Log, Color
Trails Test,
Task Per-
formance
Test,
Motricity
Index, The
Arm Func-
tional Test,
simple test
for evalu-
ating hand
function,
Modified
Barthel
Index
Winter
2011
(CDSR)
Stretch or
position-
ing
22/03/
2010
To identify
whether
specific
hands-on
ther-
apeutic in-
terven-
tions en-
hance mo-
tor activity
and func-
tion of the
RCTs Stroke Man-
ual therapy
techniques
Unclear UL func-
tion:
Action Re-
search Arm
Test,
Motric-
ity Index,
Functional
Indepen-
dence
Measure,
3 (86)
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Table 3. Characteristics of included reviews (Continued)
upper limb
post stroke
Barthel In-
dex
Woodford
2007
(CDSR)
Biofeed-
back
29/03/
2006
To assess
the effects
of EMG-
BFB
for motor
func-
tion recov-
ery follow-
ing stroke
RCTs
and quasi-
RCTs
Stroke EMG
biofeed-
back
with stan-
dard phys-
iotherapy
Stan-
dard phys-
iotherapy
or standard
physio-
therapy
and sham
feedback
Range
of motion,
improve-
ment in
gait (stride
length,
speed,
need
for ambu-
lation aids)
,
func-
tional abil-
ity, elec-
tromyo-
graphic ac-
tivity,mus-
cle
weakness
13 (269)
ABILHAND: Assessment tool that measures a patient’s perceived difficulty using his/her hands to perform manual activities in daily
life.
ADLs: Activities of daily living.
CDSR: Cochrane Database of Systematic Reviews.
CIMT: Constraint-induced movement therapy.
DARE: Database of Reviews of Effectiveness.
EMG-BF: Electromyographic biofeedback.
EMG-NMES: Electromyographic neuromuscular electrical stimulation.
EQ5D: A questionnaire to measure health-related quality of life.
FIM: Functional Independence Measure.
FU: Forced use.
MAL: Motor Activity Log.
mCIMT: Modified constraint-induced movement therapy.
MRI: Magnetic resonance imaging.
QoL: Quality of life.
RCT: Randomised controlled trial.
RFTP: Repetitive functional task practice.
RTMS: Repetitive transcranial magnetic stimulation.
SF-36: Short Form 36 questionnaire.
TEMPA: Test d’Evaluation de la performance des Membres Supérieurs des Personnes Agées.
tDCS: Transcranial direct current stimulation.
UL: Upper limb.
WHO QoL-BREF: World Health Organisation Quality of Life short instrument
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Table 4. Details of ongoing reviews
Reference Brief description of review/review aim Dates/Notes
Diermayr (Ongoing) Effects of reach-to-grasp training using trunk re-
straint in individuals with hemiparesis post stroke:
a systematic review
Anticipated publication stated as May 2013. Per-
sonal communication with author: completion
date currently unknown
PROSPERO 2012: CRD42012003464
Galvin 2012 (Ongoing) To assess whether additional exercise therapy has
an impact on recovery following stroke when com-
pared with routine exercise therapy
Protocol published June 2012
Howlett (Ongoing) Systematic review of functional electrical stimu-
lation to improve activity and participation after
stroke
Anticipated publication stated as October 2013.
Personal communication with author: February
2014 in final stages
PROSPERO 2012: CRD42012003054
Kidd (Ongoing) Systematic review of self-management interven-
tions for stroke survivors
Protocol published February 2013
PROSPERO 2013: CRD42013003592
Kinnear (Ongoing) Physical therapies as an adjunct to botulinum
toxin-injection to the upper or lower limb for the
treatment of spasticity following neurological im-
pairment: a systematic review
Personal communication with author: August
2013, in press
PROSPERO 2011: CRD42011001491
Liang 2011 (Ongoing) To assess the efficacy and possible adverse effects of
acupuncture for the treatment of poststroke upper
limb pain
Protocol published April 2011
Lindsay 2013 (Ongoing) To determine whether pharmacological interven-
tions for spasticity are more effective than no in-
tervention, normal practice or control in improv-
ing function following stroke
Protocol published February 2013
Meeran (Ongoing) To assess the effects of assistive technologies for
the management of contractures in people with
stroke
Protocol published October 2013
Monaghan 2011 (Ongoing) To determine whether physical treatment inter-
ventions are effective in preventing or minimising
activity limitation and participation restrictions in
patients developing spasticity post stroke
Protocol published July 2011
Schneider (Ongoing) Intensive treatment versus normal treatment for
improvedmotor recovery after stroke: a systematic
review
Personal communicationwith author: Publication
date anticipated around May 2014
PROSPERO 2012: CRD42012003221
Straudi (Ongoing) The role of transcranial direct current stimulation
(tDCS) inmotor rehabilitation in stroke survivors:
Protocol published May 2013
PROSPERO 2013: CRD42013003970
94Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 4. Details of ongoing reviews (Continued)
a systematic review
Table 5. Characteristics of excluded reviews
Review
(source)
Interven-
tion
Reason
for exclu-
sion
Date of
search
Objec-
tive
(as stated
within
review)
Types of
studies
included
Partici-
pants in-
cluded
Interven-
tions in-
cluded
Compar-
isons in-
cluded
Out-
comes
(as
defined
within
review)
Number
of stud-
ies
included
(number
of partic-
i-
pants in-
cluded)
Ada 2002
(DARE)
Electri-
cal stimu-
lation
Super-
seded by
more up-
to-date
review
July 2002 A meta-
analysis
of all eli-
gible ran-
domised
or quasi-
ran-
domised
trials
of electri-
cal stimu-
lation for
the treat-
ment
of shoul-
der sub-
luxation
RCTs and
quasi-
ran-
domised
trials
Stroke Surface
electrical
stimula-
tion with
motor re-
sponse
Conven-
tional
therapy
Subluxa-
tion, pain
or func-
tion
5 (183)
Aziz 2008
(CDSR)
Home re-
habilita-
tion ther-
apy
No UL
specific
outcome
- - - - - - - -
Bjork-
lund
2006
(DARE)
CIMT Super-
seded by
more up-
to-date
review
2004 To inves-
tigate the
outcomes
of nu-
merous
CIMT
trials to
gauge
improve-
ment in
upper
RCTs,
con-
trolled
trials,
pre/post
cohorts
Is-
chaemic
or haem-
orrhagic
stroke
CIMT Self as
con-
trol, con-
ventional
therapy
Fugl-
Meyer
Assess-
ment, Ac-
tion Re-
search
Arm Test,
Wolf Mo-
tor Func-
tion Test,
11 (179)
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extremity
motor
function
among
indi-
viduals
suffering
from
hemi-
paresis
experi-
enced
after
stroke
Actual
Amount
of Use
Test, Mo-
tor Activ-
ity Log,
Func-
tional In-
depen-
dence
Measure,
Arm Mo-
tor Abil-
ity Test
Bolton
2004
(DARE)
EMG-
triggered
electri-
cal stimu-
lation
Super-
seded by
more up-
to-date
review
3rd quar-
ter 2003
To assess
the mean
effect size
of EMG-
triggered
neuro-
muscular
stimu-
lation on
motor re-
covery of
the upper
limb
RCTs,
con-
trolled
trials
Stroke EMG-
triggered
neuro-
muscu-
lar electri-
cal stimu-
la-
tion (ac-
tive stim-
ulation)
with sur-
face elec-
trodes
used
to moni-
tor mus-
cle activ-
ity
and to
provide
electri-
cal stimu-
lation
Usual
therapy,
stretching
Fugl-
Meyer
Assess-
ment,
Block and
Box Test,
River-
mead
Motor
Assess-
ment
5 (86)
Bonaiuti
2007
(DARE)
CIMT Super-
seded
by up-to-
date
review
July 2004 To anal-
yse the
evidence
of effec-
tiveness
on adult
stroke pa-
tients of
CIMT
RCTs Stroke CIMT Conven-
tional
therapy
Measures
of impair-
ment
9 (243)
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Braun
2006
(DARE)
Mental
practice
Super-
seded
by up-to-
date
review
August
2005
To assess
the effects
of a men-
tal prac-
tice inter-
vention
on recov-
ery in
stroke pa-
tients
RCTs,
con-
trolled
trials
Stroke Mental
practice
Not clear Measures
of activity
lim-
itation or
impair-
ment
4 RCTs
(“Study
sizes were
small
(4 studies
had
20 partic-
ipants, 1
study had
46 pa-
tients)”)
Cardoso
2005
(DARE)
Bo-
tulinum
toxin A
Super-
seded
by up-to-
date
review
2004 To assess
whether
bo-
tulinum
toxin is an
adequate
treatment
for spas-
ticity due
to stroke
RCT Stroke Bo-
tulinum
toxin A
injections
for upper
limb
spasticity
Placebo Modified
Ashworth
Scale,
Global
Assess-
ment
Scale
5 (329)
Crosbie
2007
(DARE)
Virtual
reality
Super-
seded
by up-to-
date
review
February
2005
To assess
the util-
ity of vir-
tual real-
ity (VR)
in stroke
rehabili-
tation
RCTs,
pre/post
case series
Stroke Vir-
tual real-
ity inter-
vention
Self as
control,
healthy
con-
trols, age-
matched
controls
Impair-
ment
or activ-
ity mea-
surement
5 (30)
Galvin
2008
(DARE)
Exercise
therapy
Super-
seded
by up-to-
date
review
(3 trials
included
in this re-
view were
excluded
from
more up-
to-date
review)
Not
reported
(2006)
This
article fo-
cuses on
the
impact of
increased
dura-
tion of ex-
ercise
therapy
on func-
tional re-
covery af-
ter stroke
RCTs Stroke “Addi-
tional,”
“aug-
mented”
or “in-
creased
du-
ration” of
exercise
therapy
Exer-
cise ther-
apy was
defined as
motion of
The same
exer-
cise ther-
apy, but a
lesser du-
ration or
dose
Fugl-
Meyer
Up-
per Limb,
Action
Research
Arm Test,
Dy-
namome-
ter, Func-
tional
Test
of the
Hemi-
paretic
8 (863)
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the body
or its
parts
to relieve
symp-
toms
or to im-
prove
function,
leading to
physical
fitness,
but
not phys-
ical edu-
cation
and train-
ing
Upper
Extrem-
ity, Jebsen
Test of
Hand
Function,
Motor
Assess-
ment
Scale,
Motricity
Index,
Frenchay
Arm Test,
Barthel
Index,
Activities
of Daily
Living
Index,
River-
mead
Motor
Assess-
ment,
Ten-Hole
Peg Test,
Motor
Club As-
sessment,
Nine-
Hole Peg
Test
Glanz
1996
(DARE)
Biofeed-
back
Super-
seded
by up-to-
date
review
Not
reported
To
assess the
efficacy of
biofeed-
back ther-
apy in
post-
stroke re-
habilita-
tion
RCTs Stroke Biofeed-
back for
upper ex-
tremity
paresis
Conven-
tional
therapy
Impair-
ment
3 (82)
Glanz
1996
(DARE)
Electri-
cal stimu-
lation
Super-
seded
by up-to-
date
review
1994 To
assess the
efficacy of
func-
RCT Stroke Func-
tional
electri-
cal stimu-
Control Wrist
torque
1 UL (
30)
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tional
electrical
stimula-
tion
(FES) in
the reha-
bilitation
of hemi-
paresis in
stroke
lation
Green
2003
(CDSR)
Interven-
tions
for shoul-
der pain
Not
stroke
- - - - - - - -
Hakkennes
2005
(DARE)
CIMT Super-
seded
by up-to-
date
review
March
2005
To inves-
tigate the
effects on
function,
quality
of life,
health-
care
costs and
patient/
carer sat-
isfaction
of con-
straint-
induced
move-
ment
therapy
(CIMT)
for upper
limb
hemi-
paresis
following
stroke
RCTs and
system-
atic
reviews
Stroke CIMT or
mCIMT
Alterna-
tive ther-
apy, con-
trol,
dose-
matched
therapy
or com-
parison
between
CIMT
and
mCIMT
Action
Research
Arm Test,
Func-
tional
Indepen-
dence
Measure,
Fugl-
Meyer
Assess-
ment,
Motor
Activity
Log and
Wolf
Motor
Function
Test
14 (292)
Handy
2003
(DARE)
Electri-
cal stimu-
lation
Super-
seded
by up-to-
date
review
2002 To exam-
ine the ef-
fective-
ness
of electri-
cal stim-
ulation in
RCTs and
quasi-ex-
perimen-
tal studies
Stroke Func-
tional
electri-
cal stim-
ulation or
transcu-
taneous
Con-
trol or al-
ternative
therapy
Subluxa-
tion,
pain,
range
of motion
or func-
tion
5 (224)
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treating
the upper
extremi-
ties of pa-
tients
who suf-
fer cere-
brovascu-
lar
accidents
(strokes)
electri-
cal nerve
stimula-
tion
Hayward
2010
(DARE)
Mixed No addi-
tional
studies
March
2009
To inves-
tigate the
effects of
interven-
tions that
promote
UL recov-
ery
in stroke
survivors
with se-
vere pare-
sis
RCTs Stroke
with
severe UL
paresis
Interven-
tions that
enabled
stroke
survivors
with
severe UL
paresis
to partici-
pate in
repet-
itive task-
oriented
training
Alterna-
tive
or control
treatment
Out-
comes for
impair-
ment, ac-
tivity
and/
or partici-
pation
17 (486)
Hender-
son
2007
(DARE)
Virtual
reality
Super-
seded by
more up-
to-date
review
January
2006
To evalu-
ate scien-
tific evi-
dence for
the effec-
tiveness
of virtual
reality in
rehabil-
itation of
the
UL post
stroke
RCTs,
single-
sub-
ject stud-
ies and
pre/post
study de-
signs
Stroke
(acute,
sub-
acute and
chronic)
Immer-
sive or
non-im-
mersive
virtual re-
ality
Conven-
tional
ther-
apy or no
therapy
Fugl-
Meyer
Assess-
ment,
Func-
tional In-
depen-
dence
Measure,
Wolf Mo-
tor Func-
tion Test
6 (95)
Koog
2010
(DARE)
Treat-
ment
for shoul-
der pain
No
UL func-
tion-spe-
cific out-
come
- - - - - - - -
de Kroon
2002
(DARE)
Electri-
cal stimu-
lation
Super-
seded
Decem-
ber 2001
Assess-
ment of
RCTs Stroke Thera-
peu-
Stan-
dard ther-
Measure-
ment
6 (207)
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Table 5. Characteristics of excluded reviews (Continued)
by up-to-
date
review
avail-
able evi-
dence on
the effects
of thera-
peu-
tic electri-
cal stimu-
lation
of the af-
fected up-
per ex-
tremity in
improv-
ingmotor
control
and func-
tional
abil-
ities after
stroke
tic electri-
cal stimu-
lation
apy, sen-
sory stim-
ulation,
dose-
matched
therapy
of motor
control or
func-
tional
abilities
de Kroon
2005
(DARE)
Electri-
cal stimu-
lation
Super-
seded
by up-to-
date
review
Decem-
ber 2003
To ex-
plore the
relation-
ship
between
charac-
teristics
of stimu-
la-
tion and
the effects
of electri-
cal stimu-
lation on
the recov-
ery of up-
per limb
motor
control
following
stroke
Clinical
trials
Stroke Surface
electri-
cal stimu-
lation
No treat-
ment, ex-
ercises,
placebo,
dose-
matched
therapy
Range of
motion,
grip
strength,
Fugl-
Meyer
Assess-
ment,
Motor
Assess-
ment
Scale,
Box and
Block
Test,
Motor
Activity
Log,
Ashworth
Scale,
Barthel
Index,
Rankin
Scale,
Pain
19 (578)
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Table 5. Characteristics of excluded reviews (Continued)
Kwakkel
2008
(DARE)
Robotics Super-
seded by
more up-
to-date
review
October
2006
The
aim of the
study was
to present
a system-
atic
review
of studies
that in-
vestigate
the effects
of robot-
assisted
therapy
on motor
and func-
tional re-
covery in
patients
with
stroke
RCTs Stroke Robot-
assisted
therapy
for
the upper
limb
Control
(robot ex-
posure),
neurode-
velop-
mental
therapy,
electri-
cal stimu-
lation
Fugl-
Meyer,
Chedoke-
McMas-
ter
10 (218)
Latimer
2010
(DARE)
Bilat-
eral arm
training
Super-
seded by
more up-
to-date
review
Before
2008
To deter-
mine the
evidence
for bilat-
eral ther-
apy inter-
ventions
aimed at
improv-
ing upper
limb
function
in
adults
with
a range of
up-
per limb
activ-
ity limita-
tions due
to a first-
time
chronic
stroke
RCTs and
cohort
studies
6 months
post
stroke
Bilat-
eral upper
limb in-
terven-
tion
RCTs:
• Dose-
matched
exercises
• No
treatment
• Motor
practice
• Unilateral
training
Upper
Extrem-
ity of
Fugl-
Meyer
Assess-
ment,
Frenchay
Arm Test,
River-
mead
Motor
Assess-
ment,
Wolf
Motor
Function
Test,
Modified
Motor
Assess-
ment
Scale
9 (166):
RCTs-4
(85)
Co-
hort stud-
ies-5 (81)
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Table 5. Characteristics of excluded reviews (Continued)
Legg
2006
(CDSR)
Therapy
for ADL
No UL-
specific
outcome
- - - - - - - -
Ma 2002
(DARE)
Therapy No UL
outcome
measure
- - - - - - - -
McIntyre
2012
(DARE)
CIMT No addi-
tional
studies
July 2012 To deter-
mine
the effec-
tiveness
of con-
straint-
induced
move-
ment
therapy
(CIMT)
in the
hemi-
paretic
upper
extremity
(UE)
among
indi-
viduals
who were
more
than 6
months
post
stroke
RCTs Over
50%
stroke; ≥
6 months
post
stroke
CIMT Tradi-
tional re-
habilita-
tion ther-
apy
Motor
Activity
Log
Amount
of Use,
Motor
Activity
Log
Quality
of Move-
ment,
Wolf
Motor
Function
Test,
Fugl-
Meyer
Assess-
ment,
Action
Research
Arm Test,
Func-
tional
Indepen-
dence
Measure
16 (572)
Mehrholz
2011
(CDSR)
Exercise No UL
outcome
measure
- - - - - - - -
Moreland
1994
(DARE)
Biofeed-
back
Super-
seded by
more up-
to-date
review
1992 To exam-
ine the ef-
ficacy
of elec-
tromyo-
graphic
(EMG)
biofeed-
back
RCTs Stroke EMG
biofeed-
back
alone or
with
conven-
tional
physical
Conven-
tional
physical
therapy
(ex-
clusion of
feedback
devices or
Any func-
tional
measure
of the up-
per ex-
tremity,
including
upper ex-
6 RCTs
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com-
pared
with con-
ventional
physical
therapy
for
improv-
ing upper
extremity
function
in pa-
tients fol-
lowing a
stoke
therapy func-
tional
electrical
stimula-
tion)
trem-
ity func-
tion test-
ing,
stage of
motor re-
covery,
range of
motion
and mus-
cle
strength
Moreland
1998
(DARE)
Biofeed-
back
LL
outcomes
only
- - - - - - - -
Morten-
son
2003
(DARE)
Position-
ing and
stretching
Brain in-
jury and
stroke
outcomes
com-
bined
- - - - - - - -
Nijland
2011
(DARE)
Con-
straint-
induced
move-
ment
therapy
(CIMT)
No addi-
tional
studies
January
12, 2010
To ex-
amine the
literature
on
the effects
of con-
straint-
induced
move-
ment
therapy
in acute
or suba-
cute
stroke
RCTs Acute or
subacute
stroke
(within
10 weeks
of stroke)
High-
intensity
CIMT,
low-
intensity
CIMT
Usual
care im-
plied
Fugl-
Meyer
Assess-
ment, Ac-
tion Re-
search
Arm Test,
Motor
Ac-
tivity Log
Amount
of
Use, Mo-
tor Ac-
tivity Log
Quality
of Move-
ment
5 (106)
Nilsen
2010
(DARE)
Mental
practice
Super-
seded by
more up-
to-date
February
2009
To deter-
mine
whether
Cate-
gorised all
levels of
Stroke Men-
tal prac-
tice alone
Other
therapies
Fugl-
Meyer
Assess-
15 (145)
RCTs-4
(72)
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review mental
practice is
an effec-
tive inter-
vention
to im-
prove up-
per limb
re-
covery af-
ter stroke
evidence,
RCTs
to case re-
ports
or in
combina-
tion with
other
therapies
ment,
Wolf
Motor
Function
Test,
Action
Research
Arm Test,
Motor
Activity
Log,
Motricity
Index,
Pegboard
Test, Dy-
namome-
ter, po-
sition
sense,
2-point
discrim-
ination,
Recovery
Locus of
Control
Scale,
Barthel
Index,
Func-
tional
Limi-
tations
Profile,
kinemet-
ics of
reaching
and
grasping,
Jebsen
Hand
Function
Test,
pinch
Cohort 3
(43)
Case se-
ries
or single
case stud-
ies-8 (30)
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Table 5. Characteristics of excluded reviews (Continued)
strength,
grip
strength,
Chedoke
McMas-
ter, range
of motion
Outpa-
tients
Service
Trialists
2003
(CDSR)
Therapy-
based re-
habili-
tation ser-
vices
No UL-
specific
outcome
- - - - - - - -
Peurala
2011
(DARE)
Con-
straint-
induced
move-
ment
therapy
(CIMT)
Super-
seded by
more up-
to-date
review
January
5, 2011
To exam-
ine
the effects
of con-
straint-
induced
move-
ment
therapy
and mod-
ified con-
straint-
induced
move-
ment
ther-
apy on ac-
tivity and
partic-
ipation of
patients
with
stroke (i.
e. the ef-
fects of
different
treatment
duration
and fre-
quency)
RCTs Stroke CIMT;
modified
CIMT
(not
forced
use)
Usual
care im-
plied
Motor
Activity
Log,
Action
Research
Arm Test,
Wolf
Motor
Function
Test,
Func-
tional
Indepen-
dence
Measure,
Stroke
Impact
Scale,
Barthel
Index
27 RCTs
12 (560)
within
meta-
analysis
Platz
2003
(DARE)
Mixed Super-
seded by
more up-
October
2002
To iden-
tify
all studies
System-
atic
reviews,
Stroke
with
hemi-
Exercise
therapy
or neuro-
Not
stated
No mea-
sures or
scores re-
30 refer-
ences
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to-date
review
pro-
viding ev-
idence to
support
interven-
tions
compris-
ing exer-
cise ther-
apy
or neuro-
muscu-
lar electri-
cal stim-
ulation to
improve
arm pare-
sis or en-
su-
ing activ-
ity limita-
tions after
stroke
meta-
analyses,
RCTs,
con-
trolled
cohort
studies
pare-
sis/ hemi-
plegia af-
fecting
the upper
limb
muscular
electrical
stimu-
lation
aimed at
improv-
ing arm
paresis or
ensuing
activity
limita-
tions after
stroke.
This
included
physio-
therapy
ap-
proaches,
arm
ability
training,
CIMT,
repetitive
sensori-
motor
training,
EMG
biofeed-
back,
kines-
thetic
feedback,
electros-
timu-
lation,
robot-
assisted
arm reha-
bilitation.
Training
intensity
was also
investi-
gated
ported,
only
generic
terms, e.
g.
“strength,
” “func-
tion,” “se-
lectiv-
ity,” “effi-
ciency of
arm func-
tion”
Poltawski
2012
(PROS-
PERO)
No inter-
vention
No upper
limb in-
terven-
- - - - - - - -
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tions
Pomeroy
2006
(CDSR)
Electros-
timula-
tion
Super-
seded by
more up-
to-date
review
January
1, 2004
To find
whether
electros-
timu-
lation im-
proved
func-
tional
mo-
tor ability
and
the ability
to under-
take ac-
tivities of
daily liv-
ing
RCTs
or quasi-
RCTs
Stroke Electros-
timula-
tion
No treat-
ment,
placebo,
conven-
tional
therapy
Func-
tional
motor
ability-
included
the fol-
lowing:
River-
mead
Mobility
Index,
Walking
En-
durance,
Timed
Up and
Go Test,
Motor
Assess-
ment
Scale,
Box and
Block
Test, Up-
per Ex-
tremity
Drawing
Test,
Action
Research
Arm Test,
Jebsen
Hand
Function
Test,
Nine--
Hole Peg
Test
Measures
of ADL-
included
the fol-
24 (888)
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lowing:
Barthel
Index,
Func-
tional In-
depen-
dent
Measure
Measures
of motor
impair-
ment-
included
the fol-
lowing:
Muscle
tone-
Ashworth
and
spasticity
scores,
resistance
to passive
move-
ment,
Warten-
berg Pen-
dulum
Test Re-
laxation
Index;
Muscle
function-
joint
move-
ment,
sustained
muscle
contrac-
tion,
premotor
reaction
time,
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motor
reaction
time,
isometric
torque,
co-con-
traction
ratio of
agonist
and
antago-
nist mus-
cles, grip
strength,
joint
range of
active
move-
ment,
physio-
logical
cost
index,
Fugl-
Meyer
Assess-
ment
Prange
2006
(DARE)
Robotics Super-
seded by
more up-
to-date
review
August 1,
2005
To inves-
tigate
the effects
of robot-
aided
therapy
on upper
limb mo-
tor con-
trol
and func-
tional
abilities
of stroke
patients
Pre/post
studies
and RCTs
Stroke Robot
therapy
Conven-
tional
therapy
Fugl-
Meyer
Assess-
ment,
Motor
Status
Score,
Motor
Power,
Func-
tional
Indepen-
dence
Measure,
Barthel
Index
8 (246)
Price
2000
(CDSR)
Electri-
cal stimu-
lation
Pain out-
comes, no
func-
tional UL
outcomes
- - - - - - - -
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Péter
2011
(DARE)
Robotics Super-
seded by
more up-
to-date
review
January
11, 2010
To review
robot-
sup-
ported
up-
per limb
physio-
therapy
focusing
on
the shoul-
der, el-
bow and
wrist.
Clinical
trial (ran-
domised
or non-
ran-
domised,
self-con-
trolled or
with con-
trol
group)
Hemi-
pare-
sis due to
up-
permotor
neuron
lesion
Shoulder,
el-
bow and/
or wrist
robot-
mediated
therapy
Conven-
tional
therapy
or electri-
cal stimu-
lation
Fugl-
Meyer
Assess-
ment,
Func-
tional
Indepen-
dence
Measure,
Barthel
Index,
Motor
Power
Scale,
Motor
Status
Scale,
Medical
Research
Council
Muscle
Grading,
Wolf
Motor
Function
Test,
range of
motion,
spasticity,
Arm
Motor
Ability
Test,
Rancho
Los Ami-
gos Func-
tional
Test
30 (393)
Richards
2008
(DARE)
TMS No func-
tional
outcomes
- - - - - - - -
Saposnik
2010
(DARE)
Virtual
reality
Super-
seded by
more up-
to-date
review
January
7, 2010
To deter-
mine
the added
benefit of
virtual re-
ality tech-
RCTs and
pre/post
design
Stroke Immer-
sive or
non-im-
mersive
virtual re-
Conven-
tional re-
habilita-
tion,
sham vir-
Fugl-
Meyer
Assess-
ment,
Wolf Mo-
12 (195)
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Table 5. Characteristics of excluded reviews (Continued)
nology
for arm
motor re-
covery af-
ter stroke
ality tual real-
ity, recre-
ational
activi-
ties or or-
thoses
tor Func-
tion Test,
Box
andBlock
Test, Jeb-
sen Hand
Function
Test
Shi 2011
(DARE)
Con-
straint-
induced
move-
ment
therapy
(CIMT)
Super-
seded by
more up-
to-date
review
January
4, 2010
To com-
pare
the effec-
tiveness
of modi-
fied con-
straint-
induced
move-
ment
therapy
with tra-
ditional
rehabili-
tation
ther-
apy in pa-
tients
with
upper ex-
tremity
dysfunc-
tion
after
stroke
RCTs Stroke Modified
CIMT
Tradi-
tional re-
habilita-
tion ther-
apy
Fugl-
Meyer
Assess-
ment,
Action
Research
Arm Test,
Func-
tional
Indepen-
dence
Measure,
Motor
Activity
Log
Amount
of Use,
Motor
Activity
Log
Quality
of Move-
ment,
reaction
time,
peak
velocity
13 (278)
Steven-
son
2012
(DARE)
Con-
straint-
induced
move-
ment
therapy
(CIMT)
No addi-
tional
studies
January
2, 2011
To exam-
ine con-
straint-
induced
move-
ment
therapy,
relative to
dose-
matched
control
interven-
RCTs or
cross-
over
design
Stroke CIMT Dose-
matched
control
Motor ca-
pacity-
Fugl-
Meyer
Assess-
ment,
kinemat-
ics, indi-
rect indi-
cators
of neuro-
Motor ca-
pacity-15
(432)
UL abil-
ity-14
(351)
FIM 6
(182)
Mo-
tor Activ-
ity Log 12
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tions, for
upper
limb dys-
function
in
adult sur-
vivors of
stroke
physio-
logi-
cal mech-
anisms
UL abil-
ity-Ac-
tion Re-
search
Arm Test,
Nine-
Hole Peg
Test,
Wolf Mo-
tor Func-
tion Mea-
sure
Compre-
hensive-
Func-
tional
Indepen-
dence
Measure,
Barthel
Index,
self-
report
(Motor
Activity
Log,
Stroke
Impact
Scale)
(352)
Stewart
2006
(DARE)
Bilat-
eral arm
training
Super-
seded by
more up-
to-date
review
2nd quar-
ter 2005
To deter-
mine the
overall ef-
fective-
ness of
rehabili-
ta-
tion with
bilateral
move-
ments
Pre/post
and RCTs
Upper ex-
trem-
ity stroke
hemi-
pare-
sis, with
enough
resid-
ual motor
control in
the
impaired
arm to
permit
Bilateral
move-
ment
training
or bilat-
eral train-
ing
with au-
ditory cu-
ing or ac-
tive neu-
romuscu-
lar stimu-
lation
Pretreat-
ment/
single-
arm tasks
Kine-
matic
perfor-
mance,
Fugl-
Meyer
Upper
Extrem-
ity Test,
Motor
Assess-
ment
Scale,
Box and
11 (171)
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perfor-
mance of
motor ca-
pabilities
tests
Block
Test
Tang
2012
(DARE)
Repet-
itive tran-
scranial
magnetic
stimula-
tion
(rTMS)
Unable to
find full
paper
- - - - - - - -
Timmer-
manns
2009
(DARE)
No inter-
vention
Scoping
review of
treatment
rationale
- - - - - - - -
Tyson
2011
(DARE)
Stretch-
ing (or-
thoses)
No addi-
tional
studies
July 2009 To estab-
lish
whether
an or-
thosis can
improve
function
and/or
impair-
ments
RCTs Adults
with
stroke or
the stable
non-pro-
gressive
se-
quelae of
a brain le-
sion (such
as in-
fection or
traumatic
brain in-
jury) that
resulted
in motor
impair-
ments
Orthoses
to man-
age upper
limb
motor
impair-
ments
(The
following
types of
orthoses
were
excluded:
splinting
during
con-
straint-
induced
move-
ment
therapy,
devices to
prevent
shoulder
sublux-
ation,
orthoses
Compari-
son of an
orthosis
with no
treat-
ment,
normal
care,
placebo
treat-
ment. Or
compari-
son of an
orthosis
plus
normal
man-
agement
versus
normal
man-
agement
alone
Upper
limb im-
pair-
ments,
activ-
ity limi-
tations or
incidence
of adverse
events
4 (126)
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that were
part of
a hybrid
device to
deliver
func-
tional
electrical
stimu-
lation,
taping,
strap-
ping, air-
pressure
splints,
serial
casting)
van der
Lee 2001
(DARE)
Exercise
therapy
Super-
seded by
more up-
to-date
review
August
2000
Assess-
ment of
avail-
able evi-
dence for
the effec-
tive-
ness of ex-
ercise
therapy
RCTs Stroke Exercise
therapy
Other
treatment
or no
treatment
Barthel
In-
dex, Ac-
tion Re-
search
Arm Test,
Fugl-
Meyer
Assess-
ment
13 (939)
van Dijk
2005
(DARE)
Biofeed-
back
Super-
seded by
more up-
to-date
review
Decem-
ber 2004
Assess-
ment of
avail-
able evi-
dence re-
garding
the effects
of aug-
mented
feedback
on motor
function
of the
upper ex-
tremity in
rehabili-
tation pa-
tients
RCTs Up-
per limb
rehabili-
tation pa-
tients
(Parkin-
son’s
disease-3
studies;
spinal
cord
injury-2
studies;
cerebral
palsy-
1 study,
traumatic
brain
injury-
Aug-
mented
feedback
Placebo,
conven-
tional
therapy,
no treat-
ment
Active
range of
motion,
Brunnstrom’s
stages of
recovery,
elec-
tromyo-
graphical
activity,
Upper
Extrem-
ity Func-
tional
Scale,
Nine-
Hole Peg
Test, est
26 (927)
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1 study;
stroke
and
traumatic
brain
injury-2
studies,
stroke-16
studies
Evaluant
des
Membres
Supérieurs
des Per-
sonnes
Agées,
Box and
Block
Test,
Fugl-
Meyer
Assess-
ment,
wrist
extension
torque,
Action
Research
Arm Test,
Frenchay
Arm Test,
McGill
Pain
Ques-
tionnaire
van Kuijk
2002
(DARE)
Bo-
tulinum
toxin in-
jection by
any route,
including
but not
limited
to intra-
muscular,
subcuta-
neous, in-
tradermal
and intra-
articular
routes
Super-
seded by
more up-
to-date
review
January
10, 2000
The goal
of this
study was
to pro-
vide pre-
liminary
clini-
cal guide-
lines as to
the
method
of admin-
istration
and opti-
mal
dosage in
the focal
treatment
of upper
limb
spasticity
following
stroke
Excluded
studies
with
fewer
than 10
partici-
pants, but
included
case series
(for phe-
nol or al-
cohol in-
jections)
Stroke Bo-
tulinum
toxin
Placebo
but not
always
specified
Modified
Ashworth
Scale,
grip
strength,
Fugl-
Meyer
Assess-
ment,
Func-
tional
Indepen-
dence
Measure,
Barthel
Index,
Frenchay
Arm Test,
Motricity
Index
12 (not
reported)
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van
Peppen
2004
(DARE)
Phys-
ical ther-
apy inter-
ventions
Super-
seded by
more up-
to-date
review
January
2004
To deter-
mine the
evidence
for phys-
ical ther-
apy inter-
ventions
aimed at
improv-
ing func-
tional
out-
comes af-
ter stroke
RCTs and
CCTs
Stroke Exercises
for upper
limb
Control Action
Research
Arm Test,
Arm Mo-
tor Activ-
ity
Test, Mo-
tor Activ-
ity Log
5 (104)
Wu 2006
(CDSR)
Acupunc-
ture
No UL-
specific
interven-
tion
- - - - - - - -
Zimmer-
mann-
Schlatter
2008
(DARE)
Mental
practice
Super-
seded by
more up-
to-date
review
January
8, 2005
To evalu-
ate
how mo-
tor im-
agery and
conven-
tional
therapy
(physio-
therapy
or
occupa-
tional
therapy)
compare
with con-
ventional
ther-
apy only
in their
effects on
clinically
relevant
outcomes
during re-
habil-
itation of
RCTs Stroke Motor
imagery
plus con-
ventional
therapy
Conven-
tional
therapy
Fugl-
Meyer
Upper
Extrem-
ity Score;
Action
Research
Arm Test
4 (86)
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Table 5. Characteristics of excluded reviews (Continued)
per-
sons with
stroke
CCT: Controlled clinical trial.
CIMT: Constraint-induced movement therapy.
CDSR: Cochrane Database of Systematic Reviews.
DARE: Database of Reviews of Effectiveness.
EMG: Electromyography.
FES: Functional electrical stimulation.
LL: Lower limb.
mCIMT: Modified constraint-induced movement therapy.
RCT: Randomised controlled trial.
rTMS: Repetitive transcranial magnetic stimulation.
UE: Upper extremity.
UL: Upper limb.
Table 6. Overview of interventions covered by reviews
Intervention Reviews included in
qualitative synthesis
Reviews included in
quantitative synthesis
Ongoing reviews Excluded, as
superseded
by more up-to-date re-
view/
contains no additional
studies
Acupuncture Liang 2011 (Ongoing)
Bilateral arm training Coupar 2010
van Delden 2012
Coupar 2010
van Delden 2012
Latimer 2010
Stewart 2006
Biofeedback Molier 2010
Woodford 2007
Woodford 2007 Glanz 1995
Moreland 1994
van Dijk 2005
Bobath therapy Luke 2004 Luke 2004
Brain stimulation Elsner 2013
Hao 2013
Elsner 2013
Hao 2013
Straudi (Ongoing)
CIMT Corbetta 2010
Sirtori 2009
Corbetta 2010 (SGonly)
Sirtori 2009
(Farmer 2014*)
Bjorklund 2006
Bonaiuti 2007
Hakkennes 2005
McIntyre 2012
Nijland 2011
Peurala 2011
Shi 2011
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Table 6. Overview of interventions covered by reviews (Continued)
Stevenson 2012
Electrical stimulation (Farmer 2014a)
Meilink 2008
Nascimento 2014
(Farmer 2014a)
Meilink 2008
Nascimento 2014
Howlett (Ongoing) Ada 2002
Bolton 2004
Glanz 1996
Handy 2003
de Kroon 2002
de Kroon 2005
Pomeroy 2006
Tyson 2011
“Hands-on” therapy Winter 2011 van der Lee 2001
Mental practice Barclay-Goddard 2011
Braun 2013
Wang 2011
Barclay-Goddard 2011
(SG only)
Braun 2013
Wang 2011
Braun 2006
Nilsen 2010
Zimmermann-Schlatter
2008
Mirror therapy Thieme 2012 Thieme 2012
Music therapy Bradt 2010
Pharmacological inter-
ventions
Demetrios 2013
Elia 2009
Olvey 2010
Singh 2010
Elia 2009
Singh 2010
Kinnear (Ongoing)
Lindsay 2013 (Ongoing)
Cardoso 2005
van Kuijk 2002
Repetitive task training French 2007
French 2008
French 2007
Robotics Mehrholz 2012
Norouzi-Gheidari 2012
Mehrholz 2012
Norouzi-Gheidari 2012
(SG only)
(Farmer 2014*)
Kwakkel 2008
Prange 2006
Péter 2011
Self-management Kidd (Ongoing)
Sensory interventions Doyle 2010
Schabrun 2009
Doyle 2010
Schabrun 2009
Strength training Harris 2010 Harris 2010
Stretching and position-
ing
Ada 2005
Borisova 2009
Hijmans 2004
Katalinic 2010
Lannin 2003
Ada 2005
Borisova 2009 (SG only)
Katalinic 2010
Lannin 2003
Meeran (Ongoing)
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Table 6. Overview of interventions covered by reviews (Continued)
Task-specific training
(reach-to-grasp exercise)
Pelton 2012
(Urton 2007a)
Diermayr (Ongoing)
Virtual reality Laver 2011 Laver 2011 Crosbie 2007
Henderson 2007
Saposnik 2010
Mixed Farmer 2014
Urton 2007
Farmer 2014 Monaghan 2011
(Ongoing)
Hayward 2010
Platz 2003
van Peppen 2004
Factors in service deliv-
ery: dose of intervention
Cooke 2010 Cooke 2010 Galvin 2012 (Ongoing)
Schneider (Ongoing)
Galvin 2008
Factors in service deliv-
ery: location of interven-
tion
Coupar 2012
Laver 2013
Coupar 2012
Laver 2013
Numbers of reviews 40 31 of 40 reviews
27 of 31 reviews-data
from
main comparisons in-
cluded;
4 of 31 reviews-overlap
with trials
included in main com-
parisons:
data from subgroup
comparisons included
only
(marked as “SG only”)
11 37
CIMT: Constraint-induced movement therapy.
SG: Subgroup.
aReviews covering a mixture of different interventions (listed under ’Mixed’).
Table 7. Descriptions of reviews included in qualitative synthesis only
Review Intervention Brief description of re-
view
Results: effects of inter-
ventions
Reasons for not includ-
ing quantitative data
from review
Bradt 2010 (CDSR) Music therapy The aim of this review
was to examine the ef-
fects of music therapy
with standard care ver-
sus standard care alone
Narrative descriptions of
the results of the trials are
provided:
One trial: “examined the
effects of RAS on spa-
Data from the 2 trials
were not pooled
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
or standard care com-
bined with other thera-
pies on gait, upper ex-
tremity function, com-
munication, mood and
emotions,
social skills, pain, be-
havioural outcomes, ac-
tivities of daily living and
adverse events in partici-
pants with brain injury
A total of 7 studies
(184 participants) were
included, but only 2 (41
participants) were rele-
vant to the upper limb:
“Two trials measured the
effects of music ther-
apy on upper extremity
function in hemispheric
stroke patients. Elbow
extension angle was the
only common outcome
measure
in these two studies.
However, because of the
significant clinical het-
erogeneity of the studies,
their effect sizes were not
pooled”
tiotemporal control of
reaching movements of
the paretic arm in 21 pa-
tients. Results indicated
that RAS increased the
elbow extension angle by
13.8% compared to the
non-rhythmic trial, and
this difference was statis-
tically significant (P = 0.
007). Results further in-
dicated that variability of
timing and reaching tra-
jectories were reduced
significantly (35% and
40.5%, respectively, P <
0.05).”
One trial: “evaluated the
effects of music-mak-
ing activity on elbow
extension in 20 par-
ticipants with hemiple-
gia. The elbow exten-
sion (measured from135
to 0 with negative num-
bers expressing limita-
tions) post-intervention
was -29.4 (SD 29.49) for
the experimental group
and -39.2 (SD38.19) for
the control group. This
difference was not statis-
tically significant. Post-
test shoulder
flexion data indicated
no statistically signifi-
cant difference (P =0.44)
between the music ther-
apy group (85.6°, SD26.
71) and the
control group (71.8°, SD
39)”
Demetrios 2013
(CDSR)
Multi-disciplinary reha-
bilitation fol-
lowing botulinum toxin
or other focal neuromus-
cular treatment
The
aim of this review was to
assess the effectiveness of
multi-disciplinary reha-
bilitation, following bo-
tulinum neurotoxin and
Descriptions of the re-
sults from the 3 in-
cluded studies are pro-
vided. The review au-
thors classify all evidence
as “low quality” and con-
Data from the 3 trials
were not pooled
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
other focal intramuscu-
lar treatments such as
phenol, in improving
activity limitations and
other outcomes in adults
and children with post-
stroke spasticity
Three RCTs (91 partici-
pants), all classed as ’low
quality,’ were included.
“All studies investigated
various types and inten-
sities of outpatient reha-
bil-
itation programmes fol-
lowing botulinum neu-
rotoxin for upper limb
spasticity in adults with
chronic stroke. Rehabil-
itation programmes in-
cluded: mod-
ified constraint-induced
movement
therapy (mCIMT) com-
pared with a neurodevel-
opmental therapy pro-
gramme; task practice
therapy with cyclic func-
tional electrical stimu-
lation (FES) compared
with task practice ther-
apy only; and occupa-
tional, manual therapy
with dynamic elbow ex-
tension splinting com-
pared with occupational
therapy only.”
“Due to the
limited number of in-
cluded studies, with clin-
ical, methodological and
statistical heterogeneity,
quantitative meta-analy-
sis was not possible”
clude: “At best there was
’low level’ evidence for
the effectiveness of out-
patient MD rehabilita-
tion in improving ac-
tive function and im-
pairments following bo-
tulinum neurotoxin for
upper limb spasticity
in adults with chronic
stroke.” The review au-
thors conclude that there
is a need for “robust tri-
als”
French 2008 (DARE) “Repetitive functional
task practice,” includ-
ing repetitive task train-
ing (RTT), constraint-
The aim was to deter-
mine whether repetitive
functional task practice
(RFTP) after stroke im-
Arm function
Data from 8 RTT trials
(412 participants) and 7
CIMT trials (285 partic-
This review pools the
data from 2 interven-
tions: RTT and CIMT.
Data from these inter-
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
induced movement ther-
apy (CIMT) and tread-
mill training
proves limb-specific or
global function or ac-
tivities of daily living
and whether treatment
effects are dependent on
the amount of practice,
or the type or timing
of the intervention. Also
to provide estimates of
the cost effectiveness of
RFTP
Eighteen trials (634 par-
ticipants)
measured arm function.
These included 8 RTT
trials (467 participants)
and 10 CIMT trials (167
participants)
ipants) were pooled. The
pooled effect for the im-
pact of RFTP on arm
function was as follows:
SMD0.24, 95%CI 0.06
to 0.42; I2 = 22%
Hand function
Data from 5 RTT trials
(281 participants) and 2
CIMT trials (27 partici-
pants) were pooled. The
pooled effect for RFTP
on hand function was as
follows: SMD0.19, 95%
CI -0.03 to 0.42; I2 = 0%
ven-
tions are included from
French 2010 (RTT) and
Corbetta 2010 and
Sirtori 2009 (CIMT).
The French 2010 RTT
data are exactly the same
as these French 2008
data. The Corbetta 2010
and Sirtori 2009 data
are more comprehensive
than the French 2008
data; this review has a
much earlier search date
and includes far fewer
trials
Including the data from
this French 2008 review
would effectively result
in “double-counting” of
the data presented un-
der the separate inter-
ventionheadings ofRTT
and CIMT
Hijmans 2004 (DARE) Elbow orthoses The aim was to review
papers related to the use
of elbow
orthoses.
Only 2 studies included
participants with stroke.
One was an RCT (18
participants), and one
used a cross-over design
(16 participants)
No data are provided.
The review authors state
that (based on the cross-
over study) “wrist func-
tion and elbow range of
movement seem to ben-
efit from custom made
Lycra garments applied
at the elbow,” but (based
on the RCT) probably
no benefits are associated
with an inflatable pres-
sure splint
No data are available for
inclusion
Molier 2010 (DARE) Augmented feedback The aim was to inves-
tigate the effects of dif-
ferent aspects and types
of augmented feedback
on motor functions and
motor activities of the
hemiparetic arm after
stroke
8 RCTs, 4 non-ran-
domised studies, 9 pre/
For each study, it was
stated whether benefi-
cial effect, no effect or
inconclusive effect was
found for each outcome
assessed. No data were
provided
The results are discussed
in the text. The authors
state:
No data are available for
inclusion
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
post treatment design, 1
observational study and
1 single case study were
included
“There are some trends
in favour of providing
augmented knowledge
of performance feed-
back, augmented audi-
tory and combined sen-
sory and visual feedback.
No consistent effects on
motor relearning were
observed for summary
or faded, terminal or
concurrent, solely visual
or solely sensory aug-
mented feedback.” And
conclude that “ it was
not possible to deter-
mine which combina-
tions of aspects and types
of augmented feedback
are most essential for a
beneficial effect on mo-
tor activities and motor
functions of the hemi-
paretic arm after stroke.
This was due to the com-
bination of multiple as-
pects and types of aug-
mented feedback in the
included studies
This systematic re-
view indicates that aug-
mented feedback in gen-
eral has an added value
for stroke rehabilitation”
Olvey 2010 (DARE) Pharmacological thera-
pies for upper limb spas-
ticity
The aim was to re-
view studies of “contem-
porary pharmacological
therapies” for upper limb
spasticity after stroke
54 studieswere included:
23 RCTs and 31 non-
randomised studies. 51
of these investigated bo-
tulinum toxin
The results of the in-
cluded studies are tab-
ulated, with data from
individual studies de-
scribed
23 studies assessed func-
tional ability:
FIM-6 studies. 5 found
no benefit; 1 significant
benefit.
Fugl-Meyer-5 studies. 2
found significant bene-
fit.
Barthel Index-8 studies.
No data are available for
inclusion
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
2 report improvement; 6
no improvement
Disability Assess-
ment Scale-5 studies. All
report some benefit
Results from measures
of upper limb function
“were inconsistent.”
26 studies
evaluated range of mo-
tion; 15 reported a sig-
nificant improvement in
1 or more parameters af-
ter treatment
Pelton 2012 (DARE) Any intervention tar-
geted at co-ordination of
arm and hand segment
for reach to grasp after
stroke
The aim was to de-
termine the effectiveness
of current treatments
for improving co-ordina-
tion of reach to grasp fol-
lowing stroke
7 studies were included:
1 RCT, 2 case-control
studies, 2 pre/post tests,
1 cross-over, 1 observa-
tional
Interventions identified
fell
into 3 categories: “func-
tional therapy, biofeed-
back or electrical stimu-
lation and robot or com-
puterised training”
The results of each study
are tabulated, and the ef-
fect is reported as posi-
tive, negative or no effect
“Four studies (one RCT
and three experimental
studies without controls)
report a result in favour
of the experimental in-
tervention for improved
hand and arm coordi-
nation, whereas one ex-
perimental study with-
out controls found no
benefit. Two experimen-
tal studies with controls
did not report specific
training effects for hand
and arm coordination af-
ter stroke”
No data are available for
inclusion
Urton 2007 (DARE) Any interventions for
upper extremity hemi-
paresis following stroke
The aim was to criti-
cally analyse the litera-
ture on effective inter-
ventions for upper ex-
tremity hemiparesis fol-
lowing stroke
11 experimental studies
that evaluated interven-
tions for upper extremity
hemiparesis after stroke
were included
Interventions included
augmented exercise ther-
Study details are tabu-
lated, and the results of
each study are described
narratively
No data are available for
inclusion
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Table 7. Descriptions of reviews included in qualitative synthesis only (Continued)
apy, electrical stimula-
tion, goal-directed
reaching and reach-to-
grasp movements
Winter 2011 (CDSR) Hands-onphysical inter-
ventions (manual ther-
apy techniques)
The aim was to explore
the ef-
fectiveness of “clearly de-
scribed hands-on phys-
ical intervention (man-
ual therapy techniques)
, or treatment compo-
nent schedules, for the
upper limb following
stroke, either as the ex-
perimental intervention
or as the control group.
” Pharmacological, elec-
trical or psychological (e.
g. mental imagery, relax-
ation) techniques were
excluded, and only trials
with interventions that
addressed physical im-
pairment were included
Three trials (86 partic-
ipants) were included,
each of which investi-
gated different interven-
tions (including manual
stretch, passive extension
and hands-on therapy)
Note: In the trial of pas-
sive extension (22 par-
ticipants), passive exten-
sion was actually deliv-
ered as the control in-
tervention and electros-
timulation as the experi-
mental intervention
Because of the hetero-
geneity between studies,
no meta-analysis is per-
formed. The results of
each of the 3 studies
are described narratively.
Methodological limita-
tions are identified for all
3 studies
The study authors con-
clude: “The findings of
the review demonstrated
that the limited evidence
of benefit of stretching,
passive exercises andmo-
bilization when applied
to the hemiplegic up-
per limb following stroke
merits further research.”
No data are available for
inclusion
CDSR: Cochrane Database of Systematic Reviews.
CI: Confidence interval.
CMIT: Constraint-induced movement therapy.
DARE: Database of Reviews of Effectiveness.
FES: Functional electrical stimulation.
mCIMT: Modified constraint-induced movement therapy.
MD: Medical Department
RAS: Rhythmic auditory stimulation.
RCT: Randomised controlled trial.
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RFTP: Repetitive functional task practice.
RTT: Repetitive task training.
SD: Standard deviation.
SMD: Standardised mean difference.
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Table 8. AMSTAR results
Review
source
Author 1. Was
an ’a
priori’
design
pro-
vided?
The re-
search
ques-
tion
and in-
clusion
criteria
should
be
estab-
lished
before
the
con-
duct
of the
review
2. Was
there
dupli-
cate
study
selec-
tion
and
data
extrac-
tion?
There
should
be at
least
two in-
depen-
dent
data
extrac-
tors,
and a
con-
sensus
proce-
dure
for dis-
agree-
ments
should
be in
place
3. Was
a com-
pre-
hensive
liter-
ature
search
per-
formed?
At least
two
elec-
tronic
sources
should
be
searched.
The
report
must
include
years
and
databases
used
(e.g.
CEN-
TRAL,
EM-
BASE,
and
MED-
LINE)
. Key
words
and/or
MeSH
terms
must
be
stated
and
where
feasible
the
search
4. Was
the
status
of
publi-
cation
(i.e.
grey
liter-
ature)
used as
an in-
clusion
crite-
rion?
The
au-
thors
should
state
that
they
searched
for
reports
regard-
less of
their
publi-
cation
type.
The
au-
thors
should
state
whether
or not
they
ex-
cluded
any
reports
(from
the sys-
tematic
5. Was
a list of
stud-
ies (in-
cluded
and ex-
cluded)
pro-
vided?
A list of
in-
cluded
and ex-
cluded
studies
should
be pro-
vided
6. Were
the
charac-
teris-
tics of
the in-
cluded
studies
pro-
vided?
In an
aggre-
gated
form
such as
a table,
data
from
the
studies
should
be pro-
vided
on the
partic-
ipants,
inter-
ven-
tions
and
out-
comes.
The
ranges
of
charac-
teris-
tics in
all the
studies
anal-
ysed (e.
g. age,
race,
sex, rel-
7. Was
the sci-
entific
quality
of the
in-
cluded
studies
as-
sessed
and
docu-
mented?
’A
priori’
meth-
ods of
assess-
ment
should
be pro-
vided
(e.g.
for ef-
fective-
ness
studies
if the
author
(s)
chose
to
include
only
ran-
domised,
dou-
ble-
blind,
placebo-
con-
trolled
stud-
ies, or
8. Was
the sci-
entific
quality
of the
in-
cluded
studies
used
appro-
pri-
ately in
formu-
lating
conclu-
sions?
The
results
of the
method-
olog-
ical
rigour
and
scien-
tific
quality
should
be con-
sidered
in the
anal-
ysis
and the
conclu-
sions
of the
review,
and ex-
plicitly
stated
in
formu-
9. Were
the
meth-
ods
used to
com-
bine
the
find-
ings of
studies
appro-
priate?
For the
pooled
results,
a test
should
be
done to
ensure
the
studies
were
com-
bin-
able, to
assess
their
homo-
geneity
(i.e.
Chi2
test for
homo-
gene-
ity, I
2). If
hetero-
geneity
exists,
a ran-
dom-
10.
Was
the
likeli-
hood
of
publi-
cation
bias as-
sessed?
An
assess-
ment
of
publi-
cation
bias
should
include
a com-
bina-
tion of
graphi-
cal aids
(e.g.
funnel
plot,
other
avail-
able
tests)
and/
or sta-
tistical
tests
(e.g.
Egger
regres-
sion
test)
11.
Was
the
conflict
of
interest
stated?
Po-
tential
sources
of sup-
port
should
be
clearly
ac-
knowl-
edged
in both
the sys-
tematic
review
and
the in-
cluded
studies
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Table 8. AMSTAR results
strat-
egy
should
be pro-
vided.
All
searches
should
be
supple-
mented
by con-
sulting
current
con-
tents,
re-
views,
text-
books,
spe-
cialised
regis-
ters or
experts
in the
par-
ticular
field of
study,
and by
review-
ing the
refer-
ences
in the
studies
found
review)
, based
on
their
publi-
cation
status,
lan-
guage,
etc
evant
socioe-
co-
nomic
data,
disease
status,
dura-
tion,
sever-
ity) or
other
dis-
eases
should
be re-
ported
allo-
cation
con-
ceal-
ment
as in-
clusion
crite-
ria)
; for
other
types
of
stud-
ies,
alter-
native
items
will be
rele-
vant
lating
recom-
men-
dations
effects
model
should
be used
and/
or the
clinical
appro-
priate-
ness of
com-
bining
should
be
taken
into
consid-
eration
(i.e. is
it sen-
sible to
com-
bine?)
CDSR Ada
2005;
Foong-
chom-
chaey
2005
Y U Y Y Y Y U N Y N Y
CDSR Bar-
clay-
Y Y Y Y Y Y Y N Y N Y
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Table 8. AMSTAR results (Continued)
God-
dard
2011
DARE
Borisova
2009
Y N N U N N Y N U N N
CDSR Bradt
2010
Y Y Y Y Y Y Y Y N/A N Y
OTHER
Braun
2013
Y Y Y N Y N Y Y Y Y Y
DARE Cooke
2010
Y Y Y N Y N Y N Y N Y
DARE Cor-
betta
2010
Y N U Y N N Y Y Y N Y
CDSR Coupar
2010
Y Y Y U Y Y Y Y Y N Y
CDSR Coupar
2012
Y Y Y Y Y Y Y Y Y N Y
CDSR
Demetrios
2013
Y Y Y Y Y Y Y Y N/A N Y
CDSR Doyle
2010
Y Y Y Y Y Y Y Y N/A N Y
DARE Elia
2009
Y U N U Y Y U Y Y N Y
CDSR Elsner
2013
Y Y Y Y Y Y Y Y Y Y Y
OTHER
Farmer
2014
Y N N N N N U N N/A N Y
DARE French
2008
Y Y Y Y Y Y Y Y Y Y n
CDSR French
2007;
French
2010
Y Y Y Y Y Y Y Y Y Y Y
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Table 8. AMSTAR results (Continued)
CDSR Hao
2013
Y Y Y Y Y Y Y Y Y Y Y
DARE Harris
2010
Y U N N N Y N Y Y N Y
DARE Hij-
mans
2004
N N Y U Y N N N N/A N N
CDSR Katal-
inic
2010
Y Y Y Y Y Y Y Y Y Y Y
DARE Lannin
2003
Y N Y N Y N Y Y N/A N N
CDSR Laver
2011
Y Y Y Y Y Y Y Y Y N Y
CDSR Laver
2013
Y Y Y Y Y Y Y Y Y N Y
DARE Luke
2004
y N N N N Y Y Y N N N
CDSR
Mehrholz
2012
Y Y Y Y Y Y Y Y Y Y Y
DARE Meilink
2008
N U Y N N N Y Y Y N N
DARE Molier
2010
Y Y Y N N Y N N N/A N Y
PROS-
PERO
Nasci-
mento
2014
Y Y Y Y Y Y Y Y Y N Y
DARE
Norouzi-
Ghei-
dari
2012
Y U Y N Y N U U Y N Y
DARE Olvey
2010
N N Y N N N N Y N/A N Y
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Table 8. AMSTAR results (Continued)
DARE Pelton
2012
Y Y Y N N Y Y Y N/A N U
DARE
Schabrun
2009
Y U N N Y Y N Y Y N Y
CDSR Singh
2010
Y U Y U Y Y Y Y Y N Y
CDSR Sirtori
2009
Y Y Y U Y Y U Y Y N Y
CDSR Thieme
2012
Y Y Y Y Y Y Y Y Y N Y
DARE Urton
2007
N N N N N N N N N/A N N
DARE van
Delden
2012
Y Y Y N Y Y Y U Y N N
DARE Wang
2011
Y U U N N N Y U Y Y N
CDSR Winter
2011
Y Y Y Y Y Y Y Y N/A N Y
CDSR Wood-
ford
2007
Y U Y Y Y U Y Y Y N Y
Num-
ber
of re-
sponses:
all
reviews
YES 36 23 31 19 29 27 29 29 27 8 30
NO 4 8 7 15 11 12 6 8 1 32 9
UN-
CLEAR
0 9 2 6 0 1 5 3 1 0 1
N/A 0 0 0 0 0 0 0 0 11 0 0
Num-
ber
of re-
sponses:
CDSR
reviews
YES 19 16 19 16 19 18 17 17 15 5 19
NO 0 0 0 0 0 0 0 2 0 14 0
UN-
CLEAR
0 3 0 3 0 1 2 0 0 0 0
N/A 0 0 0 0 0 0 0 0 4 0 0
132Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 8. AMSTAR results (Continued)
Num-
ber
of re-
sponses:
other
reviews
YES 17 7 12 3 10 9 12 12 12 3 11
NO 4 8 7 15 11 12 6 6 1 18 9
UN-
CLEAR
0 6 2 3 0 0 3 3 1 0 1
N/A 0 0 0 0 0 0 0 0 7 0 0
CDSR: Cochrane Database of Systematic Reviews.
DARE: Database of Reviews of Effectiveness.
N: No.
N/A: Not applicable.
U: Unclear.
Y: Yes.
See Figure 4 for results of mAMSTAR.
Table 9. Reviews contributing data only to subgroup analyses
Intervention Reviews contributing data to
main comparisons
Reviews contributing data to
subgroup comparisons only
Justification for decisions
Constraint-induced movement
therapy (CIMT)
Corbetta 2010 Sirtori 2009 Studies included in these 2 re-
views overlap. Corbetta 2010
was judged to be most up-
to-date and comprehensive.
Corbetta 2010 pools data com-
paring CIMT with control.
However, no sub-group analy-
ses are reported. Sirtori 2009 in-
cludes subgroup analyses to ex-
plore time post stroke and ex-
tent of treatment. Data related
to main comparisons are there-
fore extracted from Corbetta
2010, and data related to
subgroup comparisons are ex-
tracted from Sirtori 2009
Mental practice Braun 2013; Wang 2011 Barclay-Goddard 2011 Braun 2013 has the most up-
to-date search and includes
trials that are not included
within (or considered for inclu-
sion in)Barclay-Goddard 2011.
Methodological quality is sim-
ilar. Data from Braun 2013
are therefore extracted for the
main comparisons. However,
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Table 9. Reviews contributing data only to subgroup analyses (Continued)
no subgroup analyses are re-
ported. Barclay-Goddard 2011
includes subgroup analyses to
explore time post stroke and
extent of treatment. Data re-
lated to main comparisons are
therefore extracted from Braun
2013, and data related to
subgroup comparisons are ex-
tracted from Barclay-Goddard
2011. Additional impairment
datawere extracted for themain
comparisons from Wang 2011,
as this included Chinese lan-
guage trials not included within
Braun 2013
Robotics Mehrholz 2012 Norouzi-Gheidari 2012 Mehrholz 2012 has the most
up-to-date search and includes
trials that are included within
(or considered for inclusion
in) Norouzi-Gheidari 2012.
Methodological quality of
Mehrholz 2012 was judged to
be considerably greater than
that of Norouzi-Gheidari 2012.
Data from Mehrholz 2012
are therefore extracted for the
main comparisons. However,
no subgroup analyses are re-
ported.Norouzi-Gheidari 2012
includes subgroup analyses to
explore time post stroke and ex-
tent of treatment. Data related
to main comparisons are there-
fore extracted from Mehrholz
2012, and data related to
subgroup comparisons are ex-
tracted from Norouzi-Gheidari
2012
Stretching and positioning Katalinic 2010 Borisova 2009 Katalinic 2010 is a review
of stretching interventions, in-
cluding positioning interven-
tions. Borisova 2009 includes
positioning interventions only.
The methodological quality of
Katalinic 2010 is judged to be
considerably greater than that
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Table 9. Reviews contributing data only to subgroup analyses (Continued)
of Borisova 2009, anddata from
Katalinic 2010 are therefore ex-
tracted for the main compar-
isons. All trials included in
Borisova 2009 are also included
in Katalinic 2010; however, as
this is a subgroup of a particu-
lar type of stretching interven-
tion, data from Borisova 2009
have been included as a sub-
group analysis
Table 10. Effects of interventions on upper limb function: immediate outcomes. Moderate-level GRADE evidence
Interven-
tion
Compari-
son
Review Outcome
category
Outcome
measures
Number
of trials
Num-
ber of par-
ticipants
Effect size 95% CI Evidence
of effect?
Bilateral
arm train-
ing (bilat-
eral exer-
cise train-
ing)
Unilateral
exercise
training
van
Delden
2012
Arm func-
tion
ARAT,
WMFT
6 375 SMD 0.20 (-0.00 to 0.
41)
Favours
unilateral
exercise
training
CIMT Control Corbetta
2010
Arm func-
tion
ARAT,
WMFT,
EFT, MAS
14 477 SMD 0.44 (0.03 to 0.
84)
Beneficial
effect
Repetitive
task train-
ing
Any
control
French
2007
Arm func-
tion
ARAT,
WMFT,
BBT,
FTHUE,
SMGA
8 412 SMD 0.17 (-0.03 to 0.
36)
No benefit
or harm
Hand
function
9HPT,
10HPT,
MAS
5 281 SMD 0.16 (-0.07 to 0.
40)
No benefit
or harm
Mental
practice
Any
control
Braun
2013
Arm func-
tion
ARAT 7 197 SMD 0.62 (0.05 to 1.
19)
Beneficial
effect
Mirror
therapy
Any other
interven-
tion
Thieme
2012
UL func-
tion + im-
pairment
ARAT,
MAS,
FMA
10 421 SMD 0.53 (0.04 to 1.
01)
Beneficial
effect
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Table 10. Effects of interventions on upper limb function: immediate outcomes.Moderate-level GRADE evidence (Continued)
Sensory
impair-
ment
No
treatment
Doyle
2010
Arm func-
tion
mMAS 1 29 MD 1.58 (0.98 to 2.
18)
Beneficial
effect
Virtual re-
ality
Other
treatment
Laver 2011 UL func-
tion + im-
pairment
ARAT,
WMFT,
FMA
7 205 SMD 0.53 (0.25 to 0.
81)
Beneficial
effect
Fac-
tors in ser-
vice deliv-
ery: dose of
interven-
tion (aug-
mented
therapy)
Standard
therapy
Cooke
2010
Arm func-
tion
ARAT 3 258 ES 0.1 (-5.7 to 6.
0)
No benefit
or harm
Factors in
service de-
livery: lo-
cation:
home-
based ther-
apy
Usual care Coupar
2012
Arm func-
tion
WMFT 1 100 MD 2.25 (-0.24 to 4.
73)
No benefit
or harm
10HPT: Ten-Hole Peg Test.
9HPT: Nine-Hole Peg Test.
ARAT: Action Research Arm Test.
BBT: Box and Block Test.
EFT: Emory Function Test.
ES: Effect size.
FMA: Fugl-Meyer Assessment/
FTHUE: Functional Test of the Hemiparetic Upper Extremity.
MAS: Motor Assessment Scale.
MD: Mean difference.
mMAS: Modified Motor Assessment Scale.
SMD: Standardised mean difference.
SMGA: Southern Motor Group Assessment.
WMFT: Wolf Motor Function Test.
Table 11. Effects of interventions on upper limb function: follow-up data. Moderate-level GRADE evidence
Interven-
tion
Compar-
ison
Review Out-
come
category
Out-
come
measures
Number
of trials
Number
of partic-
ipants
Effect
size
95% CI Evidence
of effect?
FU time
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Table 11. Effects of interventions on upper limb function: follow-up data. Moderate-level GRADE evidence (Continued)
Repet-
itive task
training
Any con-
trol
French
2007
Up-
per limb
function
ARAT,
WMFT,
BBT,
FTHUE,
SMGA,
JTHF,
SMES,
10HPT
6 246 SMD 0.
08
(-0.17 to
0.33)
No
benefit or
harm
All FU
outcomes
Factors in
ser-
vice deliv-
ery: dose
of inter-
ven-
tion (aug-
mented
therapy)
Standard
therapy
Cooke
2010
Arm
function
ARAT 3 319 ES -6.4 (-12.8 to
0.0)
No
benefit or
harm
6 months
10HPT: Ten-Hole Peg Test.
ARAT: Action Research Arm Test.
BBT: Box and Block Test.
ES: Effect size.
FTHUE: Functional Test of the Hemiparetic Upper Extremity.
JTHF: Jebsen Taylor Hand Function Test.
SMD: Standardised mean difference.
SMES: Sodring Motor Evaluation Scale.
SMGA: Southern Motor Group Assessment.
WMFT: Wolf Motor Function Test.
Table 12. Effects of interventions on upper limb impairment: immediate outcomes. Moderate-level GRADE evidence
Interven-
tion
Compari-
son
Review Outcome
category
Outcome
measures
Number
of trials
Num-
ber of par-
ticipants
Effect size 95% CI Evidence
of effect?
Bilateral
arm train-
ing (bilat-
eral exer-
cise train-
ing)
Unilateral
exercise
training
van
Delden
2012
Motor im-
pairment
FMA,
MSS
4 228 SMD 0.06 (-0.20 to 0.
33)
No differ-
ence
Brain stim-
ulation:
tDCS
Placebo or
control
Elsner
2013
Motor im-
pairment
FMA 7 304 SMD 3.45 (1.24 to 5.
67)
Beneficial
effect
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Table 12. Effects of interventions on upper limb impairment: immediate outcomes. Moderate-level GRADE evidence (Con-
tinued)
Mental
practice
Conven-
tional
treatment
Wang
2011
Motor im-
pairment
FMA 5 216 MD 7.81 (1.96 to
13.65)
Beneficial
effect
Robotics Any other
interven-
tion
Mehrholz
2012
Motor im-
pairment
FMA 16 586 SMD 0.45 (0.2 to 0.
69)
Beneficial
effect
Strength Strength 10 321 SMD 0.48 (-0.06 to 1.
03)
No benefit
or harm
Sensory
impair-
ment
No
treatment
Doyle
2010
Motor im-
pairment
BMR 1 29 MD 0.19 (0.09 to 0.
29)
Beneficial
effect
Stretch-
ing andpo-
sitioning
(stretch)
Any Katalinic
2010
Range of
movement
Joint mo-
bility
7 193 MD 2.17 (-1.63 to 5.
97)
No benefit
or harm
Spasticity Spasticity 4 109 SMD 0.08 (-0.30 to 0.
45)
No benefit
or harm
Virtual re-
ality
Other
treatment
Laver 2011 Motor im-
pairment
FMA 5 171 MD 4.43 (1.98 to 6.
88)
Beneficial
effect
Strength Grip
strength
2 44 MD 3.55 (-0.20 to 7.
30)
No benefit
or harm
Fac-
tors in ser-
vice deliv-
ery: dose of
interven-
tion (aug-
mented
therapy)
Standard
therapy
Cooke
2010
Strength Hand grip
force/
strength
2 195 ES -10.1 (-19.1 to -
1.2)
Ben-
efit of stan-
dard ther-
apy dose
Factors in
service de-
livery: lo-
cation:
home-
based ther-
apy
Usual care Coupar
2012
Motor im-
pairment
FMA 3 156 MD 1.46 (-0.58 to 3.
51)
No benefit
or harm
Factors
in service
delivery:
location:
telemedicine
Usual care Laver 2013 Motor im-
pairment
FMA 2 46 MD 3.65 (-0.26 to 7.
57)
No benefit
or harm
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BMR: Brunnstrom motor recovery.
FMA: Fugl-Meyer Assessment.
MSS: Motor status score.
tDCS: Transcranial direct current stimulation.
Table 13. Effects of interventions on upper limb impairment: follow-up data. Moderate-level GRADE evidence
Interven-
tion
Compar-
ison
Review Out-
come
category
Out-
come
measures
Number
of trials
Number
of partic-
ipants
Effect
size
95% CI Evidence
of effect?
FU time
Stretch-
ing
and posi-
tioning
(stretch)
Any Katalinic
2010
Range of
move-
ment
Joint mo-
bility
3 77 MD -0.
09
(-3.58 to
3.40)
No
benefit or
harm
24 hours
to 1 week
4 134 MD -0.
32
(-4.09 to
3.44)
No
benefit or
harm
> 1 week
Katalinic
2010
Spasticity Spasticity 1 42 SMD -0.
5
(-1.12 to
0.11)
No
benefit or
harm
> 1 week
Factors in
ser-
vice deliv-
ery: loca-
tion:
home-
based
therapy
Usual
care
Coupar
2012
Motor
impair-
ment
FMA 1 36 MD 4.3 (0.19 to
8.41)
Beneficial
effect
Any FU
FMA: Fugl-Meyer Assessment.
FU: Follow-up.
MD: Mean difference.
SMD: Standardised mean difference.
Table 14. Effects of interventions on ADL outcomes: immediate outcomes. Moderate-level GRADE evidence
Interven-
tion
Compari-
son
Review Outcome
category
Outcome
measures
Number
of trials
Num-
ber of par-
ticipants
Effect size 95% CI Evidence
of effect?
Bilateral
arm train-
ing (bilat-
eral exer-
cise train-
ing)
Unilateral
exercise
training
van
Delden
2012
Activity MAL:
AOU
3 146 SMD 0.42 (0.09 to 0.
76)
Favours
unilateral
exercise
training
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Table 14. Effects of interventions on ADL outcomes: immediate outcomes. Moderate-level GRADE evidence (Continued)
Bilateral
arm train-
ing (bilat-
eral exer-
cise train-
ing)
Unilateral
exercise
training
van
Delden
2012
Activity MAL:
QOM
3 146 SMD 0.45 (0.12 to 0.
78)
Favours
unilateral
exercise
training
Brain stim-
ulation:
tDCS
Placebo or
control
Elsner
2013
Generic
ADL
BI 5 286 SMD 5.31 (-0.52 to
11.14)
No benefit
or harm
Mental
practice
Any
control
Braun
2013
Generic
ADL
BI 3 135 MD 0.87 (-0.8 to 2.
53)
No benefit
or harm
Mirror
therapy
Any other
interven-
tion
Thieme
2012
Generic
ADL
BI, FIM 4 217 SMD 0.33 (0.05 to 0.
60)
Beneficial
effect
Robotics Any other
interven-
tion
Mehrholz
2012
Generic
ADL + UL
function
BI, FIM,
ABIL-
HAND,
SIS, FAT
13 552 SMD 0.43 (0.11 to 0.
75)
Beneficial
effect
Stretch-
ing andpo-
sitioning
(stretch)
Any Katalinic
2010
Generic
ADL
MAS,
mBI,
DASH
4 130 SMD 0.2 (-0.24 to 0.
65)
No benefit
or harm
Factors in
service de-
livery: lo-
cation:
home-
based ther-
apy
Usual care Coupar
2012
Generic
ADL
BI 2 113 MD 2.85 ([-1.43 to
7.14)
No benefit
or harm
ABILHAND: Assessment tool that measures a patient’s perceived difficulty using his/her hands to perform manual activities in daily
life.
ADL: Activity of daily living.
BI: Barthel Index.
CI: Confidence interval.
DASH: Disabilities of the Arm Shoulder and Hand outcome.
FAT: Frenchay Arm Test.
FIM: Functional Independence Measure.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MAL: AOU: Motor Activity Log: Amount of Use.
MAL: QOM: Motor Activity Log: Quality of Movement.
MAS: Motor Assessment Scale.
mBI: Modified Barthel Index.
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MD: Mean difference.
SIS: Stroke Impact Scale.
SMD: Standardised mean difference.
tDCS: Transcranial direct current stimulation.
UL: Upper limb.
Table 15. Effect of interventions on ADL outcomes: follow-up data. Moderate-level GRADE evidence
Interven-
tion
Compar-
ison
Review Out-
come
category
Out-
come
measures
Number
of trials
Number
of partic-
ipants
Effect
size
95% CI Evidence
of effect?
FU time
Stretch-
ing
and posi-
tioning
(stretch)
Any Katalinic
2010
Generic
ADL
MAS 1 40 MD 1.7 (-0.40 to
3.80)
No
benefit or
harm
24 hours
to 1 week
MAS,
DASH
4 136 SMD 0.
14
(-0.29 to
0.58)
No
benefit or
harm
> 1 week
Factors in
ser-
vice deliv-
ery: loca-
tion:
home-
based
therapy
Usual
care
Coupar
2012
Generic
ADL
BI 1 80 MD -1.
70
(-5.51 to
2.11)
No
benefit or
harm
Any
ADL: Activity of daily living.
BI: Barthel Index.
DASH: Disabilities of the Arm Shoulder and Hand outcome.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MAS: Motor Assessment Scale.
MD: Mean difference.
SMD: Standardised mean difference.
Table 16. Effects of interventions on upper limb function: immediate outcomes. Further research required (low- and very low-
level GRADE evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Partic-
ipants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level of
evidence
Bilat-
eral
arm
Usual
care
Coupar
2010
Arm
func-
tion +
BBT,
WMFT,
MAL:
4 127 SMD -
0.07
(-
0.42 to
0.28)
1 1 0 1 Low
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Table 16. Effects of interventions on upper limb function: immediate outcomes. Further research required (low- and very low-
level GRADE evidence) (Continued)
train-
ing
ADL AOU
Other
upper
limb
inter-
ven-
tion
Coupar
2010
Arm
func-
tion
BBT,
ARAT,
MAS,
mMAS
5 189 SMD -
0.2
(-
0.49 to
0.09)
1 1 0 1 Low
Usual
care
Coupar
2010
Hand
func-
tion
PPT 2 73 SMD -
0.04
(-0.
5 to 0.
42)
2 1 0 1 Low
Other
upper
limb
inter-
ven-
tion
Coupar
2010
Hand
func-
tion
MAS,
mMAS,
SIS
(hand
func-
tion),
9HPT
4 173 SMD -
0.21
(-
0.51 to
0.09)
1 1 0 1 Low
Biofeed-
back:
EMG
BF
Phys-
iother-
apy
Wood-
ford
2007
Arm
func-
tion
UEFT 1 29 SMD -
0.17
(-0.
9 to 0.
56)
2 1 0 1 Low
Bo-
bath
ther-
apy
Con-
trol
Luke
2004
Arm
func-
tion
UEFT 1 29 ES 0.
17
(-
0.56 to
0.90)
2 1 0 2 Low
MAS 1 61 ES -0.
29
(-
0.80 to
0.21)
2 1 0 2 Low
Arm
func-
tion
SMES 1 61 ES -0.
32
(-
0.83 to
0.19)
2 1 0 2 Very low
Brain
stimu-
lation:
rTMS
Con-
trol
Hao
2013
Upper
limb
func-
tion
JTHF,
PPT,
WMFT,
ARAT
4 73 SMD
0.51
(-
0.99 to
2.01)
2 1 1 0 Low
Elec-
trical
stimu-
lation
Con-
trol
Nasci-
mento
2014
Arm
func-
tion +
ADL
ARAT,
BBT,
BI
3 122 SMD
0.79
(ran-
(-
0.11 to
1.69)
1 1 0 1 Low
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Table 16. Effects of interventions on upper limb function: immediate outcomes. Further research required (low- and very low-
level GRADE evidence) (Continued)
(for
strength)
dom
effects)
Elec-
trical
stimu-
lation
(NMES)
No
treat-
ment
Farmer
2014
Arm
func-
tion
ARAT 4 319 0.04 to
0.5
(-
0.35 to
0.44)
to (-
0.69 to
1.68)
0 0 1 2 Low
Elec-
trical
stimu-
lation
(stochas-
tic
reso-
nance)
Con-
trol
Farmer
2014
Arm
func-
tion
ARAT 1 30 0.15 (-
0.66 to
0.96)
2 0 0 2 Low
Elec-
trical
stimu-
lation
(EMG-
trig-
gered)
No
treat-
ment
Meilink
2008
Arm
func-
tion
BBT 3 42 0.37 (-
0.27 to
1.01)
2 1 0 2 Very low
Cycli-
cal
electri-
cal
stimu-
lation
Meilink
2008
Arm
func-
tion
ARAT 2 48 0 (-
0.56 to
0.57)
2 0 0 2 Low
Sen-
sory
im-
pair-
ment
(inter-
ven-
tions
for
sen-
sory
im-
pair-
ment)
No
treat-
ment
Doyle
2010
Hand
func-
tion
Hand
Func-
tion-
Test
1 36 MD -
1.16
(-
2.10 to
-0.22)
2 1 0 0 Low
Placebo
or
atten-
Doyle
2010
Arm
func-
tion
ARAT 1 21 MD
12.9
(5.65
to 20.
15)
2 1 0 0 Low
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Table 16. Effects of interventions on upper limb function: immediate outcomes. Further research required (low- and very low-
level GRADE evidence) (Continued)
tion
control
Sen-
sory
im-
pair-
ment
(pas-
sive
sen-
sory re-
train-
ing)
Not re-
ported
Schabrun
2009
Hand
func-
tion
JTHF 3 Un-
clear
MD 8.
72
(2.48
to 14.
95)
2 1 1 2 Very low
Strength
train-
ing
Con-
trol
Harris
2010
Upper
limb
func-
tion
MAS,
TEMPA,
RMA,
PPB,
WMFT,
BBT,
ARAT,
FTHUE
11 465 SMD
0.21
(0.03
to 0.
39)
0 1 0 2 Low
Stretch-
ing
and
posi-
tion-
ing:
shoul-
der
sup-
port
Con-
trol
Ada
2005
Arm
func-
tion
MAS 1 83 MD 0.
83
(-
1.46 to
3.12)
2 0 0 1 Low
9HPT: Nine-Hole Peg Test.
ADL: Activity of daily living.
ARAT: Action Research Arm Test.
BBT: Box and Block Test.
BI: Barthel Index.
EMG BF: Electromyographic biofeedback.
ES: Effect size.
FTHUE: Functional Test of the Hemiparetic Upper Extremity.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
JTHF: Jebsen Taylor Hand Function Test.
JTHF: Jebsen Test of Hand Function.
MAL: AOUMotor Activity Log: Amount of Use.
MAS: Motor Assessment Scale.
MD: Mean difference.
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mMAS: Modified Motor Assessment Scale.
NMES: Neuromuscular electrical stimulation.
PPB: Purdue Peg Board.
PPT: Purdue Peg Test.
RMA: Rivermead Motor Assessment.
rTMS: Repetitive transcranial magnetic stimulation.
SIS: Stroke Impact Scale.
SMD: Standardised mean difference.
SMES: Sodring Motor Evaluation Scale.
TEMPA: Test d’Evaluation des Membres Superieurs de Personnes Agees.
TEMPA: Upper Extremity Performance Test for Elderly (Test d’Evaluation des Membres Supérieurs de Personnes Agées).
UEFT: Upper Extremity Function Test.
WMFT: Wolf Motor Function Test.
Table 17. Effects of interventions on upper limb function: follow-up data. Further research required (low- and very low-level
GRADE evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Par-
tici-
pants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level
of evi-
dence
Fol-
low-up
Fac-
tors in
ser-
vice
deliv-
ery:
dose
of
inter-
ven-
tion
(aug-
mented
ther-
apy)
Stan-
dard
ther-
apy
Cooke
2010
Arm
func-
tion
ARAT 2 168 2.2 (-6.0
to 10.
4)
1 1 1 1 Low FU1
ARAT: Action Research Arm Test.
FU: Follow-up.
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Table 18. Effects of interventions on upper limb impairment: immediate outcomes. Further research required (low- and very
low-level GRADE evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Partic-
ipants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level of
evidence
Bilat-
eral
arm
train-
ing
Usual
care
Coupar
2010
Mo-
tor im-
pair-
ment
FMA 4 127 SMD
0.67
(-
0.43 to
1.77)
1 1 1 1 Low
Other
upper
limb
inter-
ven-
tion
Coupar
2010
Mo-
tor im-
pair-
ment
FMA,
RMA
4 175 SMD -
0.25
(-
0.55 to
0.05)
1 1 0 1 Low
Biofeed-
back:
EMG
BF
Phys-
iother-
apy
Wood-
ford
2007
Range
of
move-
ment
Wrist
ROM
1 9 SMD
0.96
(-
0.48 to
2.40)
2 1 0 1 Low
Shoul-
der
ROM
1 26 SMD
0.88
(0.07
to 1.
70)
2 1 0 1 Low
Mo-
tor im-
pair-
ment
BMR 2 57 SMD
0.69
(0.15
to 1.
23)
2 1 0 1 Low
FMA 1 29 SMD
0.44
(-
0.19 to
1.07)
2 1 0 1 Low
Elec-
trical
stimu-
lation
(for
strength)
Con-
trol
Nasci-
mento
2014
Strength Strength
6 162 SMD
0.55
(0.23
to 0.
86)
1 1 0 1 Low
Elec-
trical
stimu-
lation
(NMES)
Con-
trol
Farmer
2014
Mo-
tor im-
pair-
ment
FMA 5 152 ES
0.01 to
2.43
(-0.
8 to 0.
81) to
(-
0.74 to
5.59)
1 0 1 2 Low
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Table 18. Effects of interventions on upper limb impairment: immediate outcomes. Further research required (low- and very
low-level GRADE evidence) (Continued)
Strength
Grip
strength,
power
3 93 ES
0.00 to
0.38
(-
0.88 to
0.88)
(to -
0.16 to
0.93)
2 0 1 2 Very low
Elec-
trical
stimu-
lation
(EMG-
trig-
gered)
Cycli-
cal
electri-
cal
stimu-
lation
Meilink
2008
Mo-
tor im-
pair-
ment
FMA 3 57 SMD
0.1
(0.43
to 0.
64)
2 0 0 2 Low
Bo-
tulinum
neuro-
toxin
Placebo
Singh
2010
Spas-
ticity
Spas-
ticity
2 45 MD -
0.62
(-
1.40 to
0.17)
2 1 0 2 Very low
Phar-
maco-
logical
inter-
ven-
tions:
bo-
tulinum
neuro-
toxin
Placebo
Singh
2010
Range
of
move-
ment
Shoul-
der
flexion
1 29 MD 3 (-15.
54 to
21.54)
2 0 0 2 Low
Shoul-
der ab-
duc-
tion
3 65 MD 8.
49
(-
2.40 to
19.39)
2 1 0 2 Very low
Shoul-
der ex-
ter-
nal ro-
tation
3 70 MD 9.
84
(0.20
to 19.
49)
2 1 0 2 Very low
Elia
2009
Spas-
ticity
Area
under
curve
of Ash-
worth
score:
elbow
2 101 MD -
6.28
(-16.
02 to -
3.47)
1 1 1 2 Very low
Area
under
curve
of Ash-
worth
score:
2 101 MD -
11.71
(-16.
72 to
6.71)
1 1 0 2 Low
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Table 18. Effects of interventions on upper limb impairment: immediate outcomes. Further research required (low- and very
low-level GRADE evidence) (Continued)
wrist
Area
under
curve
of Ash-
worth
score:
fingers
2 101 MD -
7.79
(-13.
44 to
2.74)
1 1 0 2 Low
Phar-
maco-
logical
inter-
ven-
tions:
bo-
tulinum
toxin
type A:
Dys-
port
500U
Placebo
Elia
2009
Spas-
ticity
Num-
ber of
partici-
pants
with
reduc-
tion
in Ash-
worth
score
of at
least 2
points
1 41 OR 0.
22
(0.06
to 0.
81)
2 1 0 2 Very low
Phar-
maco-
logical
inter-
ven-
tions:
bo-
tulinum
toxin
type A:
Dys-
port
1000U
Placebo
Elia
2009
Spas-
ticity
Num-
ber of
partici-
pants
with
reduc-
tion
in Ash-
worth
score
of at
least 2
points
2 100 OR 0.
22
(0.09
to 6.
52)
1 1 0 2 Low
Phar-
maco-
logical
inter-
ven-
tions:
bo-
tulinum
toxin
type A:
Dys-
Placebo
Elia
2009
Spas-
ticity
Num-
ber of
partici-
pants
with
reduc-
tion
in Ash-
worth
score
1 36 OR 0.
42
(0.11
to 1.
56)
2 1 0 2 Very low
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Table 18. Effects of interventions on upper limb impairment: immediate outcomes. Further research required (low- and very
low-level GRADE evidence) (Continued)
port
1500U
of at
least 2
points
Sen-
sory
im-
pair-
ment
(inter-
ven-
tions
for)
No
treat-
ment
Doyle
2010
Mo-
tor im-
pair-
ment
FMA-
upper
limb
1 18 MD -6 (-16.
58 to
4.58)
2 1 0 0 Low
FMA-
wrist
and
hand
1 18 MD -
0.12
(-
9.06 to
8.82)
2 1 0 0 Low
Placebo
or
atten-
tion
control
Doyle
2010
Mo-
tor im-
pair-
ment
FMA 1 23 MD
11.5
(-
5.45 to
28.45)
2 1 0 0 Low
Sen-
sory
inter-
ven-
tions:
passive
sen-
sory re-
train-
ing
Not re-
ported
Schabrun
2009
Strength
Muscle
Strength
1 Un-
clear
MD -
3.5
(-
8.13 to
1.13)
2 1 1 2 Very low
Sen-
sory
inter-
ven-
tions:
active
sen-
sory re-
train-
ing
Not re-
ported
Schabrun
2009
Sen-
sory
Propri-
ocep-
tion
1 Un-
clear
MD 0.
14
(-
2.77 to
3.05)
2 1 1 2 Very low
Strength
train-
ing
Con-
trol
Harris
2010 Strength
Grip
strength
6 306 SMD
0.95
(0.05
to 1.
85)
0 1 1 2 Low
149Interventions for improving upper limb function after stroke (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Table 18. Effects of interventions on upper limb impairment: immediate outcomes. Further research required (low- and very
low-level GRADE evidence) (Continued)
Stretch-
ing
and
posi-
tion-
ing:
shoul-
der
sup-
port
Con-
trol
Ada
2005
Range
of
move-
ment
Con-
trac-
ture
1 81 MD -
1.2
(-10.
90 to
8.10)
2 1 0 1 Low
Loss of
shoul-
der ex-
ter-
nal ro-
tation
1 14 OR 1 (0.11
to 9.
34)
2 0 0 1 Low
Stretch-
ing
and
posi-
tion-
ing: in-
flatable
splint
No
splint
Lannin
2003
Mo-
tor im-
pair-
ment
FMA 1 18 MD -
0.12
(-9.8
to 9.6)
2 1 0 2 Very low
Stretch-
ing
and
posi-
tion-
ing:
hand
splint
(12
hours
at
night)
30-
minute
stretch
Lannin
2003
Range
of
move-
ment
Con-
trac-
ture
1 28 MD 1
degree
(-
3.7 to
6.1 de-
grees)
2 0 0 2 Low
Fac-
tors in
service
deliv-
ery: lo-
cation:
home-
based
ther-
apy
Same
treat-
ment
in hos-
pital
Coupar
2012
Mo-
tor im-
pair-
ment
FMA 1 10 MD 0.
6
(-
8.94 to
10.14)
2 1 0 0 Low
BMR: Brunnstrom motor recovery.
EMG BF: Electromyographic biofeedback.
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ES: Effect size.
FMA: Fugl-Meyer Assessment.
MD: Mean difference.
NMES: Neuromuscular electrical stimulation.
OR: Odds ratio.
SMD: Standardised mean difference.
RMA: Rivermead Motor Assessment.
ROM: Range of movement.
Table 19. Effects of interventions on upper limb impairment: follow-up data. Further research required (low- and very low-
level GRADE evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Par-
tici-
pants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level
of evi-
dence
Time
of FU
Brain
stimu-
lation:
tDCS
Placebo
or
con-
trol
Elsner
2013
Motor
im-
pair-
ment
FMA 2 68 SMD
9.22
(-13.
47
to 31.
90)
2 1 1 0 Low
Elec-
trical
stimu-
lation
Con-
trol
Nasci-
mento
2014
Strength Strength
2 89 SMD
0.38
(-0.
04 to
0.80)
2 0 0 1 Low
Phar-
maco-
logical
inter-
ven-
tions:
bo-
tulinum
neu-
ro-
toxin
Placebo
Singh
2010
Spasc-
itity
Spas-
ticity
2 45 MD -
0.13
(-0.
65 to
0.38)
2 1 0 2 Very
low
Range
of
move-
ment
Shoul-
der
flex-
ion
1 29 MD 1 (-17.
87
to 19.
87)
2 0 0 2 Low
Range
of
move-
ment
Shoul-
der
ab-
duc-
tion
2 45 MD
17.72
(-9.61
to 45.
04)
2 1 0 2 Very
low
Range
of
move-
ment
Shoul-
der
exter-
2 50 MD
11.86
(-0.61
to 24.
33)
2 1 0 2 Very
low
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Table 19. Effects of interventions on upper limb impairment: follow-up data. Further research required (low- and very low-
level GRADE evidence) (Continued)
nal ro-
tation
Stretch-
ing
and
posi-
tion-
ing:
hand
splint
(12
hours
at
night)
30-
minute
stretch
Lan-
nin
2003
Range
of
move-
ment
Con-
trac-
ture
1 28 -2 de-
grees
(-7.
2 to 3.
2 de-
grees)
2 0 0 2 Low
Fac-
tors in
ser-
vice
deliv-
ery:
dose
of
inter-
ven-
tion
(aug-
mented
ther-
apy)
Stan-
dard
ther-
apy
Cooke
2010
Motor
im-
pair-
ment
Motric-
ity
2 168 10.7 (1.7 to
19.8)
1 1 1 1 Low
AMSTAR: Measurement tool to assess the methodological quality of systematic reviews.
FMA: Fugl-Meyer Assessment.
FU: Follow-up.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MD: Mean difference.
ROB: Risk of bias.
SMD: Standardised mean difference.
tDCS: Transcranial direct current stimulation.
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Table 20. Effects of interventions on ADL outcomes: immediate outcomes. Further research required (low- and very low-level
GRADE evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Partic-
ipants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level of
evidence
Bilat-
eral
arm
train-
ing
Usual
care
Coupar
2010
Generic
ADL
FIM 3 106 SMD
0.25
(-
0.14 to
0.63)
1 1 0 1 Low
Other
upper
limb
inter-
ven-
tion
Coupar
2010
Generic
ADL
FIM,
BI
3 151 SMD -
0.25
(-
0.57 to
0.08)
1 1 0 1 Low
Biofeed-
back:
EMG
BF
Phys-
iother-
apy
Wood-
ford
2007
Generic
ADL
BI 1 16 SMD -
0.21
(-
1.20 to
0.77)
2 1 0 1 Low
Brain
stimu-
lation:
rTMS
Con-
trol
Hao
2013 Generic
ADL
BI 2 183 SMD
15.92
(-
2.11 to
33.95)
2 1 1 0 Low
CIMT Con-
trol
Cor-
betta
2010
Generic
ADL
FIM,
BI
8 276 SMD
0.21
(-
0.08 to
0.50)
0 1 0 2 Low
Elec-
trical
stimu-
lation
(NMES)
Con-
trol
Farmer
2014 Generic
ADL
FIM,
BI
4 112 ES
0.15 to
1.78
(-
0.61 to
0.91)
to (0.
00 to
3.56)
1 0 1 2 Low
Activ-
ity
MAL:
AOU
1 (2
com-
par-
isons
in one
study)
28 ES
2.24 to
2.52
(-
3.24 to
7.72)
to (-
8.09 to
13.13)
2 0 1 2 Very low
Activ-
ity
MAL:
QOM
1 (2
com-
28 ES
2.09 to
(-
1.76 to
2 0 1 2 Very low
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Table 20. Effects of interventions on ADL outcomes: immediate outcomes. Further research required (low- and very low-level
GRADE evidence) (Continued)
par-
isons
in one
study)
2.48 5.94)
to (-
7.03 to
11.99)
Elec-
trical
stimu-
lation
(stochas-
tic
reso-
nance)
Con-
trol
Farmer
2014 Generic
ADL
SIS 1 30 ES -0.
03
(-
0.77 to
0.71)
2 0 0 2 Low
Strength
train-
ing
Con-
trol
Harris
2010 Generic
ADL
SF36,
FIM,
BI
5 210 SMD
0.26
(-
0.10 to
0.63)
0 1 0 2 Low
ADL: Activity of daily living.
AMSTAR: Measurement tool to assess the methodological quality of systematic reviews.
BI: Barthel Index.
ES: Effect size.
FIM: Functional Independence Measure.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MAL: AOU: Motor Activity Log: Amount of Use.
MAL: QOM: Motor Activity Log: Quality of Movement.
NMES: Neuromuscular electrical stimulation.
ROB: Risk of bias.
SF36: Short Form (36) Health Survey.
SIS: Stroke Impact Scale.
Table 21. Effects of interventions onADL outcomes: follow-up data. Further research required (low- and very low-level GRADE
evidence)
Inter-
ven-
tion
Out-
come
Re-
view
Out-
come
cate-
gory
Out-
come
mea-
sure
Stud-
ies
Par-
tici-
pants
Effect
size
95%
confi-
dence
inter-
val
Study
size
down-
grades
ROB
down-
grades
I2 AM-
STAR
down-
grades
GRADE
level
of evi-
dence
FU
time
Brain
stimu-
lation:
tDCS
Placebo
or
con-
trol
Elsner
2013 Generic
ADL
BI 3 99 SMD
11.16
(2.89
to 19.
43)
2 1 0 0 Low
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Table 21. Effects of interventions onADL outcomes: follow-up data. Further research required (low- and very low-level GRADE
evidence) (Continued)
Men-
tal
prac-
tice
Any
con-
trol
Braun
2013 Generic
ADL
BI 2 57 MD
0.46
(-2.
36 to
3.27)
2 0 1 1 Low
ADL: Activity of daily living.
AMSTAR: Measurement tool to assess the methodological quality of systematic reviews.
BI: Barthel Index.
FU: Follow-up.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MD: Mean difference.
ROB: Risk of bias.
SMD: Standardised mean difference.
tDCS: Transcranial direct current stimulation.
Table 22. Subgroup results: upper limb function. Moderate-level GRADE evidence
Details
of sub-
group
Inter-
vention
Com-
parison
Review Out-
come
cate-
gory
Number
of trials
Number
of par-
tici-
pants
Effect
size
95% CI P value Evi-
dence of
effect?
Severity Mild Bilat-
eral arm
training
Unilat-
eral arm
training
van
Delden
2012
Arm
function
5 203 SMD 0.
3
(0.02 to
0.58)
0.60 Low
quality
Moder-
ate
3 137 SMD 0.
08
(-0.25 to
0.42)
No bene-
fit or
harm
Severe 1 35 SMD 0.
11
(-0.58 to
0.81)
Low
quality
Time
post
stroke
> 6
months
post
stroke
Mental
practice
+ other
treat-
ment
Other
treat-
ment
Barclay-
God-
dard
2011
Arm
function
4 66 SMD 1.
55
(0.38 to
2.72)
0.78 Low
< 6
months
post
stroke
1 36 SMD 1.
35
(0.62 to
2.08)
Low
0 to 15
days
post
stroke
Repet-
itive task
training
Any
control
French
2007
Up-
per limb
function
4 239 SMD 0.
21
(-0.04 to
0.47)
0.98 No bene-
fit or
harm
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Table 22. Subgroup results: upper limb function. Moderate-level GRADE evidence (Continued)
16
days to 6
months
post
stroke
4 105 Low-
quality
evidence
Low-
quality
evidence
No bene-
fit or
harm
> 6
months
post
stroke
3 140 SMD 0.
25
(-0.08 to
0.59)
No bene-
fit or
harm
< 6
months
post
stroke
Virtual
reality
Other
treat-
ment
Laver
2011
Up-
per limb
function
2 54 SMD 0.
76
(0.18 to
1.34)
0.37 Benefi-
cial effect
> 6
months
post
stroke
5 151 SMD 0.
46
(0.13 to
0.78)
Benefi-
cial effect
Dose < 360
minutes
Mental
practice
+ other
treat-
ment
Other
treat-
ment
Barclay-
God-
dard
2011
Arm
function
2 46 SMD 2.
79
(-0.60 to
1.60)
0.30 Low
> 360
minutes
3 56 SMD 0.
95
(0.31 to
1.60)
Low
0 to 20
hours
Repet-
itive task
training
Any
control
French
2007
Up-
per limb
function
8 371 SMD 0.
18
(-0.02 to
0.39)
0.31 No bene-
fit or
harm
> 20
hours
3 113 SMD 0.
40
(0.03 to
0.78)
Benefi-
cial effect
< 15
hours
Virtual
reality
Other
treat-
ment
Laver
2011
Up-
per limb
function
2 31 SMD 0.
58
(-0.12 to
1.29)
0.87 No bene-
fit or
harm
> 15
hours
5 171 SMD 0.
52
(0.21 to
0.83)
Benefi-
cial effect
CI: Confidence interval.
GRADE: Grades of Recommendation, Assessment, Development and Evaluation.
MD: Mean difference.
SMD: Standardised mean difference.
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Table 23. Methods of assessing and reporting quality of studies within included reviews
Method of assessment/reporting quality Discussion
Cochrane ’Risk of bias’ tool This is used within all Cochrane reviews; however this tool has de-
veloped over time. Some of the reporting within earlier Cochrane
reviews is limited primarily to an assessment of concealed allocation,
whereas more recent reviews tend to have assessed random sequence
generation, allocation concealment, blinding of participants, blind-
ing of outcome assessment, incomplete outcome data, selective re-
porting and other bias. Developments in the Cochrane ’Risk of bias’
tool therefore contribute toward improved reporting over time
PEDro scale (Maher 2003; PEDro) This scale assesses reporting of absence or presence of eligibility cri-
teria; random allocation; allocation concealment; baseline similar-
ity; participant, therapist and assessor blinding; dropouts/follow-
up; intention-to-treat; statistical comparisons and variability. How-
ever within some reviews, only the total PEDro ’score’ was given,
limiting our ability to judge specific issues related to risk of bias
associated with randomisation, allocation concealment, etc. When
reviews reported responses to the PEDro scale for each study, we
had sufficient information to judge risk of bias for key criteria. Deci-
sions around reporting this information within a published journal
article are likely to be influenced by publication restrictions related
to article length and number of tables
’Levels of evidence’ (Levels of Evidence) These levels of evidence are based primarily on the methodological
design of a study. Some reviews based their reports of quality on
the types of study designs of included studies, using these levels
of evidence. Often these were reviews that included a variety of
different study types (i.e. were not limited to RCTs). These levels
of evidence did not provide us with any information relatedto the
issues associated with risk of bias, such as randomisation method,
participant blinding or how incomplete data were managed
Assessment of study quality as part of review inclusion criteria Some non-Cochrane reviews (e.g. Farmer 2014) used an assessment
of quality of studies as part of the eligibility criteria, including only
studies that were judged to be at low risk of bias. Application of
quality assessment in this way clearly has consequent implications
related to the need to consider the scientific quality of included stud-
ies. The AMSTAR tool does not necessarily enable acknowledge-
ment of the fact that all included studies had been judged to be at
low risk of bias, and such reviews may be ’marked down’ when this
is, arguably, not appropriate
AMSTAR: Measurement tool to assess the methodological quality of systematic reviews.
PEDro: Physiotherapy Evidence Database.
RCT: Randomised controlled trial.
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A P P E N D I C E S
Appendix 1. CDSR and DARE (The Cochrane Library) search strategy
#1. [mh ˆ”cerebrovascular disorders”] or [mh “basal ganglia cerebrovascular disease”] or [mh “brain ischemia”] or [mh “carotid artery
diseases”] or [mh “intracranial arterial diseases”] or [mh “intracranial embolism and thrombosis”] or [mh “intracranial hemorrhages”]
or [mh ˆstroke] or [mh “brain infarction”] or [mh ˆ”stroke, lacunar”] or [mh ˆ”vasospasm, intracranial”] or [mh ˆ”vertebral artery
dissection”] OR [mh “brain injuries”] or [mh “brain injury, chronic”]
#2. stroke or poststroke or “post-stroke” or cerebrovasc* or “brain next vasc*” or “cerebral next vasc*” or cva* or apoplex* or SAH
#3. (brain* or cerebr* or cerebell* or intracran* or intracerebral) NEAR/5 (isch*emi* or infarct* or thrombo* or emboli* or occlus*)
#4. (brain* or cerebr* or cerebell* or intracerebral or intracranial or subarachnoid) NEAR/5 (haemorrhage* or hemorrhage* or
haematoma* or hematoma* or bleed*)
#5. [mh hemiplegia] or [mh paresis]
#6. hemipleg* or hemipar* or paresis or paretic or brain next injur*
#7. #1 or #2 or #3 or #4 or #5 or #6
#8 [mh “upper extremity”]
#9. upper next limb* or upper next extremit* or arm or shoulder or hand or axilla or elbow* or forearm* or finger* or wrist*
#10 #8 or #9
#11 #7 and #10
Appendix 2. PROSPERO search strategy
PROSPERO enables searching within the following fields.
• Review Title.
• Review Question.
• Condition/Domain.
• Participants/Population.
• Comparator.
• Outcome.
• Named Contact.
• Country.
• Funders.
ALL fields were searched with each of the following terms.
Stroke
Hemiplegia
Hemiparesis
CVA
Cerebrovascular Accident
Upper Limb
Upper Extremity
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Appendix 3. AMSTAR and mAMSTAR
In the planning stages for this overview, we had identified that modifications were required to the AMSTAR tool (mAMSTAR), and
we developed simple univariable questions to facilitate generation of responses to the original AMSTAR questions. The mAMSTAR
was applied to each review by two independent overview authors, and disagreements were resolved through discussion. Frequent
disagreements regarding responses to some of the questions led to further modifications and amendments to themAMSTAR to improve
interrater reliablity. Additional modifications to the mAMSTAR are detailed in the table below. The AMSTAR (and mAMSTAR)
questions often concentrate on documentation of the presence of information (e.g. Was there a flow diagram?) rather than the quality
of the methods (e.g. Was a rigorous comprehensive method used to track the search results and inclusion/exclusion of studies?). This
tool therefore sometimes failed to record judgements about review methods. For example, overview authors had to make decisions
about which outcome measures to pool within meta-analyses; some reviews pooled a relatively diverse range of outcome measures (e.g.
combining measures of function with ADLs, or combining measures of sitting balance with arm function). The AMSTAR tool does
not record a judgement related to the validity of these sorts of methdological decisions. Clearly further work is required to develop
appropriate tools for assessing and recording the assessment of quality of reviews.
We made the decision to report in the text (in Methodological quality of included reviews) the number of ’yes’ responses to the 11
AMSTAR questions. This decision was made to provide a rapid accessible overview of the varied quality of the included reviews, and to
visually depict the clear difference in the number of ’yes’ responses between theCochrane reviews and some of the non-Cochrane reviews.
Arguably the AMSTAR is not designed to provide a ’score,’ and reducing this information to a single number is an oversimplification.
We would emphasise that we believe it is essential to consider the responses to all mAMSTAR questions to fully judge the quality of a
review, and that the visual depiction of the number of ’yes’ responses is meant only as a summary of the full information within Figure
4 (and summarised in Table 8). We do not advocate reporting the AMSTAR (or mAMSTAR) as a single number only.
TABLE. Details of development of modified AMSTAR questions and objective criteria for determining AMSTAR response from
mAMSTAR
Original AMSTAR questions Modified AMSTAR
questions, as first presented in
protocol
Modified AMSTAR
questions-final
Minimum criteria for ’yes’ re-
sponse to AMSTAR
1. Was an ’a priori’ design pro-
vided? The research question
and inclusion criteria should be
established before the conduct
of the review
1.1Were review subjects clearly
defined?
1.2 Were review interventions
described?
1.3 Were review comparisons
specified?
1.4Were review outcomes spec-
ified?
(no change) ’Yes’ on mAMSTAR 1.1, 1.2
and 1.4
2. Was there duplicate study
selection and data extraction?
There should be at least 2 in-
dependent data extractors, and
a consensus procedure for dis-
agreements should be in place
2.1Were studies assessed for in-
clusion by 2 independent re-
viewers?
2.2Were data extracted by 2 in-
dependent reviewers?
2.3 Was there a clear proce-
dure for resolving any disagree-
ments?
(no change) ’Yes’ on mAMSTAR 2.1, 2.2
and 2.3
3. Was a comprehensive litera-
ture search performed? At least
2 electronic sources should be
searched. The report must in-
clude years and databases used
3.1 Were at least 2 major
databases searched?
3.2 Were dates searched re-
ported?
3.3 Were key words stated?
(no change)
Clarification note: For 3.6, any
one of the listed supplementary
searches would get a ’yes’ on
the mAMSTAR; this includes
’Yes’ on mAMSTAR 3.1, 3.2, 3.
5, 3.6
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(Continued)
(e.g. CENTRAL, EMBASE,
MEDLINE). Key words and/
or MeSH terms must be stated,
and where feasible, the search
strategy should be provided.
All searches should be supple-
mented by consulting current
contents, reviews, textbooks,
specialised registers or experts in
the particular field of study, and
by reviewing the references in
the studies found
3.4 Were MeSH terms stated?
3.5Was the search strategy pro-
vided or available on request?
3.
6 Were searches supplemented
by consulting current contents,
reviews, textbooks, specialised
registers or experts in the par-
ticular field of study, and by
reviewing the references in the
studies found?
searching the references of in-
cluded studies
4. Was the status of publica-
tion (i.e. grey literature) used
as an inclusion criterion? The
overview authors should state
that they searched for reports
regardless of their publication
type. The overview authors
should state whether or not
they excluded any reports (from
the systematic review), based
on their publication status, lan-
guage, etc
4.1 Were studies searched for
and included regardless of their
publication type?
4.2 Were papers included re-
gardless of language of publica-
tion?
(no change)
Clarification note: If there is
no specific statement about lan-
guage and/or publication type,
then should enter ’unclear’
’Yes’ on mAMSTAR 4.1 and 4.
2
If either 4.1 or 4.2 is ’unclear,
’ then the AMSTAR must also
be rated as ’unclear’
5.Was a list of studies (included
and excluded) provided? A list
of included and excluded stud-
ies should be provided
5.1 Was there a list of included
studies?
5.2 Was there a list of excluded
studies?
5.3 Was there a flow diagram?
(no change) ’Yes’ on mAMSTAR 5.1 and 5.
2
6. Were the characteristics of
the included studies provided?
In an aggregated form such as
a table, data from the original
studies should be provided on
the participants, interventions
and outcomes. The range of
characteristics in all the studies
analysed (e.g. age, race, sex, rel-
evant socioeconomic data, dis-
ease status, duration, severity,
other diseases) should be re-
ported
6.1 Were details provided on
the participants of included
studies (including age, gender,
severity of stroke, time since
stroke)?
6.2 Were details provided on
the interventions of included
studies?
6.3 Were details provided on
the outcomes reported by in-
cluded studies?
(no change)
Clarification notes, for ’yes’:
6.1 Need the following to be
provided: age, time since stroke,
stroke severity (at baseline)
6.2 Need type of intervention
+ details of dose, including du-
ration, frequency and length of
intervention period
6.3 Need list of outcomes that
studies included
’Yes’ on AMSTAR 6.1, 6.2 and
6.3
7. Was the scientific quality
of the included studies assessed
and documented? ’A priori’
7.1 Was the scientific quality of
included studies assessed?
7.2 Was this done by at least 2
(no change)
Clarification note, for ’yes’:
7.1 Need the following to be
’Yes’ on mAMSTAR 7.1, 7.2
and 7.3
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(Continued)
methods of assessment should
be provided (e.g. for effective-
ness studies if the author(s)
chose to include only random-
ized, double-blind, placebo-
controlled studies or allocation
concealment as inclusion crite-
ria); for other types of studies,
alternative itemswill be relevant
independent reviewers?
7.3 Was the scientific quality of
studies documented?
assessed: randomisation; alloca-
tion concealment; blinding of
outcome assessor
7.3 The 3 criteria listed above
need to be documented for each
study
8. Was the scientific quality of
the included studies used ap-
propriately in formulating con-
clusions? The results of the
methodological rigour and sci-
entific quality should be con-
sidered in the analysis and the
conclusions of the review, and
explicitly stated in formulating
recommendations
8.1Were the results of scientific
quality considered in the anal-
ysis and conclusions of the re-
view?
8.2Were the results of method-
ological rigour considered in
the analysis and conclusions of
the review?
8.1Were the results of method-
ological rigour of the included
studies considered in the analy-
sis of the review?
8.2 Were the results of the sci-
entific quality of the included
studies considered in the con-
clusions and/or recommenda-
tions of the review?
’Yes’ on mAMSTAR 8.1 and 8.
2
9. Were the methods used to
combine the findings of stud-
ies appropriate? For the pooled
results, a test should be done
to ensure the studies were com-
binable, to assess their homo-
geneity (i.e. Chi2 test for ho-
mogeneity, I2). If heterogeneity
exists, a random-effects model
should be used and/or the clin-
ical appropriateness of combin-
ing should be taken into con-
sideration (i.e. Is it sensible to
combine?)
9.1 Were the methods used to
combine the findings of stud-
ies clearly described and/or ref-
erenced to appropriate text?
9.2 If results are pooled, is a test
of heterogeneity reported?
9.3 Have the authors stated a
definition of statistical hetero-
geneity?
9.4 If heterogeneity is present or
suspected, has a random-effects
model been used?
(no change) If there is no pooling of data,
then ’not applicable’ should be
entered into the AMSTAR
If ’yes’ on mAMSTAR 9.1 and
9.4, then ’yes’ on AMSTAR
If ’yes’ on 9.1, 9.2 and 9.3AND
there is no heterogeneity, then
enter ’N/A’ for 9.4. In this case,
enter ’yes’ for the AMSTAR
10. Was the likelihood of pub-
lication bias assessed? An as-
sessment of publication bias
should include a combination
of graphical aids (e.g. funnel
plot, other available tests) and/
or statistical tests (e.g. Egger re-
gression test)
10.1Was the likelihood of pub-
lication bias considered?
10.1Was the likelihood of pub-
lication bias assessed?
Response as mAMSTAR
11. Was the conflict of interest
stated? Potential sources of sup-
port should be clearly acknowl-
edged in both the systematic re-
view and the included studies
11.1 Was there a conflict of in-
terest statement?
11.2 Were sources of support
acknowledged?
11.1 Was there a conflict of in-
terest statement?
11.2 Was the review free of any
conflicts of interest?
Note: Agreed that it was im-
portant to record the presence
of any conflict of interest (in-
cluding those associated with
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Note: If there is no conflict of
interest statement, then enter
’unclear’ for mAMSTAR 11.2
sources of support), rather than
simply if there was a statement.
However, to get a ’yes’ on the
AMSTAR, need a ’yes’ only on
11.1
Appendix 4. GRADE levels of evidence-objective criteria
Each comparison was assessed on the basis of the following criteria.
Downgrade? Size ROB I2 AMSTAR 1-4
No downgrade ≥ 200 ≥ 75% of participants have low
ROB for (1) randomisation and
(2) observer blinding
I2 ≤ 75% 4/4 are all ’yes’ (i.e. low ROB)
Downgrade 1 level 100-199 < 75% of participants have low
ROB for (1) randomisation and
(2) observer blinding
I2 > 75% 3/4 are ’unclear’ or ’no’ on AMSTAR
Downgrade 2 levels 1-99 < 3/4 are ’unclear’ or ’no’ on AMSTAR
Size = number of participants in the pooled analysis.
ROB = risk of bias of trials included in the pooled analysis (as assessed by the review authors), for risk of bias related to randomisation
and observer blinding. This was determined on the basis of the percentage of participants contributing to the trials. If risk of bias for
individual trials was not reported within the review, we were conservative and assumed that 75% of participants had low ROB.
I2 = I2 statistic for heterogeneity, as reported within the review. If not reported, assumed to be greater than 75%.
AMSTAR 1-4 = consideration of our agreed responses to the original AMSTAR questions 1 to 4.
The total number of downgrades (maximum 6) was determined for each comparison, and the GRADE level of evidence was applied
accordingly.
GRADE level of evidence
High 0 downgrades
Moderate 1 or 2 downgrades
Low 3 or 4 downgrades
Very low 5 or 6 downgrades
Discussion
This method of objectively determining GRADE levels of evidence has been developed specifically for this overview and was not
previously tested. Currently no clear guidance is available to aid decisions related to objective criteria for this process, and the overview
team reached consensus on the criteria and the ’cutoffs’ within these criteria through discussion involving Professor Wiffen, who has
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considerable expertise in this area. We acknowledge that selection of different methodological criteria, or cutoffs within these criteria,
will have impacted GRADE levels allocated to evidence within this overview. The ’weightings’ that our methods gave to different
methodological criteria were considered in detail by the review team, and care was taken to ensure that the resultant objectively
determined GRADE levels reflected overview authors’ more subjective views of the quality of the evidence.
Clearly a complex relationship exists between the criteria contributing to our judgement of quality of evidence. Pooling of data from
a large number of trials increases the number of participants but also often increases heterogeneity within the meta-analysis. Some
review authors report a decision to not combine data because of differences in populations, interventions or outcomes between trials.
This decision impacts the GRADE level of evidence, as the number of participants within pooled comparisons is reduced, and the
evidence is more likely to be downgraded on the basis of numbers of participants. However, we argue that it is clearly appropriate
to downgrade this evidence, as consequently it arises from only small numbers of participants (generally single trials), and the review
authors have identified differences between available single trials. Thus, it is clear that pooling of data from a large number of trials
results in evidence that is downgraded if heterogeneity is substantial, but similarly if the data are not pooled to avoid heterogeneity,
the evidence is downgraded to reflect the small participant numbers. Therefore, we believe that our criteria appropriately reflect issues
associated with quality of the evidence.
Appendix 5. Applicability of evidence: additional discussion points
Within this overview, in addition to variations in participants, interventions, setting and context, we specifically found that the dose of
interventions, outcomes and comparisons were central to the assessment of potential applicability of evidence.
Dose of interventions
Dose of intervention is likely to impact effect size, and it is likely that a specific minimum dose will be required to result in a change in
outcomes. The necessary dose has not been established, and we cannot be certain that the dose of intervention delivered within RCTs
was sufficiently high. Consequently, evidence of ’no benefit or harm’ may be a product of insufficient dose rather than of an ineffective
intervention.
Outcomes
We defined our primary outcome measure as upper limb function, and measures of upper limb impairment and ADLs as secondary
outcomes. We clearly defined and pre-stated which outcome measures we would categorise under each of these headings. However,
inconsistencies in the terminology used in relation to categorisation of outcome measures within both reviews and trials add complexity
to the interpretation of evidence. For this overview, we pre-stated that the Fugl-Meyer Assessment would be classed as a motor
impairment scale. However, in several reviews and trials, the Fugl-Meyer Assessment is referred to as a measure of ’upper limb function’
(e.g. Laver 2013). Although these differences in terminology do not impact the quality of the evidence, or directly affect the applicability
of evidence, the potential for confusion in relation to interpretation of these terms is clear. However, in some cases, reviews pool several
outcome measures, and the details of the specific measures are unclear; in these cases, there is the potential for misinterpretation, and
it is possible that we may have inadvertently wrongly categorised some outcome measures owing to inconsistencies in the terminology
used to define measures of upper limb function and impairment.
Comparisons
Huge diversity has been noted in the comparison interventions provided within RCTs included in the reviews, as well as variation
in relation to which comparison interventions have been pooled together. Some reviews pool together trials with comparison groups
comprising no treatment, standard care or alternative active intervention, whilst others explored these as separate subgroups. Clearly
there is a difference between evidence of a beneficial effect of an intervention in comparison with no treatment, and evidence of a
beneficial effect of an intervention in comparison with an equivalent dose of conventional or alternative treatment. Similarly, if evidence
of no benefit or harm of an intervention is found in comparison with a dose-matched conventional intervention, this is very different
from evidence of no benefit or harm when compared with no treatment or with an intervention of a lesser dose. We have attempted to
describe the comparison groups when describing available evidence; however, these are poorly described in some reviews, limiting our
ability to draw conclusions. It is important that the comparison group is carefully considered when available evidence of effectiveness
of any intervention is reviewed. Central to this must be consideration of the dose of the comparison group; ideally the dose of an
intervention will be equivalent to the dose of the comparator (with the exception of trials investigating dose per se).
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Furthermore, some reviews have extracted data from the control arm of a study to accumulate data for their intervention of interest;
consequently, the comparison group may comprise an active, perhaps novel, intervention. This may affect differences between review
subjects and review comparators in an uncontrolled manner, and again it is essential that this is considered when available evidence is
reviewed.
Appendix 6. Characteristics of Veerbeek 2014
Review Veerbeek 2014
Intervention Physical therapy
Date of search June-August 2011
Objective “The aim of this systematic review was to provide an update of the
evidence for stroke rehabilitation interventions in the domain of
PT.” “The first aim of the present systematic review was to update
our previous meta-analyses of complex stroke rehabilitation inter-
ventions in the domain of physical therapy, based on RCTs with
a low risk of bias (i.e. a moderate to good methodological quality)
with no restrictions to the comparator.” “The second aim was to
explore whether the timing of interventions poststroke moderated
the main effects”
Types of studies included “RCT including those with a two-group parallel, multi-arm par-
allel, crossover, cluster, or factorial designs.” Quantitative analyses
included only RCTs with a PEDro score greater than or equal to 4
Participants included Patients with stroke (study had to exclusively include stroke pa-
tients, over 18 years old)
Interventions included 53 interventions identified: These included all aspects of physical
therapy; “physical therapy interventions for the rehabilitation of
patients with stroke were divided into: (1) interventions related to
gait and mobility-related functions and activities, including novel
methods focusing on efficient resource use, such as circuit class
training and caregiver mediated exercises; (2) interventions related
to arm-hand activities; (3) interventions related to activities of daily
living; (4) interventions related to physical fitness; and (5) other
interventions which could not be classified into one of the other
categories. In addition, attentionwas paid to (6) intensity of practice
and (7) neurological treatment approaches”
Interventions relevant to this overview are classed as related to arm-
hand activities. 23 interventions were related to arm-hand activities
Comparisons included Usual care, another intervention, the same intervention with a dif-
ferent dose or no intervention
Outcomes Outcomes that “belonged to the domain of physical therapy” re-
ported in the included RCTs were included
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Number of studies included (number of participants included) 467 (25,373). 224 trials were classed as ’arm-hand activities’
mAMSTAR question Veerbeek 2014
1.1 Were review subjects clearly defined? Y
1.2 Were review interventions described? Y
1.3 Were review comparisons specified? Y
1.4 Were review outcomes specified? Y
2.1 Were studies assessed for inclusion by 2 independent review
authors?
N
2.2 Was data extracted by 2 independent review authors? N
2.3 Was there a clear procedure for resolving disagreements? N/A
3.1 Were at least 2 major databases searched? Y
3.2 Were search dates reported? Y
3.3 Were key words stated? Y
3.4 Were MeSH terms stated? Y
3.5 Was the search strategy provided or available on request? Y
3.6 Were searches supplemented by consulting current contents,
reviews, textbooks, specialised registers or experts in the par-
ticular field of study, and by reviewing references in the studies
found?
Y
4.1 Were studies searched for and included regardless of their pub-
lication type?
U
4.2 Were papers included regardless of language of publication? N
5.1 Was a list of included studies provided? Y
5.2 Was a list of excluded studies provided? N
5.3 Was a flow diagram presented? Y
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6.1 Were details provided on the participants of included studies
(including age, gender, severity of stroke, time since stroke)?
N
6.2 Were details provided on the interventions of included studies? N
6.3 Were details provided on the outcomes reported by included
studies?
N
7.1 Was the scientific quality of included studies assessed? Y
7.2 Was this done by at least 2 independent reviewers? Y
7.3 Was the scientific quality of studies documented? N
8.1 Were results on the methodological rigour of the included
study considered in the analysis of the review?
Y
8.2 Were results on the scientific quality of included studies con-
sidered in the conclusions and/or recommendations of the re-
view?
Y
9.1 Were methods used to combine the findings of studies clearly
described and/or referenced to appropriate text?
Y
9.2 If results are pooled, is a test of heterogeneity reported? Y
9.3 Have the authors stated a definition of statistical heterogene-
ity?
Y
9.4 If heterogeneity is present or suspected, has a random-effects
model been used?
Y
10.1 Was the likelihood of publication bias assessed? N
11.1 Was a conflict of interest statement provided? Y
11.2 Was the review free of conflicts of interest? Y
Original AMSTAR questions Veerbeek 2014
1. Was an ’a priori’ design provided? The research question and
inclusion criteria should be established before the conduct of the
review
y
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2. Was there duplicate study selection and data extraction? There
should be at least two independent data extractors and a consensus
procedure for disagreements should be in place
n
3. Was a comprehensive literature search performed? At least two
electronic sources should be searched. The report must include
years and databases used (e.g. CENTRAL, EMBASE, MED-
LINE). Key words and/or MeSH termsmust be stated and, where
feasible, the search strategy should be provided. All searches should
be supplemented by consulting current contents, reviews, text-
books, specialised registers or experts in the particular field of
study, and by reviewing the references in the studies found
y
4. Was the status of publication (i.e. grey literature) used as an
inclusion criterion? The review authors should state that they
searched for reports regardless of their publication type. The re-
view authors should state whether or not they excluded any reports
(from the systematic review), based on their publication status,
language, etc
n
5. Was a list of studies (included and excluded) provided? A list
of included and excluded studies should be provided
n
6. Were the characteristics of the included studies provided? In
an aggregated form such as a table, data from the studies should
be provided on the participants, interventions and outcomes. The
ranges of characteristics in all the studies analysed (e.g. age, race,
sex, relevant socioeconomic data, disease status, duration, severity,
other diseases) should be reported
n
7. Was the scientific quality of the included studies assessed and
documented? ’A priori’ methods of assessment should be provided
(e.g. for effectiveness studies if the author(s) chose to include only
randomised, double-blind, placebo-controlled studies, or alloca-
tion concealment as inclusion criteria); for other types of studies,
alternative items will be relevant
n
8. Was the scientific quality of the included studies used appro-
priately in formulating conclusions? The results of the method-
ological rigour and scientific quality should be considered in the
analysis and the conclusions of the review, and explicitly stated in
formulating recommendations
y
9. Were the methods used to combine the findings of studies
appropriate? For the pooled results, a test should be done to ensure
the studies were combinable, to assess their homogeneity (i.e. Chi
2 test for homogeneity, I2). If heterogeneity exists, a random-
effects model should be used and/or the clinical appropriateness
y
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of combining should be taken into consideration (i.e. Is it sensible
to combine?)
10. Was the likelihood of publication bias assessed? An assessment
of publication bias should include a combination of graphical aids
(e.g. funnel plot, other available tests) and/or statistical tests (e.g.
Egger regression test)
n
11.Was the conflict of interest stated? Potential sources of support
should be clearly acknowledged in both the systematic review and
the included studies
y
C O N T R I B U T I O N S O F A U T H O R S
All overview authors contributed to the development ofmethods proposedwithin the protocol. The protocol waswritten by Alex Pollock
and Sybil Farmer, and was read and commented on by all other overview authors. All overview authors contributed to methodological
decisions related to development of the mAMSTAR and the objective algorithm used to determine GRADE quality of evidence. Alex
Pollock led this overview, identified relevant reviews, assessed the quality of reviews using mAMSTAR, assessed the quality of evidence
within reviews, extracted data, provided methodological and content expertise and wrote all final drafts. Sybil Farmer ran searches,
identified relevant reviews, assessed the quality of reviews using mAMSTAR, assessed the quality of evidence within reviews, extracted
data, entered data, provided content expertise and read and commented on overview drafts. When disagreement arose between Alex
Pollock and Sybil Farmer in relation to review inclusion or quality assessment, this was resolved through discussion involving Frederike
van Wijck. Frederike van Wijck, Marian Brady, Peter Langhorne, Gillian Mead and Jan Mehrholz provided additional content and
methodological expertise, contributed to assessment of review quality using the mAMSTAR and read and commented on overview
drafts.
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Sybil E Farmer: has an interest in using published evidence to improve the management of contractures after stroke and is exploring
this with colleagues through a systematic review with a recently approved protocol.
Marian C Brady: received a small consultancy fee paid to employer from Genentech in respect of time spent on a research project
investigating the properties of EQ5-D.
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N O T E S
Definition of ’dose’
Rehabilitation can be delivered at different intensities and frequencies and for different durations; these three concepts are commonly
referred to as the ’dose’ of rehabilitation (Bosch 2014; Kwakkel 2006), although definitions of these terms may be inconsistent (Page
2012). Often ’dose’ is described in terms of (1) time (including minutes per session; sessions/d/wk and number of days/wk) and (2) effort
(often described in terms of amount of work or power) (Cooke 2010; Kwakkel 2006). Agreement regarding definitions of frequency
and duration, quantified in time, is common, but less agreement is seen regarding definitions and measurements of intensity (Bosch
2014). For this overview, we use the term ’dose’ to refer to the intensity (effort), frequency and duration (time) of an intervention,
with reference to definitions recommended by the American Congress of Rehabilitation Medicine Stroke Movement Interventions
Subcommittee (Page 2012) as follows.
• Intensity: “the amount of physical or mental work put forth by the client during a particular movement or series of movements,
exercise or activity during a defined period of time.”
• Duration: “the length of time during which a single session is administered (measured in minutes, but other units of
measurement can also be used).” Can also describe “the total amount of time that an intervention period occupies.”
• Frequency: “how often during a fixed period the regimen is administered (e.g. how many times per week a patient is
administered a particular regimen).”
Determining when a review is out-of-date
There is no simple formula for determining when an individual review is out-of-date and requires updating, as many factors influence
the need to update. These factors include the priority placed on the topic of the review, the current evidence base, the state of any
technology involved and the likelihood of new trials. However, to ensure consistency of terminology within this overview, when a
review search date was more than five years previous (before May 2009), we described this review as ’out-of-date,’ and when a review
search date was more than 10 years previous (before May 2004), we described this review as ’considerably out-of-date.’ Nevertheless,
judgement of the need to update a review must include consideration of the factors described above and should not be based only on
the date of the last search.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Imagination; ∗Recovery of Function; ∗Robotics; ∗Stroke Rehabilitation; ∗Upper Extremity; Activities of Daily Living; Exercise Move-
ment Techniques [∗methods]; Exercise Therapy [∗methods]; Review Literature as Topic; Therapy, Computer-Assisted [methods]
MeSH check words
Humans
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